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ABSTRACT 
 
A QUALITATIVE STUDY OF COUNSELING STUDENTS’ ATTITUDES TOWARD THE 
USE OF MEDICATION ASSISTED TREATMENTS WITH OPIOID DEPENDENT CLIENTS 
 
 
 
 
By  
Bethany L. Ackerman 
 
Dissertation supervised by Dr. William Casile 
Counseling students’ perceptions of medication assisted treatment for opioid addition was 
explored.  This study sought to understand how the students’ attitudes and beliefs regarding the 
use of medication assisted treatments developed, and also how these attitudes and beliefs may 
affect client care and professional career choices.  Specifically, this study examined how their 
professional counselor education experiences played a role in the formation/development of 
these attitudes and beliefs. 
This qualitative study was conducted with six counseling students who participated in 
semi-structured, individual interviews.  At the time of the study, all of the students were 
currently enrolled in a CACREP-accredited counselor education program and were currently 
participating in their fieldwork experience.  The data was analyzed using Thematic Analysis 
informed by Cognitive Behavioral Theory in order to determine how students’ educational 
 v 
experiences and personal experiences affect the development of their attitudes and beliefs 
regarding the use of medication assisted treatment for the treatment opioid dependence and the 
clients who use this treatment option.   This study found that the students’ perceptions of clients 
who chose medication assisted treatment appeared to be influenced by their perception of 
medication assisted treatment as formed in response to both their professional education and 
their personal experiences.  Specifically, it appears that the participants’ limited exposure to 
medication asisted treatment during their formal education and training negatively affected their 
perception of medication assisted treatment as a treatment modality.  However, this study also 
found that their attitudes toward MAT did not appear to negatively impact students’ attitudes 
toward providing care and treatment for these clients.  The potential implications for practice and 
suggestions for future research are provided. 
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CHAPTER I:  INTRODUCTION 
 Opioid dependence is an increasing epidemic in the United States, and recently resulted 
in the current United States President declaring the opioid epidemic a national public health 
emergency (Merica, 2017). Despite this declaration, there continues to be limited treatment 
options to address the growing opioid epidemic. There are currently two primary treatment 
options: abstinence-based treatment and medication assisted treatment, which is also known as 
harm reduction.  Two of the more common medication assisted treatment options are Methadone 
and Suboxone.  
Approximately two million people in the U.S. are dependent on or abuse opioids, 
including heroin and prescription opioids. Of these two million, it is estimated that 
approximately 21 to 25% of all substance abusers have been involved in Methadone treatment 
and an additional 32,000 individuals have received Suboxone treatment for opioid dependence 
(Substance Abuse and Mental Health Services Administration, Center for Behavioral Health 
Statistics and Quality, 2013).  Methadone has long been recognized as an effective treatment for 
opioid dependence (Schwartz, et al., 2008; Aletraris, Edmond, Paino, Fields, & Roman, 2016).  
Methadone is used to prevent withdrawal symptoms for opioid dependent individuals and so that 
the clients no longer experience peaks of euphoria or the adverse effects of withdrawal once they 
are stabilized on Methadone (Douaihy & Kelly, 2013). In addition to Methadone, Suboxone is a 
more recently developed treatment for opioid dependence that was approved by the U.S. Food 
and Drug Administration (FDA) for office-based treatment of opioid dependence in 2002.  
Suboxone was developed in part due to the need for an alternative medication that did not have 
the strict laws and treatment regulations associated with Methadone (Jaffe & O’Keefe, 2003; 
Walsh & Eissenberg, 2003).  
 2 
Despite the addiction statistics noted above, counselor education programs accredited by 
the Council for Accreditation of Counseling and Related Educational Programs (CACREP) 
continue to provide limited education to counseling students regarding substance abuse 
treatment, and in particular regarding medication assisted treatment.  The CACREP requirements 
do not require that students be taught about medication assisted treatment specifically.  With the 
growing opioid epidemic, however, this lack of educational exposure exposes a potential 
weakness, as counseling students are more likely to see clients addicted to opioids than ever 
before.  Additionally, by not exposing students to the medication assisted treatment modality, 
programs increase the likelihood of maintaining underlying stigma and limiting the number of 
counselors available to treat clients with opioid dependence.  Despite CACREP not requiring 
specific additions to education, approximately 82% of CACREP programs have incorporated 
substance abuse training into their curriculum.   However, only 30% require students to take one 
or more courses in substance abuse training. (Whittinghill, Carroll, & Morgan, 2004)   Within 
these substance abuse courses, approximatley 24% of students were taught about Methadone and 
5% were educated about Suboxone in their respective counseling program (Madison, Bethea, 
Daniel, & Necaise, 2008).   
Students’ limited educational exposure to addictions and medication assisted treatment 
specifically has the potential to affect their perception of this treatment modality and the clients 
who choose to use this treatment option.  The negative attitudes of providers towards the use of 
medications used to treat opioid dependence have been identified as a potential barrier for 
treatment by professionals and clients (Smye, Browne, Varcoe, & Josewski, 2011).  Clients in 
Methadone Maintenance Treatment (MMT) report that they often feel misunderstood, looked 
down upon, and stigmatized by addictions counselors (Conner & Rosen, 2008).  Even though 
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evidence-based treatment for Methadone and Suboxone has been proven effective for the 
treatment of opioid dependence, the use of these medications remains a point of contention 
among providers (Matusow, et al., 2013; Fitzgerald & McCarty, 2009; Atlas, 1982).     
This disagreement, and the conflicting opinions and attitudes among counselors regarding 
the use of medication for the treatment of opioid dependence, have significant consequences for 
the client with an addiction to opioids who is seeking treatment.  Development of negative 
professional attitudes toward the efficacy of using these types of medications, even in light of the 
evidence to support their efficacy, may affect a client’s willingness to enter treatment, 
development of the therapeutic relationship, the personal self-perception of the client, and the 
therapist’s perception of the client (Conner & Rosen, 2008; Hunt, Lipton, Goldsmith, Strug, & 
Spunt, 1985-86).  This study seeks to explore the origin and development of counselors’ attitudes 
and beliefs towards the use of medication assisted treatment.  
Statement of the Problem 
Counselors who treat individuals prescribed medication assisted treatments may have 
varying views about the medications despite the research supporting their effectiveness 
(Knudsen, Ducharme, Roman, & Link, 2005; Rieckmann, Daley, Fuller, Thomas, & McCarty, 
2007; Fitzgerald & McCarty, 2009; Rieckmann, Kovas, McFarland, & Abraham, 2010).  While 
the thoughts and beliefs regarding the use of medication assisted treatment have been reported 
for counselors and other healthcare providers who provide medication assisted treatment, 
(Conner & Rosen, 2008; Knudsen, Ducharme, Roman, & Link, 2005; Rieckmann, Daley, Fuller, 
Thomas, & McCarty, 2007; Fitzgerald & McCarty, 2009; Rieckmann, Kovas, McFarland, & 
Abraham, 2010), there is a lack of research regarding the attitudes and beliefs of counseling 
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students towards this treatment approach.  As a result, there is an inadequate understanding of 
the relationship between counseling students’ experiences and how they might develop either 
positive or negative attitudes and beliefs surrounding the use of medication assisted treatments as 
part of a treatment protocol for opioid addicitions.  Futhermore, little is known about the 
implications these attitudes and beliefs have on the behaviors of these counselors in their 
treatment practices.  
 While many factors may have influenced where or how such perceptions developed, it is 
possible that limited education about or exposure to the use of these medications can play a 
significant role in the counseling student’s development of negative attitudes and bias against the 
use of this approach to addiction treatment.  The 2016 Council for Accreditation of Counseling 
and Related Educational Programs (CACREP) standards are vague in their requirements for 
addictions and counseling education; the requirements appear to be dependent on the specialty or 
major within a counselor education program.  The standards for the Clinical Mental Health and 
School Counseling specialties only briefly mention addictions while the Marriage, Couple, and 
Family Specialty does not mention addiction education as part of the curriculum requirements.  
None of the specialties specifically address harm reduction education, or in particular medication 
assisted treatment, as being a required topic in the education of counselors. (Council for 
Accrediation of Counseling and Related Educational Programs, 2015).  Additionally, there 
appears to be a lack of literature regarding the perceptions of counseling students and counseling 
professionals’ attitudes and beliefs about the use of medication assisted treatment for the 
treatment of opioid dependence and how it affects outcomes for individuals seeking recovery 
from opiate addiction.  This failure to ensure that these topics are adequately addressed in the 
counselor-in-training’s professional preparation may contribute to their limited knowledge and 
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may negatively influence their beliefs and attitudes about harm reduction programs.  Also, this 
lack of educational experiences regarding this treatment modality may have implications for how 
treatment is provided and, eventually, the client’s success. 
The treatment of addictions is a complex and long-term process that often requires many 
years of various types of treatments before recovery can be achieved.  A significant factor that 
has been shown to influence the efficacy of a treatment modality is the therapeutic relationship 
(Conner & Rosen, 2008; Hunt, Lipton, Goldsmith, Strug, & Spunt, 1985-86).  While the 
thoughts and beliefs regarding the use of prescription Methadone and Suboxone have been 
reported for counselors who provide medication assisted treatment, the lack of research on the 
attitudes and beliefs of counseling students towards this treatment approach presents a gap in 
developing an understanding of the development of these attitudes and beliefs.  Additionally, it is 
unclear if and how educational experiences affect the development of positive or negative beliefs 
towards the use of medication assisted treatment for the treatment of opioid dependence, and the 
implications these attitudes and beliefs have on the behaviors of counselors’ career choices and 
treatment practices is also unclear.   
Purpose and Research Questions 
The purpose of this qualitative study is to examine, describe, and understand how the 
attitudes and beliefs of counseling students regarding the use of medication assisted treatments 
develop and how these attitudes and beliefs may affect client care and professional career 
choices.  This study will specifically examine how students’ professional counselor education 
experiences played a role in the formation/development of these attitudes and beliefs. 
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A thorough review of the literature related to the development of attitudes and beliefs of 
counseling students toward the use of medication assisted treatment for opioid addicted clients 
revealed a dearth of research activity.  Therefore, the primary research questions that guide this 
study are:  
1. “What are the attitudes and beliefs of counseling students towards clients who use 
medication assisted treatments for the treatment of opioid dependence?”   
2. “How do the attitudes and beliefs of counseling students regarding the use of 
medication assisted treatments for the treatment of opioid dependence affect their perceptions of 
individuals using these treatment options?”   
3. “How do pre-professional counselor education experiences affect the attitudes and 
beliefs of counselors regarding the use of medication assisted treatments as a treatment option?”   
4. “What other experiences influence the counselor-in-training’s development of attitudes 
and beliefs towards clients who use medication assisted treatments as a treatment option?”   
5. “How do these attitudes and perceptions influence the counselor’s provision of client 
care?”   
6. “How do these attitudes and perceptions influence the counselor’s professional career 
choices?”   
Significance of the Study 
There have been several studies that analyze the attitudes and beliefs of counselors who 
treat clients using medication assisted treatments; however, there is a limited understanding of 
the development of these attitudes and beliefs and how students’ educational experiences may 
have contributed to these developments.  This study is significant because it will provide insight 
into the development of these attitudes and beliefs, and how students’ personal and educational 
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experiences may have positively or negatively affected their attitudes and beliefs towards the use 
of medication assisted treatments as a treatment option, as well as their career choices and 
treatment practices. 
The examination of the development of the attitudes and beliefs of counseling students 
and how their educational experiences may have contributed to these developments will allow 
for a better understanding of how counselor training programs affect the attitudes and beliefs of 
counseling students regarding the use of medication assisted treatments as a treatment option.  
Additionally, examining these attitudes and beliefs will assist the counseling community in 
understanding any stigma that exists around the use of medication assisted treatments and aid in 
developing ways to assist counselors in overcoming any possible negative beliefs towards the 
use of these treatment options. 
Theoretical Framework  
This study uses the basic principles of Cognitive Behavioral Theory to understand human 
behavior.  In Cognitive Behavioral Theory, the stimulus influences the development of thoughts 
and feelings, which then affect behaviors (National Alliance on Mental Illness, 2014).  This 
theory as applied in this study suggests that the stimulus, a client addicted to opioids who uses 
medication assisted treatments as part of a treatment protocol, stimulates thoughts and feelings in 
the counselor who, based on these thoughts and feelings, will form attitudes and beliefs that will 
in turn influence their behavior toward the client and in their career decision-making process.  
The beliefs and attitudes of counseling students regarding individuals who are either 
enrolled in or have previous experience with medication assisted treatments can influence their 
professional experience as a counselor by influencing how they treat clients in the medication 
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assisted treatment programs.  The attitudes and beliefs counseling students develop about a 
particular treatment modality could also limit their career choices and employment opportunities.  
If their attitudes and beliefs about the use of medication assisted treatments are negatively 
biased, a counseling student may not be able to work effectively with clients engaged in these 
types of addictions treatment.  Furthermore, they may choose not to work in therapeutic 
situations where they would be required to work with clients in medication assisted treatment 
programs, thus limiting their career opportunities.  If counselors develop inaccurate and negative 
perceptions of the use of medication assisted treatments for the treatment of opioid dependence, 
they may behave differently towards individuals who have chosen this form of treatment 
protocol or they may avoid working with this client population altogether, again limiting their 
career opportunities.  
This study examined the underlying thoughts and feelings counseling students had in 
response to clients using medication assisted treatments for opioid dependence as well as the 
treatment modality.  By exploring and understanding how counseling students develop attitudes 
and beliefs toward clients who have chosen to use medically assisted treatment approaches, this 
study will help to illuminate how these participants’ responses to such clients might impact their 
career choices and their ability to form effective therapeutic relationships and provide 
appropriate treatment.  
Summary of Methodology  
This study is a qualitative study designed to explore the attitudes and beliefs that 
counseling students develop regarding the use of medication assisted treatments as a treatment 
option for opioid dependence.  An individual’s experiences and interpretations become 
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intertwined into one and, until an individual brings these experiences to conscious awareness, it 
is difficult to understand how such experiences affect their worldview and, in essence, their 
attitudes and beliefs towards a particular phenomenon (Patton, 2002).  A qualitative study 
focuses on the meaning people make of their experiences and how that process influences their 
behavior (Creswell, 2013).  This study explores how counseling students’ personal and 
educational experiences with the medically assisted treatment might influence their treatment 
and career decision-making process.   
Definitions of Key Terms 
Addict:  A person who meets the DSM V criteria for Substance Use Disorder or Opioid Use 
Disorder.   
Counselor-in-training:  In this study, a counselor-in-training must be in the process of 
completing a master’s or doctoral degree in counselor education from a CACREP accredited 
program and currently enrolled in their fieldwork experience. 
Client or individual in treatment:  A person who is addicted to opioids and is currently or has 
used Methadone or Suboxone as part of a medication assisted treatment.   
Medication Assisted Treatment (MAT):  Medication assisted treatment, also known as harm 
reduction treatment, is a method of addictions treatment that uses medication to assist an opioid 
dependent individual in obtaining and maintaining abstinence from opioids.  For the purposes of 
this study, medication assisted treatment will be limited to treatment that uses prescription 
Methadone and Suboxone to assist opioid dependent individuals in obtaining and maintaining 
abstinence. 
 10 
Methadone:  Methadone is an opioid blocker used for the treatment of opioid dependence.  It is 
dispensed as a pill or liquid.  Methadone is available legally by prescription from a specially 
trained physician and is usually dispensed in a clinic or at a private practice. 
Suboxone:  Suboxone, also known as Buprenorphine, is a prescription medication combination 
of buprenorphine and naloxone, which is used for the treatment of individuals addicted to 
opiates.  It is dispensed as a pill or a sublingual film, and usually prescribed by a specially 
trained physician as part of a private practice or as a part of group practice or in a clinic. 
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CHAPTER II:  REVIEW OF THE LITERATURE 
Introduction 
 The opioid epidemic continues to increase rapidly.  Despite an elevated awareness of the 
problem, however, there continues to be limited understanding of the overall problem and the 
treatment options available to individuals affected by opioid dependence.  This section will 
explore the relevant literature related to opioid dependence in the United States, available 
treatment options, stigma, and the current educational standards of CACREP accredited 
universities, as well as how it all applies to this study. 
Opioid Dependence in the United States 
The growing epidemic of opioid dependence in the United States continues to be a 
problem that affects all aspects of an addicted individual’s life and treatment.  According to the 
Substance Abuse and Mental Health Administration (SAMHSA), the number of individuals in 
the U.S. who used heroin alone increased from 373,000 users in 2007 to 669,000 users in 2012 
(Substance Abuse and Mental Health Services Administration, Center for Behavioral Health 
Statistics and Quality., 2013; Jaslow, 2013).  It is estimated that approximately two million 
people in the U.S. are dependent on or abuse opioids, including heroin and prescription opioids. 
Of these two million, it is estimated that, in 2011, approximately 21 to 25% of all substance 
abusers in treatment received Methadone; or, approximately 306,000 individuals were involved 
in Methadone treatment for opioid dependence.  An additional 32,000 individuals received 
Suboxone treatment from either a private Suboxone prescribing doctor or a treatment program 
for opioid dependence (Substance Abuse and Mental Health Services Administration, Center for 
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Behavioral Health Statistics and Quality, 2013).  With the growing availability of Suboxone 
treatment, it is likely these numbers have since increased. 
Due to the large numbers of opioid dependent individuals in the United States, opioid 
dependence has a significant impact on the social, medical, and economic situation in the United 
States (Mark, Woody, Juday, & Kleber, 2001; Rosenheck & Kosten, 2001).  According to a 
study by Mark, Woody, Juday, & Kleber (2001), it was estimated that the annual cost of heroin 
addiction was, at best guess, between $19.6 to $33.4 billion U.S. dollars in 1996.  This estimate 
includes the cost of unemployment, lost productivity, incarceration, crime, policing, legal 
services, social services, substance abuse treatment, and medical treatment.  Of this estimated 
amount, approximately $862 million was spent on substance abuse treatment and approximately 
23% (or $4.5 billion) was spent on healthcare costs.  One can assume that this amount was 
significantly higher in 2016 due to the ever-increasing costs of healthcare services, addictions 
treatment, and inflation.  With the large numbers of individuals involved in treatment and the 
extensive financial costs of treating these individuals, there is also an increased need for an 
understanding of the providers and their attitudes towards the effectiveness of treatment.  Based 
on the personal, social, and economic costs involved in the epidemic, it is likely that counselors 
in every aspect of the counseling community have encountered in their practice someone with 
addiction.  
In addition to the high cost of addiction, there is the high risk of potential overdose and 
death to be considered.  In 2007, there were approximately 27,000 unintentional drug overdoses 
in the United States.  Since 2003, more overdose deaths have involved opioid analgesics than 
heroin and cocaine combined.  This can be partially accounted for by an increase in the number 
of prescriptions for a class of prescription drugs called opioid analgesics.  A majority of health 
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care providers receive minimal education regarding addiction and might indecently prescribe 
drugs that contribute or encourage addiction (Paulozzi, et al., 2012).  While a lack of education 
may be contributing to these statistics, the stigma related to addiction and addiction treatment is 
another possible factor involved in these statistics.  
While the risk of overdose is great with heroin and prescription drugs, if Methadone or 
Suboxone is used for addiction treatment, the risk of overdose decreases.  Methadone and 
Suboxone treatments protect against death by overdose in heroin addicts.  Additionally, the 
majority of Methadone and Suboxone overdoses that do occur are not due to legally prescribed 
prescriptions, but to those obtained as a result of diversion (Bell, Butler, Lawrance, Batey, & 
Salmelainen, 2009).  
Treatment Options For Opioid Dependence 
  While there have been multiple attempts made to manage addiction in general, the 
severity of and unique challenges associated with opioid dependence have generated specific 
treatment responses.  In addition to the more general approaches to addiction, such as abstinence-
based counseling and self-help support groups, specialized harm reduction techniques, including 
medication assisted treatment, have been developed as treatment options for opioid addicted 
clients.  The main difference between abstinence-based treatment and harm reduction treatment 
is found in their separate definitions of progress.  In abstinence-based treatment, the goal is to 
maintain complete abstinence from the addictive substance.  In harm reduction programs, the 
goal is to decrease the risk to the client and decrease their amount of overall use while they 
continue to explore the negative consequences of their behavior.  
 14 
One type of harm reduction program is a needle exchange program.  Needle exchange 
programs were developed in the mid-1980s to stop the spread of blood-borne illnesses such as 
HIV and Hepatitis C among IV drug users.  In addition to providing individuals the opportunity 
to exchange used needles for sterile needles, they may offer referrals to other treatment options 
(Logan & Marlatt, 2010).  Woodak and Cooney (2006) conducted a comprehensive review of 
over 45 studies, from 1989 to 2002, and found that these programs are a safe, effective, and cost-
effective option.  Despite their being proven to be an effective option, however, the United States 
federal government implemented a ban on federal funding being used to support these programs.  
As a result of the increasing opioid epidemic, the ban was lifted in 2016, which allowed agencies 
to seek federal funding to cover some of their administrative costs, but not the syringes 
themselves (Ungar, 2016). 
Safe injection sites for illegal drugs is another harm reduction approach.  At these 
locations, opioid dependent individuals can use clean equipment and inject their own drugs while 
having access to medical personnel and referrals to treatment options.  There are approximately 
100 safe injection sites operating in the world, and mainly in European countries where they are 
frequently publicly funded (Logan & Marlatt, 2010); Drug Policy Alliance, 2018).  Despite this 
being a practice which is relatively accepted in European countries, there are currently no 
publicly funded safe injection sites in the United States, where this topic continues to be a 
controversial subject.  In 2017, Seattle, Washington announced plans to develop the nation’s first 
safe injection sites; however, to date, it has not occurred (Whelan, 2018).  
Medication assisted treatment is another form of harm reduction treatment.  In 
medication assisted treatment, an individual is given a medication to assist with the effects of 
opioid dependence and withdrawal.  Two of the most common MAT approaches are Methadone 
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and Suboxone treatments.  These two forms of treatment have been proven to be safe and 
effective treatment options for opioid dependence (Schwartz, et al., 2008; Aletraris, Edmond, 
Paino, Fields, & Roman, 2016). 
Stigma and Methadone 
Methadone was first used in the treatment of opioid addiction more than 40 years ago.   
The purpose of Methadone is to prevent withdrawal symptoms for opioid dependent individuals 
and help clients avoid experiencing peaks of euphoria or the adverse effects of withdrawal once 
they are stabilized on Methadone (Douaihy & Kelly, 2013).  It has long been recognized as an 
effective treatment for opioid dependence (Schwartz, et al., 2008; Aletraris, Edmond, Paino, 
Fields, & Roman, 2016).  It has also been associated with lower crime rates, increased 
employment, and decreased medical co-morbidities (Rosenblum, Magura, & Joseph, 1991).  
Despite Methadone being recognized as an effective treatment, however, a study by Aletraris, 
Edmond, Paino, Fields, & Roman (2016) found that approximately 20% of counselors were 
unfamiliar with its effectiveness.  Methadone was also perceived by the counselors in this study 
to be the least desirable of the available MATs.     
Since Methadone first came into use, it has had a love-hate relationship with many areas 
of society, including addicts, addiction professionals, the medical community, and the legal 
community.  In the legal community, the most common reason that Methadone is not offered as a 
treatment option in court is because it is not permitted or endorsed by the courts.  In some cases, 
as many as 52% of courts have not supported Methadone as a treatment option for opioid 
dependent individuals (Matusow, et al., 2013).  Many individuals see methadone as a drug 
substitute and a crutch that does not allow individuals to fully recover from their addiction.  This 
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belief often contributes to individuals in treatment feeling ostracized by their family, friends, 
peers, and treatment providers, and this feeling of being ostracized by others often creates a 
barrier to treatment (Matusow, et al., 2013; Humphreys, Noke, & Moos, 1996; Schwartz, et al., 
2008; Conner & Rosen, 2008; Kayman, Goldstein, Deren, & Rosenblum, 2006).  
Additionally, Methadone is perceived by some addicts in the drug community to be an 
easy way out or inferior to being on the street.  There are several myths, elements of 
misinformation, and misperceptions regarding the use of Methadone, all of which influence 
access to treatment (Hunt, Lipton, Goldsmith, Strug, & Spunt, 1985-86).  One of the largest 
influences on treatment is the stigma associated with entering Methadone treatment.  Stigma has 
a large impact on the emotional and psychological well-being of an individual.  It also has a 
significant impact on the recovery efforts of individuals dealing with addiction (Earnshaw, 
Smith, & Copenhaver, 2013; Fitzgerald & McCarty, 2009; Conner & Rosen, 2008; Matusow, et 
al., 2013; Hunt, Lipton, Goldsmith, Strug, & Spunt, 1985-86).   
The sources of stigma for individuals in Methadone treatment are often multi-layered.  
The individual often faces stigma from family members, peers, courts, employers, health care 
workers, society in general, 12-step programs, and addiction treatment providers themselves 
(Earnshaw, Smith, & Copenhaver, 2013; Humphreys, Noke, & Moos, 1996; Fitzgerald & 
McCarty, 2009; Conner & Rosen, 2008;  Rieckmann, Daley, Fuller, Thomas, & McCarty, 2007; 
Hunt, Lipton, Goldsmith, Strug, & Spunt, 1985-86).  Many of these stigmas are based on 
society’s overall perception of drug use in general and not necessarily on Methadone treatment.  
Some of these stigmas include the belief that Methadone addicts are simply substituting one drug 
for another, unemployed, and on welfare, and without any desire to enter recovery.   
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While society may have a negative perception of Methadone treatment, clients in 
Methadone Maintenance Treatment (MMT) report that they often feel misunderstood, looked 
down upon, and stigmatized by addiction counselors (Conner & Rosen, 2008).  Several factors 
appear to influence the acceptance of Methadone as a treatment option.  These elements include 
education level, treatment setting, and personal use history (Rieckmann, Daley, Fuller, Thomas, 
& McCarty, 2007; Humphreys, Noke, & Moos, 1996; Conner & Rosen, 2008; Caplehorn, Hartel, 
& Irwig, 1997; Aletraris, Edmond, Paino, Fields, & Roman, 2016).  This stigma also has the 
potential to influence the effectiveness of any care given.  When a person feels they are being 
stigmatized, they often are resistant to being open in regard to their concerns and behaviors, and 
this in turn effects the therapeutic relationship. 
Stigma and Suboxone 
  Stigma towards harm reduction approaches is not limited to Methadone.  Another form of 
harm reduction treatment, Suboxone, also presents with concerns about stigma.  While 
Methadone has been used to treat opioid dependence for over 40 years, Suboxone is a newer 
medication used for the treatment of opioid dependence.  Suboxone was developed in part due to 
the need for an alternative medication that did not have the complexities and strict regulations 
associated with Methadone (Jaffe & O’Keefe, 2003; Walsh & Eissenberg, 2003).  Suboxone is 
becoming a popular choice for clients seeking assistance with opioid-dependence.  The 
popularity of Suboxone over Methadone appears in part because it is often less restrictive than 
Methadone.  Suboxone can sometimes be prescribed by a doctor instead of the need for going to 
a clinic, which does not require the same level of commitment in regard to daily dosing, does not 
require the same level of counseling, and comes with less stigma then Methadone (Thomas, et 
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al., 2008; Substance Abuse and Mental Health Services Administration, Center for Behavioral 
Health Statistics and Quality, 2013).   
Suboxone was approved by the FDA for office-based treatment of opioid dependence in 
2002.  Physicians are able to prescribe Suboxone after they attend an 8-hour class and obtain a 
waiver from the Substance Abuse and Mental Health Services Administration (SAMSHA) and 
also obtain a special DEA number (Thomas, et al., 2008; Substance Abuse and Mental Health 
Services Administration, Center for Behavioral Health Statistics and Quality, 2013).  Even 
though Suboxone may be prescribed privately by a physician, it is recommended that clients also 
receive psychological counseling (Knudsen, Ducharme, Roman, & Link, 2005; Substance Abuse 
and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, 
2013).   
 Suboxone was introduced to the addictions field several decades after the introduction of 
Methadone, and hence has had the benefit of not receiving the automatic negativity Methadone 
did upon its introduction to the field (Schwartz, et al., 2008).  This has in itself been both positive 
and negative.  One of the negative effects of this lack of knowledge is that there is limited 
education among addiction professionals, counselors, and medical doctors regarding the use of 
Suboxone.  A study by Knudsen, Ducharme, Roman, & Link (2005) found that more than two-
thirds of counselors surveyed “don’t know” how to respond when asked to rate their perceptions 
of Suboxone’s effectiveness.  In another study, 20% of counselors did not know about the 
effectiveness of Suboxone despite extensive literature supporting its effectiveness (Aletraris, 
Edmond, Paino, Fields, & Roman, 2016).  Rieckmann, Kovas, McFarland, & Abraham (2011) 
also found a neutral or slightly negative view of Suboxone among counselors and clients.  
Additionally, the clients in their study seemed to be less informed or had had less experience 
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with Suboxone.  This finding indicates that limited knowledge of Suboxone may affect 
perceptions.  A positive effect of this lack of knowledge is that, among opioid dependent 
individuals, Suboxone has found a more positive perception and level of acceptance than that 
associated with Methadone (Schwartz, et al., 2008; Rieckmann, Daley, Fuller, Thomas, & 
McCarty, 2007).  Studies have also demonstrated that counselors who work in a program 
offeringSuboxone as a form of treatment appear to be more knowledgeable and supportive of 
Suboxone than counselors who do not work in these programs (Rieckmann, Kovas, McFarland, 
& Abraham, 2011; Aletraris, Edmond, Paino, Fields, & Roman, 2016).  The lack of experience 
and knowledge regarding Suboxone could negatively affect the perception and stigma of 
Suboxone as a treatment option.  Despite not having the challenges of introduction into the 
treatment field that Methadone did, Suboxone presents with its own challenges.  Since it is 
relatively newer, the literature indicates that there is a problem with acceptance and 
understanding due to a lack of familiarity with Suboxone among counselors and providers in 
general.  
Medication Assisted Treatment and CACREP Standards 
The acceptance of medication utilization in the substance abuse treatment field has been 
attributed to counselors’ levels of formal education (Forman, Bovasso, & Woody, 2001; 
Rieckmann, Kovas, McFarland, & Abraham, 2011; Fitzgerald & McCarty, 2009; Humphreys, 
Noke, & Moos, 1996).  While the level of their education is an importanant factor, the content of 
their education is also a potential variable.  When counselors are exposed to and encouraged to 
adopt evidence based practices, such as harm reduction, during their academic training, it may 
increase the possiblity of accepetace of harm reduction practices.  It has been found that formal 
training related to medication assisted treatment and employment in a program where medication 
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assisted treatment was used are the strongest predictors of counselors’ knowledge of medication 
assisted therapy (Bride, Abraham, Kintzle, & Roman, 2013).   However,  due to the lengh of 
time that Methadone has been approved by the FDA, many counselors have awareness of 
Methadone that comes from their experiences and knowledge outside of formal training.   
The lack of familiarity with medication assisted treatment may be attributed in part to the 
lack of education in counseling programs in regard to the use of harm reduction theories.  
Education about the use of medication assisted treatment is not a standard in counseling 
programs.  A 2008 study found that only 33 of 136 participants, or 24%, were taught about 
Methadone in their counseling programs.  The study also found that only 7 out of 133, or 5%, 
were educated on the use of Suboxone as a treatment option (Madison, Bethea, Daniel, & 
Necaise, 2008).  Education about the use of Methadone and Suboxone is taught in a relatively 
low percentage of substance use classes.  This number is even lower when one recognizes that 
substance use courses are not mandated or taught in all CACREP programs.  
Over the years, several studies have examined the inclusion of substance abuse courses in 
CACREP programs.  When asked by researchers, 52% of faculty believed that substance abuse 
training was “very necessary” and 27% believed it was “moderately necessary.”  However, of 
these programs, only 30% of the programs required courses in substance abuse/dependency isses.  
Of this 30%, only one course was required by 19% of the programs, two courses were required 
by one program, and three courses were required by another program. (Morgan, Toloczko, & 
Comly, 1997)  This study was later replicated and published in 2004, and found few changes to 
the incorporation of substance abuse training into CACREP cirriculums.  There was a slight 
increase, from 81% to 82%, in the number of programs that offer substance abuse classes to 
graduate students, but of these programs, the percentage of programs that required one or more 
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courses in substance abuse training remained the same at 30%.  However, there was a decline in 
the number of programs that offered one or more electives, from 77% in 1997 to 50% in 2004 
(Whittinghill, Carroll, & Morgan, 2004).  This indicates a disconnect in the perception that 
substance abuse training  is necessary versus the actual substance abuse education offered to 
students.   
   The 2016 CACREP standards in Section 5: Entry-Level Specialty Areas – Addiction 
Counseling state in Foundations letter b that “theories and models of addiction related to 
substance use as well as behavioral and process addictions” are to be taught as part of the 
foundations of addictions counseling.” However, other standards within the CACREP standards 
briefly mention addiction related teaching, but do not mention harm reduction as a particular 
theory to be taught.  In Section 5: Entry-Level Specialty Area – Clinical Mental Health 
Counseling, the text states in the Foundations section letter d that “neurobiological and medical 
foundation and etiology of addiction and co-occurring disorders” are to be taught.  In Section 5: 
Entry-Level Specialty Areas – School Counseling, it is listed not in the Foundations section but 
in the Contextual Dimensions letter i which states that “signs and symptoms of substance abuse 
in children and adolescents as well as the signs and symptoms of living in a home where 
substance use occurs” are to be taught.  In Section 5: Entry-Level Specialty Areas – Marriage, 
Couple, and Family Counseling, addictions in general are not mentioned as an area to be covered 
in regard to requirements. (Council for Accrediation of Counseling and Related Educational 
Programs, 2015) 
 While the requirements around teaching addiction treatment are not a primary focus in 
the CACREP standards, nor a component of many CACREP programs’ coursework, addictions 
are a large component of students’ practicum work.  Practicum is frequently cited as the one 
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course that includes content on substance abuse.  One study found that 71% of respondents stated 
that between 11-50% of clients seen in by their students in practicum presented with substance 
abuse issues.  Additionally, 18% responded that half of the clients seen presented with substance 
abuse issues, and 64% reported that between 11-50% of their internship students worked in 
substance abuse facilities. (Salyers, Ritchie, Cochrane, & Roseman, 2006)  Another study found 
that 87% of programs assigned students to field experiences in substance abuse counseling 
(Morgan, Toloczko, & Comly, 1997).  Despite the large number of programs that incorporate 
substance abuse counseling into their field placement experiences, a small percentage provide 
adequate training prior to these experiences. 
Oftentimes, field placement is one of the first encounters students have with susbtance 
abuse education.  When indiviudals feel unprepared to treat clients for substance use disorders, 
however, they may hesitant to address the co-morbidity of mental health and substance abuse or 
they avoid working with substance-abuse clients altogether (Cellucci & Vik, 2001).  This 
presents a problem because students who feel ill-prepared may begin to develop stigmas and 
myths based on their lack of understanding for the individuals they treat.   
The limited mention of harm reduction education, and in particular general addictions 
counseling education, in CACREP programs is concerning when one considers the widespread 
use of illicit drugs and addictions in this country.  It is also concerning when one considers the 
growing popularity of opioids in the medical community, and also the increased illicit use of 
heroin and opioids.  It is well documented that addictions affect not only an individual, but their 
family, their employer, their community, and nearly all aspects of an addict’s life.  By having 
had limited education in addictions, the counseling student may be ill-prepared to enter the field 
and, as a result, possibly develop stigma and negative attitudes towards working with opioid 
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dependent individuals, and in particular individuals who use Methadone and/or Suboxone 
treatment.    
Thematic Analysis 
In order to study the attitudes and beliefs of individuals, it is important to understand their 
lived experiences, as well as the patterns and themes represented by these experiences.  One way 
to gain understanding of the common patterns and themes is through the use of thematic analysis.  
Thematic analysis is the process by which the researcher identifies, analyzes, and reports patterns 
and themes within data.  Thematic analysis is “a way of seeing, a way of making sense out of 
seemingly unrelated material, a way of analyzing qualitative information, a way of 
systematically observing a person, an interaction, a group, a situation, an organization, or a 
culture, a way of converting qualitative information into quanitative data” (Boyatzis, 1998).   
Thematic analysis uses various themes to describe the data, and it is also a process of encoding 
data.  A theme is a pattern found in the information that describes and organizes possible 
observations and which has the ability to potentially interpret different aspects of a phenomenon 
(Braun & Clark, 2006; Boyatzis, 1998).      
Thematic analysis is a six phase process that is used by the researcher to identify the 
patterns and themes in data(Braun & Clark, 2006).  In Phase 1, the researcher becomes familiar 
with the data.  The researcher accomplishes this by immersing themselves in the data and 
becoming familiar with the depth of the content.  The researcher reads the complete data set prior 
to beginning to code, and then takes notes and starts creating ideas for coding. 
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In Phase 2, the reseacher creates initial codes regarding what is contained in the data and 
how it interests the reseacher.  The researcher begins to look for repeating data patterns and 
themes in the data.  In this phase, as many codes as possible are developed.   
In Phase 3, the researcher analyzes the codes, sorts them into different themes, and begins 
looking for patterns.  This process is often accomplished through the use of tables, mind-maps, 
or a listing of the codes on a separate piece of paper.   
In Phase 4, the researcher analyzes the themes again and determines if there is enough 
data to support each particular theme.  The researcher reviews and refines the themes by either 
combining several themes together or possibly separating a larger theme into two separate 
themes.  At the completion of this phase, the researcher should be able to tell how their themes 
work together and what the overall story of the data is. 
In Phase 5, the researcher refines the themes that will be presented in the analysis and 
begins to analyze the data within each theme.  The researcher then conducts and writes a detailed 
analysis of each theme in relation to the research question.   
In Phase 6, the researcher writes the report which describes the themes and patterns 
across the data set.  The researcher describes their findings and uses data to validate their themes.  
Even though there are six phases to thematic analysis, the phases are not necessarily 
followed in order and it is a recursive process.  The researcher will move between the phases 
throughout the analysis of the data.  By using thematic analysis, the researcher allows the data to 
determine the themes and patterns between the subjects.  
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Thematic analysis has advantages and disadvantages.  The advantage to the use of 
thematic analysis is that it allows for the use of a wide variety of data types to understand and 
interpret observations about people, events, situations, and organizations.  Thematic analysis 
allows for the communication of the research to a broader audience.  It acts as a bridge between 
various domains and varying orientations and fields (Boyatzis, 1998).  Thematic analysis allows 
the data to determine the themes instead of a researcher trying to force their codes and data into 
preexisting themes and intepretations.  Thematic analysis instead allows the data to guide the 
themes that are present (Braun & Clark, 2006).     
Thematic analysis also has disadvantages and challenges.  Thematic analysis allows for 
the researcher to have flexibility, and this can make it challenging to determine and concentrate 
on what component of the data to focus on.  Researcher projection is another challenge of 
thematic analysis.  In projection, a researcher “reads into” or “attributes” their own emotion, 
values, characteristics, or attitudes onto the data.  The sample of the data also presents a 
challenge.  If the sample has external variables effecting it, which the researcher is not aware of, 
such variables have the potential of affecting the interpretation of the data.  The researcher’s 
mood and style of intepretation may also affect interpretation of the data (Braun & Clark, 2006; 
Boyatzis, 1998). 
Summary 
This study examined the beliefs and attitudes of counseling students in regard to the use 
of medication assisted treatment as a treatment option for opioid dependent individuals.  This 
study also explored whether education or a lack of education affected the beliefs and attitudes of 
counseling students in regard to medication assisted treatment.  Additionally, this study explored 
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how counseling students’ perceptions of clients who use medication assisted treatment or the 
treatment modality are affected by education or external experiences.  Lastly, this study explored 
how these attitudes and beliefs affect the treatment provided to clients and counseling students’ 
professional career choices.  
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CHAPTER 3: METHODS 
Introduction 
This study is a qualitative study designed to explore the beliefs and attitudes that 
counseling students have regarding the use of medicated assisted treatments as a treatment option 
for opioid addiction and the effects they have on the counselors’ treatment of clients and 
decisions regarding their own careers.  A qualitative study is appropriate because it focuses on 
the meaning of people’s experiences as related to their perception of the use of medication 
assisted treatment as a treatment option.  A qualitative study provides an opportunity to 
illuminate and explore our understanding of the common and shared experiences of the 
participants, and also provides an opportunity to examine how these experiences affect 
counseling students’ perceptions of various treatment options.  
Research Design 
Participants were recruited from counselors in training enrolled in a master’s program 
within a CACREP accredited counselor education program.  The counselors in training were 
recruited from Duquesne University.  Duquesne University is a private, Catholic college located 
in Pittsburgh, Pennsylvania.  This school was selected for multiple reasons, including its 
convenient location in Western Pennsylvania, because it has a CACREP accredited counselor 
education program, and because it provided a sample of convenience that can be assessed with 
available resources.  
The program director was contacted at Duquesne University, and I asked them 
to send out an email invitation to students who were currently registered in their fieldwork 
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experiences and had completed at least one semester of fieldwork (Appendix A).  The email 
included the informed consent form (Appendix B) for the individual interview and a 
demographic survey with questions to elicit data to describe the sample (Appendix C), all for the 
students to review prior to their participation in the study.  I also asked the director to provide me 
information regarding the approximate number of students that the email was sent to.  
Unfortunately, the approximate number of students that the email was sent to could not be 
determined, as it was sent several times over the course of several semesters, and so the 
approximate number of students it was sent to overall was not made available to me. 
The participants were offered $10 Starbucks gift cards for their participation in the 
research interviews.  Interested participants responded to the email and indicated their interest in 
volunteering to be included in the study.  Additionally, I went into the Internship I and II classes 
to personally recruit participants for the individual interviews. Interested participants were asked 
to email me their name, email address, and telephone number so that I could contact them.  I 
maintained a list of interested participants from which I invited individuals to participate in 
individual interviews.  Volunteers for the individual interviews were scheduled for an in-person 
or phone interview.   
Sample   
Interested participants were asked to participate in individual interviews.  There were 6 
participants interviewed for this study.  Four interviews were conducted in person and two 
interviews were conducted via telephone. 
The in-person individual interviews were conducted at a mutually agreed upon time and 
were conducted in a private study room of Duquesne University’s Gumberg Library, which was 
mutually convenient for both the researcher and the participants.  If the student was unable to 
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meet in person, the interviews were conducted via telephone at a mutually convenient time.  The 
interviews were structured by an interview protocol. 
Purposeful Sampling 
In qualitative research, it is important that information is obtained from a sample that  is 
able to provide the researcher with rich and thick descriptions of their experiences regarding  the 
issues of central importance to the study (Patton, 1990).  The individuals used in the study are 
informants because they are experts in their own experiences.  The sample size of a  
phenomenological study may typically vary from 4 to 15 individuals experiencing the same 
phenomena (Creswell, 2013).  In addition to having participants experiencing the same 
phenomena, Maximum Variation Sampling allows for the researcher to interview participants 
who have experienced the same phenomena but with program variation (Patton, 1990).  In this 
study, six participants were interviewed who had experienced the same phenomena in regard to 
their educational experiences but done so while in three different tracks of the counseling 
education program.  The final sample size was determined when the data being collected became 
saturated.   
Key Informant Interviews 
Individuals who expressed interest in participating in the study were asked to meet at a 
mutually convenient time and place to explore their experiences with clients who use medicated 
assisted treatment as a treatment option.  The in-person interviews were conducted in a private 
study room at Duquesne University’s Gumberg Library.  If participants were unable to meet in 
person, the interviews were conducted via telephone at a mutually agreed upon time. These 
interviews took approximately 30-60 minutes to complete. 
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At the beginning of each interview, the consent form was reviewed, this portion of the 
process including a review of information regarding who I am as the researcher, the purpose of 
the study, study procedures, the expected duration of the interview, risks and benefits, 
compensation, confidentiality, the right to withdraw, the summary of results, and voluntary 
consent.  Participants also turned in the study’s demographic questionnaire (Appendix C).  A 
semi-structured research protocol was used for each of these interviews.  The questions for the 
individual interviews were pre-determined and followed a semi-structured format (Appendix D).  
Each interview was audiotaped and transcribed following the conclusion of the interview.  
Analysis 
The informant interviews were audiotaped.  As the primary investigator, I also took field 
notes which included, but were not limited to, observations, responses to additional questions, 
and other information I felt added to or clarified the data presented.  As the researcher, I then 
transcribed the individual interviews.  Once the interviews were transcribed, I began to analyze 
the collected data from these interviews and my field notes.    
In thematic analysis, the researcher identifies, analyzes, and reports patterns and themes 
within the data (Braun & Clarke, 2006).  These themes were explored and analyzed in relation to 
the students’ attitudes and beliefs towards counseling individuals on medication assisted 
treatment.  I analyzed the transcripts and the responses by using the six phases of thematic 
analysis.  Even though there are six phases of thematic analysis, this method is a recursive 
process, and so I moved between the phases as I analyzed the data.    
In Phase 1 of the thematic analysis, I read the transcripts of the data obtained from the 
audiotapes.  In order to immerse myself in the data, the complete transcripts were read at least 
twice in order that I become familiar with the content of the data.  I took notes on the data and 
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any notable observations, including body language and voice tones of the participants during the 
interviews, as I reviewed the tapes and transcripts.  As I took notes, I began formulating ideas for 
coding.  
In Phase 2, I created initial codes based on how the data naturally clustered and was 
related to my research questons.  The intent was to create as many codes as needed in order to 
fully represent the data and begin to group it into themes.     
In Phase 3, I analyzed the codes that I had created in Phase 2 and began sorting the codes 
into different themes and looking for patterns in the codes.  I accomplished this task by using a 
combination of tables and separate pieces of papers to sort the codes into different themes.  I also 
used a color-coded system to identify the participants. 
In Phase 4,  I reviewed the themes that I had created and refined them to either combine 
simliar themes or separate larger themes into smaller themes.  I reviewed the themes and 
analyzed how they worked together to offer an understanding of how the participants’ attitudes 
and beliefs surrounding medication assisted treatment as a treatment option were developed.    
In Phase 5, I continued to review the themes that had been identified in the initial analysis 
and analyzed the data in each theme, also writing an analysis of each theme’s data in relation to 
the research questions.  Even while the analysis was being written, I continued to evaluate the 
themes, and to combine and adjust them as needed. 
In Phase 6, I wrote my analysis of the data, which described the themes and patterns 
found in the data.  I used specific examples to validate the themes that were identified.  I then 
used these themes and the subsequent data to answer my research questions in regard to how 
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counselors’ personal and educational experiences affect their attitudes and beliefs towards the 
use of medication assisted treatment as a treatment option. 
I continued to collect and analyze data until the data was saturated and the themes were 
exhausted.  I accomplished this by beginning to code data statements and organize them into 
thematic groups at the end of each interview.  By the fourth interview, some statements appeared 
to be new and novel, but they did not generate any new thematic categories.  The sixth interview 
also did not present data that supported the addition of any new themes.  At this point, I decided 
that the data appeared saturated.  
The process of analyzing the themes was a recursive process.  Even while writing the 
report, I continued to evaluate the themes and adjust them as needed in order to provide 
additional evidence for the themes.  By analyzing the data organized into common themes, I was 
able to address the research questions.    
Instrumentation 
It is the role of the researcher to be an instrument in their work.  As a key instrument in 
their work, researchers are responsible for collecting data, observing behavior, and interviewing 
participants using a tool of open-ended questions that they developed themselves (Creswell, 
2013).  According to Glense (2006), the researcher is to be a researcher and learner but, while 
writing their analysis, the researcher also must be an artist, translator/interpreter, and a 
transformer.  The researcher has many roles in the research study, which contributes to the final 
analysis and understanding the data presented.  In order to have these roles in the research study, 
it is important that the researcher be qualified to perform the research study itself.  As the 
primary instrument of data collection and analysis in the research study, it is also important that 
the credibility of the researcher be established (Patton, 1990).  In order to increase credibility, I 
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have provided a description of my professional career experience, as well as my interest in this 
subject, in the following paragraphs.  
Researcher as an Instrument 
I have been working in the mental health field since the completion of my Master’s 
degree in 2006.  My first experience in the field came when I completed my fieldwork 
experience at a local facility for inmates with co-occurring disorders.  My interest in the 
counseling student’s perception of substance abuse started while I was working in this field 
placement when I began to question how I had developed my own beliefs and attitudes.  
Following graduation, I accepted a position as a drug and alcohol counselor conducting 
groups for clients with substance abuse disorders.  A few months later, I took a position as a 
counselor working with clients who used Methadone as a treatment option.  In my capacity as a 
counselor, I conducted individual assessments, and group and individual therapy with adults 
suffering from opioid dependence.  Eventually, I began co-leading an Intensive Outpatient 
Program (IOP) for clients who needed a higher level of care to assist them in developing 
abstinence from opioids.  During my approximately three years at the agency, I became 
interested in understanding the stigma that my clients faced.  I found myself interested in how 
the attitudes of my peers effected the care they provided to our clients.  Additionally, I became 
interested in why the agency had a high turnover rate.  I questioned if it was a result of the 
agency itself or due to counselors’ attitudes and beliefs about our clients.  While employed at this 
agency, I received my Pennsylvania State Professional Counselor License (LPC). 
After obtaining my license, I took a position at another agency treating clients who were 
diagnosed with chronic mental illness in an inpatient setting.  Here, I discovered that several of 
the clients also had a history of substance abuse.  Due a chance for professional advancement, I 
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took a position as outpatient counselor for another agency.  At this agency, I provided individual, 
group, and family therapy to children and adults, and subsequently became interested in the 
number of children whose parents dealt with substance abuse and how this affected them.  What 
I discovered was that many of the children and adults faced stigma due to their substance abuse 
history.  I worked at this agency for approximately one year. 
I was given the opportunity for professional advancement and took a position at my 
current employer’s drug free program.  In my role as a drug and alcohol counselor, I was now 
responsible for providing abstinence-based drug and alcohol counseling to clients.  Despite 
having a primarily abstinence-based program, we also provided medication assisted treatment in 
the form of Vivitrol.  I provided both individual and group counseling.  During this time, I also 
conducted a Partial Hospitalization program and an Intensive Outpatient Program (IOP).  I 
became interested in the counselors’ perceptions of clients who chose the abstinence-based 
program versus the medication assisted program.  I discovered that the counselors appeared to 
have a more negative attitude towards the clients who used medication assisted treatment versus 
abstinence-based treatment.  Additionally, I noticed that clients in the group also tended to have 
stigma and negative attitudes and beliefs towards other clients who were currently in medication 
assisted treatment or had previously used it.  At the same time, the medication assisted treatment 
modality Suboxone was gaining popularity, and clients did not seem to have such a strong 
reaction to this medication in comparison to other medication assisted treatment options, to the 
extent that I began to question why this might be the case.  
After approximately three years working in this department, I was offered the opportunity 
for professional advancement by taking a position in my current department, which is a 
Methadone and Suboxone clinic.  I have been working in this department for approximately the 
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past six years – with three years in the role of counselor, one year as a senior clinician, and 
approximately the last two years in my current role of supervisor.  During this time of transition, 
I also returned to school to begin working on my Ph.D. in Counseling Education and 
Supervision.  I wanted to expand my education and work to train future counselors. 
While in my role as counselor, I provided individual and group therapy, and also 
conducted assessments for clients seeking medication assisted treatment.  I also assisted in the 
development and implementation of the new Suboxone program that the agency was starting.  I 
was responsible for understanding the new medication and assisting in the formation and 
implementation of the clinical aspect of the Suboxone program.  While trying to integrate the 
new modality into the culture of the program, I became fascinated by the resistance of the 
existing Methadone clients, as well as the staff.  I observed that Methadone and Suboxone clients 
both saw themselves as superior to the other group, and had their own stigmas regarding the use 
of medications.  Despite both modalities being medication assisted treatments, clients in each 
modality brought their own attitudes and beliefs regarding the other.  Additionally, I observed 
that staff also had their own attitudes and beliefs regarding the modalities.  I observed that new 
staff often had preconceived ideas about medication assisted treatment in general while more 
experienced staff had attitudes and beliefs about Suboxone, in part due to their lack of experience 
with the modality. 
After approximately three years as a counselor, I was promoted into a senior clinician 
role, and then one year later promoted to a clinical supervisor position which I have served in for 
approximately the past two years.  This transition into leadership provided me the opportunity to 
observe the attitudes and beliefs of new hires.  My interest in how new counselors had developed 
their attitudes and beliefs regarding medication assisted treatment began to grow.  I began to 
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question how they had developed these beliefs, how it affected the care they provided to clients, 
and how it may have affected their career choices.  I felt that it was important for me, both as a 
supervisor and a future educator, to understand how these attitudes and beliefs developed and if 
anything could be done to change them.  On a larger scale, I feel this is important because, with 
the expanding opioid epidemic, the likelihood that clients will choose medication assisted 
treatment is also increasing.  
My experience working in the field, in particular with medication assisted treatment, has 
given me some insight into the stigmas, attitudes, and beliefs that clients and counselors have 
regarding the use of medication assisted treatment.  I believe that my personal experiences in 
several different aspects of the treatment modality – counselor, co-worker, and supervisor – 
provide me additional insight into these stigmas.  This insight has helped me to analyze and 
interpret the data for this study, as well as to connect with the participants in order to better 
understand their attitudes and beliefs.   
I recognize that my experiences and personal assumptions regarding others’ attitudes and 
beliefs have the potential to introduce bias into the study and, ultimately, the findings.  In order 
to decrease bias, I have consulted with my dissertation chair and my committee to gain insight 
into how to minimize this potential issue in my study.  I also reflected on my interview 
experiences through a personal journal in order to try to minimize the effect of this potential bias.  
Trustworthiness of the Data 
In qualitative research, validity and reliability are more challenging to demonstrate than 
in quantitative research.  In qualitative research, data is obtained from the thoughts and feelings 
of individuals, and they alone know the trustworthiness of the information they are providing.  It 
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is difficult to prove that the information they are providing is honest and accurate.  Despite these 
challenges, it is possible to demonstrate that the data is trustworthy.  
Guba & Lincoln (1982) describe four major traditional criteria that reseachers have an 
obligation to attend to: truth value, applicability, consistency, and neutrality.  Truth value is how 
confidence in the “truth” of the findings was carried out.  Applicaibility is how the findings can 
be made applicabile in other contexts or with other respondents.  Consistency is found in whether 
or not the findings would be consistently repeated if the same or a similar study was replicated.  
Neutrality is determined by insuring that the findings are based off the responses of the subjects 
and not the biases, motivations, interests, and perspectives of the researcher.  In order to meet the 
traditional criteria, the researcher needs to have credibility (internal validity), transferability 
(external validity), dependability (reliability), and confirmability (objectivity). 
Credibility is similar to internal validity in that it insures that the phenomena generated 
are closely related to what the subject intended.  In order to obtain credibility in this study, I used 
minimal prompts in the individual interviews so that I could allow the participants to discuss 
their thoughts and feelings with minimal guidance from myself. 
  In order to maintain neutrality and increase credibility, I engaged in the qualitative 
process of bracketing.  According to Creswell and Miller (2000), “it is important for a researcher 
to acknowledge and describe their beliefs early in the research process to allow readers to 
understand their position and then bracket or suspend those researcher biases as the study 
proceeds.”  In order to so this, I kept a journal and took field notes throughout the research 
process.  This allowed me to remain aware of my own thoughts, biases, and reactions to the 
participants and the data obtained throughout the study.  By keeping a journal, I was able to 
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increase the likelihood that my findings are based on the information provided by the participants 
and not influenced by my own biases, motivation, or interests. 
Transferability is how the data collected can be generalized beyond a present study.  In 
order for the data to be transferable, the descriptive data must fit into more than one context or 
area of study.  For a study’s findings to be transferable, enough information about the context of 
the study, the study design, and the data collected must be available.  In order to obtain this 
element, I provided detailed descriptions of the demographics of the participants and the context 
of their current study.  The individual interviews were transcribed, and this allowed for 
examination of the descriptive data provided by the participants.   
Transferability is also obtained by exploring a study’s implications and exploring any 
rival explanations (Yin, 2016).  In this case, if this study were to be duplicated in another 
counseling program with similar characteristics to the one used in this study, it is possible that 
the results would be similar.  Additionally, transferability was also increased through the use of 
multiple informants, providing detailed descriptions of their demographics and their experiences 
while maintaining confidentiality of the informants, and providing a detailed description of the 
research setting so that replication can occur.  
Dependability means insuring the reliability of the data to allow for replication of the 
study under similar circumstances in another place in time.  In order to increase dependability, a 
detailed description of the analysis process and methodology used is necessary.   I provided a 
detailed description of each step of thematic analysis and how the themes were developed.  This 
will allow a future researcher to follow the same process and replicate this study.   
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Confirmability requires insuring that the researcher maintains objectivity during the 
research.  This can often be a difficult task because a researcher generally engages in qualitative 
data collection because they have a keen interest in a subject or phenomena they want to study.  
This very interest can cause a researcher to become biased and unconsciously attempt to 
influence their results.  For this study, this element will be important to monitor, as I have 
worked in medication assisted treatment for approximately eight years and have worked in 
substance abuse treatment for over twelve years.  It is important, however, that this study 
accurately reflect the experiences of the participants and not my own experiences.  In order to 
increase confirmability of the results, I continuously monitored my thoughts and feelings through 
the use of journals and field notes.   
In order to increase the validity of my research, triangulation was used.  According to 
Guion (2002), triangulation is used “to check and establish validity in their studies.”  Guion 
identified five types of triangulation: data triangulation, investigator triangulation, theory 
triangulation, methodological triangulation, and environmental triangulation.  For the purposes 
of this study, I predominately used data triangulation, theory triangulation, and methodological 
triangulation.  Data Triangulation involves the use of different sources and data collection.  In 
order to accomplish this triangulation, I checked the data multiple times for phrases and key 
words from all of the participants to insure the accuracy of the themes presented.  In 
methodological triangulation, I used existing literature to find articles and studies that provided 
validation for the themes I was presenting.  In theory triangulation, you use other professional 
perspectives to validate the theories.  I accomplished this level of triangulation by consulting 
with a colleague in the drug and alcohol field in order to process my thoughts and ideas 
regarding the themes so that I could ensure I was correctly conveying what the participants 
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intended to say during their interviews.  By engaging in triangulation, I increased the confidence 
of my themes.  
Several methods were used to increase the credibility, transferability, dependability, and 
confirmability of the research.  It should also be noted that, even though these steps were carried 
out, complete trustworthiness of the data cannot be insured.  However, when these steps are 
followed, they greatly increase the likelihood that a reader will be persuaded to the 
meaningfulness of the research conducted (Guba & Lincoln, 1982). 
 
Ethical Considerations 
At the completion of the dissertation proposal defense, the dissertation proposal was 
submitted to Duquesne University’s Institutional Review Board (IRB) for approval.  After 
receiving approval from the IRB, the recruitment of subjects and data collection began.  The 
ethical considerations were reviewed and discussed with the dissertation chair and committee 
during the dissertation proposal and throughout the data collection process.  Additionally, ethical 
considerations were taken into account throughout the entirety of the study.  
Informed Consent 
Informed consent was obtained from each participant prior to the start of the interviews.  The 
informed consent form contained the following information: 
1. The purpose of the study, procedures, and the expected time of participation 
2. Risks and benefits 
3. Compensation 
4. Confidentiality 
5. Right to withdraw 
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6. Summary of results 
7. Voluntary consent 
At the beginning of each individual interview, the informed consent form was reviewed.  
Participants were reminded that they were not required to participate in the study.  They were 
informed that they had the right to withdraw from the study at any time, and that if they decided 
to withdraw their consent to participate, there would not be any consequences for doing so.  
Additionally, if they chose to withdraw their consent to participate, any data collected from them 
would not be used.  
Confidentiality 
At the beginning of each individual interview, the researcher reviewed the rules of 
confidentiality and advised participants that it is impossible to guarantee complete 
confidentiality.  The in-person interviews were also conducted in a private study area in 
Duquesne University’s Library.  This area provided a distraction-free environment, but also 
provided participants a safe and confidential space in which to discuss their attitudes and beliefs. 
 
 
Data Collection and Storage 
  
Participants were advised that interviews would be audiotaped and transcribed.  At the 
completion of the transcription, the recordings would be deleted.  In order to protect the 
participants’ confidentiality, all written notes, questionnaires, and transcriptions had all names 
and other identifying information redacted and replaced with a participant code number.  The 
audiotapes, field notes, transcripts, participant codes, and all data back-up files were kept in a 
safe in the researcher’s home which only the researcher had access to.  The researcher will keep 
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the field notes and transcripts in this safe for no less than three years from the study’s 
completion.   
Reports of the Findings 
Prior to the start of the interviews and data collection, participants were informed that 
their identities would be protected in the research findings of the dissertation.  During the data 
analysis and final report, the researcher quoted participants in the report; however, each 
participant’s confidentiality is maintained by avoiding the provision of any identifying 
information for the participant and by referring to them by their participant code number.  The 
final report and analysis of the data was made available to the participants upon request and at no 
charge to any participant.  
Participant Risk 
It is likely that the topics discussed in the individual interviews are topics that also 
discussed in the participants’ counseling profession and educational community.  As a result, 
there was minimal risk to each participant for participating in the study.  The researcher 
conducted individual interviews to minimize the risk to participants.  The researcher is a 
Licensed Professional Counselor in Pennsylvania with extensive experience in medication 
assisted treatment counseling. 
Delimitations 
 The delimitations of this qualitative study included the sample selected for this study, my 
research approach, and my chosen methodology.  As a researcher, I chose to study counseling 
students’ perceptions, and because I found limited research related to understanding their 
perceptions regarding medication assisted treatment, I chose to undertake an exploratory 
qualitative study.    
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The selection of participants for this study created potential limitations.  I chose this 
sample because they volunteered and agreed to participate in the study.  This sample of 
convenience was used because my limited resources made it difficult to recruit more diverse 
participants.  Additionally, the parameters of the sample were chosen because I felt that 
participants engaged in their fieldwork experience were more likely to have knowledge of 
medication assisted treatment or to have worked with opioid dependent individuals than students 
who had not yet participated in fieldwork experience.  
The qualitative research design was chosen in order to allow for exploration of the 
phenomena of the participants’ attitudes and beliefs.  To minimize the effects of structure, a 
semi-structured interview process was utilized to allow the participants and ultimately the 
researcher to explore their attitudes and beliefs with minimal prompting or guidance. 
Thematic analysis was chosen as a systematic procedure to ensure that the data was used 
to determine the themes.  Thematic analysis allowed for very precise steps to be taken in 
analyzing and constructing meaning from the data.  It is possible that, if another form of analysis 
were used, different results might occur, which presents this as a potential delimitation. 
I found that my own bias regarding the use of medication assisted treatment had the 
potential to contaminate my analysis and the construction of meaning from the data provided in 
this study.  In an attempt to minimize this influence, I maintained a journal of my thoughts and 
feelings toward medicated assisted treatment as they arose in response to my experiences in this 
study.  Additionally, I used thematic analysis and its very precise steps to analyze and construct 
meaning from the data and keep it separate from myself.   
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Contribution to the Field 
 I believe this qualitative study provides an important contribution to the field.  As the 
opioid epidemic in the United States continues to increase and the use of medication assisted 
treatments to treat opioid dependence also increases in turn, it is important to understand how the 
next generation of counseling students perceive the use of medication assisted treatment as a 
treatment option.  This knowledge is important to understanding how their perception of clients, 
the modality, and their education all affect their perceptions, career choices, and ultimately the 
care they provide.  As a counselor educator, it is important to explore how the education we 
provide can influence these perceptions.  It is also important to analyze these perceptions in order 
to determine if adjustments need to be made to the education we provide.  
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CHAPTER IV:  RESEARCH FINDINGS 
Introduction 
The findings of this study come from examining the attitudes and beliefs of counseling 
students’ perceptions of mediation assisted treatment as a treatment option for opioid 
dependence.  Using semi-structured interviews with counselor education students near the end of 
their professional training, I was able to allow these narratives to reveal the themes and guide a 
thematic analysis of the data.  The interviews provide a detailed perspective of the participants’ 
attitudes and beliefs, and how various factors affect their perceptions of MAT. 
This chapter provides a case by case analysis of the data derived from these interviews.  
These data include the information gleaned from the interviews and my case notes as collected 
during the interviews and analysis.  Each interview corresponds to a table identifying the 
supporting statements related to each theme.  This chapter also includes a table showing the 
cross-analysis of each theme and which participant indicated the theme as a way of 
demonstrating which theme is more common across multiple participants.  This case by case 
analysis allowed for an introductory analysis and understanding of the data set, which facilitated 
the development of the themes and the connections between the research questions.  The analysis 
found that students’ perceptions of medication assisted treatment was affected by their 
educational experiences, which is explained in more detail in the subsequent chapter.  
Participant Information 
There were six participants who volunteered and were selected to participate in a semi-
structured, individual interview for this study.  To protect confidentiality, the participants were 
each assigned a participant identification number, and they are identified by this number 
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throughout the report of research findings.  The age range of the participants was 24-47 years old 
(the average age being 28.8 years).  All of the participants were enrolled in CACREP accredited, 
master’s degree counselor education programs at Duquesne University at the time of their 
interviews.  Four of the participants were enrolled in the Clinical Mental Health program, one 
was enrolled in the School Counseling program, and one was enrolled in the Marriage, Family, 
and Couples program.  Three participants had been in the program for less than two years and 
three had been in the program less than three years.  Five of the students were currently enrolled 
in the Internship 2 class at the time of their interviews, meaning that they had completed more 
than 300 hours of supervised fieldwork, out of a required 600 hours, and one was currently 
enrolled in the Internship 1 class, indicating that this participant was within the first 300 hours of 
their supervised clinical experience.  The total number of addictions courses they had taken 
ranged from 0 to 5, with the average number being 1.7 classes.  Three of the participants had 
experience working with opioid dependent individuals and three did not have any related 
experience.  Two participants had experience working with individuals in medication assisted 
treatment and four participants did not have any experience with MAT.  Table 1 provides a 
comparison of relevant participant characteristics. 
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Table 1:   
Participant Demographic Information 
Participant 
ID 
Age Program Number 
of Years 
in Their 
Program 
Currently 
Enrolled 
In 
Total 
Number of 
Addictions 
Courses 
Exp. 
Working 
with Opioid 
Dependent 
Individuals 
Exp. 
Working 
with 
Patients 
in MAT 
1 47 Clinical 
Mental 
Health 
≤ 3 
years 
Internship 
1 
5 Yes No 
2 25 Clinical 
Mental 
Health 
≤ 3 
years 
Internship 
2 
1 Yes Yes 
3 25 Clinical 
Mental 
Health 
≤ 3 
years 
Internship 1 No No 
4 25 School 
Counseling 
≤ 2 
years 
Internship 
2 
0 No No 
5 27 Marriage, 
Couple, and 
Family 
≤ 2 
years 
Internship 
2 
1 Yes Yes 
6 24 Clinical 
Mental 
Health 
≤ 2 
years 
Internship 
2 
2 No No 
 
Individual Interviews 
Four of the interviews were conducted as in-person interviews in a private study room at 
Duquesne University’s Gumberg Library.  Two of the interviews were conducted via telephone 
at a mutually agreed upon time.  The interviews were conducted between April 10, 2017 and 
August 7, 2017.  Each interview took approximately 30-60 minutes to complete. 
All of the interviews followed a semi-structured interview format (Appendix D).  Each of 
the interviews was transcribed to obtain accurate, verbatim data.  I also took field notes and made 
notes of observations while completing the interview.   
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Analysis of Individual Interviews 
After the completion of the interviews, all of the interviews were transcribed verbatim.  I 
chose to note pauses in speech or other fillers such as “ah” or “uh” as a method of obtaining an 
accurate description of what the participant was saying.  I decided to transcribe the data myself 
as a way of becoming familiar with the data.  This also allowed me to become more familiar with 
patterns and recurring statements that began the ongoing analysis of the data.   In order to 
increase my familiarity, I listened to the tapes several times and read the transcriptions multiple 
times.  As I was reading the transcriptions, I took notes on the data in the margins and began to 
explore and note how the themes were connected.   
Once the transcription process was completed, I used thematic analysis to begin the 
analysis process.  In Phase 1 of the thematic analysis, I read the transcripts of the data that had 
been obtained from the audiotapes.  In order to immerse myself in the data, the complete 
transcripts were read at least twice in order that I become become familiar with the content of the 
data obtained.  I took notes on the data and any outside observations, including body language 
and voice tones of the participants.  As I was taking notes, I began formulating ideas for coding.  
In Phase 2, I created initial codes based off the data and how the data relates to my 
research questons.  I looked for data that repeated and any themes that emerged.  The intent was 
to create as many codes as possible.    
In Phase 3, I analyzed the codes that I had created in Phase 2 and began sorting the codes 
into different themes and looking for patterns in the codes.  I accomplished this task by using a 
combination of tables and separate pieces of paper to sort the codes into different themes.  I also 
used a color-coded system to identify the participants. 
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In Phase 4,  I reviewed the themes that I had created and refined the themes to either 
combine simliar themes or separate larger themes into smaller themes.  I reviewed the themes 
and analyzed how they worked together to offer an understanding of how the attitudes and 
beliefs of medication assisted treatment as a treatment option are developed.    
In Phase 5, I continued to review the themes that had been identified in the initial analysis 
and analyzed the data in each theme, also writing an analysis of each theme’s data in relation to 
the research questions.  Even while the analysis was being written, I continued to evaluate the 
themes, and to combine and adjust them as needed. 
In Phase 6, I wrote my analysis of the data, which described the themes and patterns 
found in the data.  I used specific examples to validate the themes that were identified.  I used 
these themes and the subsequent data to answer my research questions in regard to how 
counselors’ personal and educational experiences affect their attitudes and beliefs towards the 
use of medication assisted treatment as a treatment option. 
Theme Development 
The codes for the research were developed by bracketing similar words or phrases used 
by the participants.  Once the codes were developed, these codes were analyzed to look for 
patterns.  These patterns were then used for the basis of each theme.  I analyzed the themes 
several times and combined or separated them in order to gain a clearer understanding of the data 
in relation to the research question.  The names of themes were derived from similar words or 
phrases used by the participants.   
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Case by Case Analysis 
 This section provides a detailed description and analysis of each of the participants’ 
interviews.  The initial analysis was conducted in the same order that the interviews originally 
occurred.  Each narrative provides an analysis of the themes identified.   
Individual interview #1.  This interview was conducted with a 47-year-old female who 
had been enrolled full-time in the Clinical Mental Health Counseling Program for more than 
three years at the time of the interview.  She was currently enrolled in the Internship 1 class.  She 
reported that, during the course of her education, she took five courses which included 
information on addictions counseling.  She reported that she had experience working with 
opioid– addicted individuals, but did not have experience working with individuals in medication 
assisted treatment. 
The interview was conducted in a private study room in the university’s library.  The 
room provided a private, quiet area with minimal distractions where she could openly discuss her 
thoughts and experiences without the presence of others.  Prior to the interview, she had been 
emailed the demographic questionnaire and consent form for her review.  Prior to starting the 
meeting, I met her in the library’s downstairs lobby and introduced myself, and then escorted her 
to the private study room.  I reviewed the consent form and voluntary participation with her.  She 
was advised that her participation was voluntary and that she could leave at any time.  I also 
reviewed the consent form, which included information regarding who I am as the researcher, the 
purpose of the study, study procedures, the expected duration of the interview, risks and benefits, 
compensation, confidentiality, the right to withdraw, a summary of results, and voluntary 
consent.  I informed the participant of my intent to audiotape the interview and received her 
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consent to do so.  I advised her that I would be transcribing the interview and that, once it was 
transcribed, the tape would be erased.  At this time, she confirmed her willingness to participate 
in the study.  Her signature was obtained on the consent form, she completed the demographic 
questionnaire, and I began the interview.  The interview lasted approximately 27 minutes, with 
the entire process including review of consents and procedures taking approximately 40 minutes. 
Participant #1 appeared to be eager to participate in the study.  Prior to the start of the 
tape, she was asking questions about the study and noting that she found the material to be 
interesting.  She expressed a slight amount of anxiety regarding taping.  As I was preparing to 
begin the interview, I noticed that I was personally experiencing a combination of excitement 
and anxiety about my first interview.  I found myself getting ahead of myself in regard to the 
questions and wanting to make sure that I got every question on the form answered.  I was able 
to remind myself that this was a semi-structured interview and, once I began the interview, I 
found that my anxiety had decreased. 
I asked Participant #1 to describe what she knew about medication assisted treatment.  
She started by stating: “Um, I don’t know.  I am not as comfortable with the subject.”  She talked 
about her coursework: “Ahhh, we covered it a little bit in, um, ethics and addictions, ummm, 
coursework.”  Of her fieldwork experiences, she noted, “The facility that I worked in for 
practicum and internship, they were, ummm, a no substance.”  She clarified that the facility was 
abstinence-based with the answer: “Yeah, right.” 
She proceeded to provide more information regarding her knowledge of medication 
assisted treatment:   
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Um, so I mean, what do I know about it?  Ummm, I know it as Methadone clinics.  I 
know there is a difference.  Ummm, I know there is Suboxone and, ummmm, other 
different medications used but, umm...  It’s just a, ummm, I guess it would be kind of the 
opposite of what [an] abstinence-based program [is] where it is more like, ummmm, 
maintaining, ummm, life choices, I guess?  Ummmm, you are not actually, you are just 
learning skills to handle the addiction in a healthier way. 
I asked her to then reflect on her comment, “They are just learning skills in a healthier way,” to 
which she replied, “skills and not in medical and just, ummm, not sharing needles and things like 
that.  Just kind of managing the addiction rather than abstaining from use.”  I then transitioned 
into asking about what she had learned about medication assisted treatment in school.  After 
reviewing the transcription, I later realized that I should have had her elaborate on her comment 
more before moving on from the topic. 
I asked her what she had learned about it in school.  She stated “Ummm, just of kind of 
like snippets, not like a whole, I wouldn’t say we dedicated a whole lot of time, um, to it.  From 
what I recall, most of it was like the ethics surrounding it.  Ummm, the, ummm, guidelines, state 
guidelines, ummm, federal guidelines, ummm, and just some of the theories that support it.”  I 
asked her to clarify the types of guidelines she was referring to, and she answered: “Ummm, 
diagnosis and treatment guidelines, ummm, HIPPA, ummm, other ethics.” 
In order to clarify whether medication assisted treatment was discussed specifically, I 
asked her about if it was regarding the actual medications.  She replied, “I recall in Diagnosis 
and Treatment that we did have a psychiatrist come in and kinda talk a little bit about the 
neurotransmitters and things like that, but other than that, I don’t recall actual, ummm, you 
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know, like treatment plans on [the] use of… just recommendations.  As a counselor, I would just 
recommend; I wouldn’t be diagnosing.”  I further clarified that she had not learned about the 
diagnosing and only the treatment, “what to look for, what kind of things might work for a 
client.” 
In order to understand her thoughts regarding medication assisted therapy, I asked her 
what she thought about it.  She responded:  
I am apprehensive about it.  I am so used to the, umm, the abstinence side of it.  Umm, 
and I just, while I understand that it is probably a safer, umm, safer for the community to 
have it somewhat managed, ummm, I don’t know if it ever actually treats the addiction 
part or if it kind of prolongs it.  I don’t know, I’m kind of in the middle there.  I am on the 
fence, for sure.”  
I attempted to clarify what she was on the fence regarding, and she answered: “Whether it is 
effective?  Whether it’s, ummm, I’m not 100% sure it’s ethical, you know, so…”  She then 
clarified:  “I don’t know that the doctor should be prescribing things that are actually hurting 
someone’s body.” 
Participant #1 proceeded to talk about her fear related to the medications, as well as how 
this related to her concerns about ethics:   
We know that medications for, you know, just treating a headache or something like that 
can affect your liver, and you know any long-term use medication effects organs, so I just 
kinda wonder what that’s all about, but I do understand the decriminalization part of it 
and, you know, the relief of stress and that aspect, but at the same time I just don’t know 
if it is really 100% ethical. 
 54 
During this part of the interview, Participant #1’s anxiety and lack of decisiveness 
appeared to be increasing.  In order to clarify what might be affecting this, I asked where her 
apprehension might be coming from, at which point she responded: “Umm, probably 
socialization about it.  Ahh, you know, I am 47, so you, I think maybe, that plays into it.  Umm, 
for most of my life, that it has been ‘say no’ [giggling], so ‘just say no to drugs.’  So, not really 
learning to manage addiction, but rather try to eradicate it all together.”   With a follow-up 
question, she was able to clarify that she comes from the abstinence-based mindset, which was 
related to her personal experience: “Anyone I know personally who has gone through, like, AA 
or NA, and that’s, you know, just the mindset I have had for recovery.”   
Since Participant #1 stated she had a mindset favoring abstinence-based treatment, I 
wanted to understand her perception of medication assisted treatment.  I asked her what came to 
her mind when she heard the term “medication assisted treatment.”  She answered: Honestly 
[giggling], what comes to mind is something out of, like, One Flew Over the Cuckoo’s Nest, 
where they are all like lining up at the window for their meds and just kinda getting in line and 
just kind of like, just, of being in a fog and just knowing they want their meds, but really not 
working their program, so to speak.”  I asked her to reflect upon this description and tell me if 
she visualized or heard anything additional when she thought of it.  She answered: “I think of all 
the outside stuff.  I think about the… you know what happens in the parking lot.  Like, are we 
sharing drugs?  Are we sharing information?  Are we just going there to get by, you know, to the 
next?  I don’t know. Just all that kind of stuff.”    
She explained that these thoughts were related to experience. When asked to elaborate, 
she stated, “Personal experience with family members and knowing that a lot of, umm, I don’t 
know if the word ‘nefarious’ is the correct [one], but like the, you know, not really using the 
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facility the right way.”  She explained further that, based on her experience, they “use it as a 
meeting place and, you know, kind of doctor-shopped and that kind of stuff.” 
I proceeded to ask her if she had any experience with clients in medication assisted 
treatment, and she answered, “I actually don’t think I have seen any clients that have been 
through an assisted.”  She explained, “I think they were all abstinence-based.”  She also 
acknowledged that, while she does not believe any of them were in medication assisted 
treatment, she could not be certain: “I’m not quite sure.  I’m not 100%.” 
I wanted to find out how her personal and professional experience had affected her 
perception of individuals who chose medication assisted treatment.  She commented: 
I mean, I know a few people that it’s worked wonders for.  I just know a lot more where 
they kind of just prolonged the addiction.  You know, or mixed it, haven’t worked the 
whole recovery program, so to speak, so I mean I just think that there may be two people 
I personally know where they actually used the program, kind of the 18-month kind of 
use, and then I know somebody who was on it for 10 years.  Was on Methadone and then, 
umm, decided to just abstain, but he kinda worked it, you know.  He was safe. He was 
able to work, and so I mean, I can see the benefits of that.  He was able to maintain his 
family and wasn’t being separated from his family for long periods of time and not being 
separated from a job.  So, but I just don’t know if it has been 100% effective.  I don’t 
know.  That is just my perspective, I guess.  It could be changed. 
We talked about her perception of how long individuals tend to stay on medication 
assisted treatment, and she suggested: “I think I read 5, 5 years.”   She discussed how the 
individuals she had previously been referring to “were pretty successful with it” and noted that 
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the ones who were not successful, in her perception, were: “the ones who weren’t, weren’t 100% 
into it.”  She stated that she was uncertain of their motivation for the treatment, “whether they 
were there because of part court-mandated type thing, or I don’t really know.” 
She talked about her perception of the individuals she was aware of who had participated 
in treatment: “I think is a great, I think it a good concept.   I just think we’re maybe a little far off 
being perfect or as effective as it can be, and I just think that comes down to regulations.  Like 
whose regulating the facilities.  Honestly, the directors of the facilities are probably the biggest 
factors in how some things are run, are successful in some way.”  She proceeded to discuss a 
local facility that was: “being run pretty poorly, and I do believe it was recently closed, ummm, 
for tax reasons, fraud, that kind of thing.”  She stated that: “So, I just think it really does come 
down to who’s really in it for, you know, the client, and who is in it for business.”    
She also discussed how her personal experience with the individual affected her perception: 
“…because I know the individual and I know that her background was… you know, she was [a] 
recovering addict and, umm, and it just kind of like soured me on it.  Like, you know what 
people are going through and you took advantage of a pretty vulnerable population, and you 
were part of that population, so I don’t know how you could that?”  Participant #1 also connected 
her experience and perception with her concerns regarding ethics: “Yeah, yeah, yeah, ethics.  So, 
I don’t know.  I don’t know how you regulate ethics really other than check up on and make sure 
people are following procedure, but still that’s kind of, that’s kind of a daunting task.” 
I transitioned the conversation into her gaining an understanding of her attitudes toward 
the use of Methadone and Suboxone, and she answered: “While I think, like, any kind of 
medication, pharmaceutical, whatever, you know, whether it is fighting cancer or addiction, I 
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think you know it’s just… if it is used in the right way, it can be highly effective.  Ummm. 
Again, I worry about anything being abused, and being part of helping someone abuse it, that’s 
where I struggle.”  I asked her to clarify what she knew about the actual drug, and she answered: 
“Don’t they just mimic the dopamine in the body, in the brain?  That is all I really know about 
the actual drug.” 
As I was asking her about her perception, I internally reflected on her earlier statements 
regarding the Methadone clinic she had mentioned and asked her to describe how she perceived 
a clinic working. 
I believe, I am not a 100% on this, but, ummm, it is by appointment.  Well, the one I 
know of in the South Hills, it is by appointment, and I think it’s only open actually till 
mid-day.  Maybe there is a doctor that’s affiliated with it, but I don’t think that he’s on all 
the time.  I think he just comes in and out and meets with clients once in a while, but, 
umm, it is dispensed.  I believe you have to wait a certain amount of time before leaving 
the facility.   
She clarified her comment by adding: “Methadone.  I don’t know anything about a 
Suboxone clinic, though, so.” 
While reviewing the transcripts, I realized I had missed an opportunity to explore her concerns 
about the potential for abuse in more depth.  Instead, I had transitioned to her understanding of 
the counseling component of the Methadone clinic.  It is possible that my own personal concerns 
and experience in the field may have influenced the direction of the interview, as I was still 
subconsciously focused on her referring to the clinic as being like One Flew Over the Cuckoo’s 
Nest.  As result, I attempted to gage her understanding of the operations of the clinic and asked 
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her about the counseling component.  She commented: “I am sure it would be kind of like when 
somebody is in, like, a court-mandated type situation where you have to meet with a counselor at 
least once a week, you have to meet with a group at least once a week, attend a meeting.  I’m 
assuming it would be the same; I don’t know actually for sure.  I wouldn’t feel comfortable 
saying I know that 100%.” 
After discussing her knowledge regarding the operations of a medication assisted 
treatment facility, I attempted to shift the focus to her feelings about counseling a person in 
medication assisted treatment.  When asked about her feelings, she stated: “I would be fine with 
it, I’m positive.  I would be positive about that.  I think a lot of it is behavioral, I’m thinking so.” 
I asked her if she saw any difference in counseling a client who uses medication assisted 
treatment versus a client who is not.  She answered: “Because I haven’t had that experience, I 
don’t.  I couldn’t say that I have seen the difference.”  She proceeded to clarify, “On one hand, 
you might be dealing with a lot of the anxiety and, you know, depression that kind of consumes 
somebody that [is] be a substance abuser but, ummm, at the same time, you might also be 
dealing with someone who doesn’t, isn’t completely 100% into therapy.”  She also expressed 
concern about possible resistance and lack of commitment to treatment: “Some resistance, 
ummmm, you know some, definitely, some resistance for somebody who isn’t, who doesn’t have 
that, you know, ‘I want to completely quit, I just want to manage life [feeling].’  I think.” 
Since she expressed that she saw no difference between individuals in medication 
assisted treatment and individuals not in MAT, I transitioned the questioning forward to her 
thoughts about taking a position as a counselor in a medication assisted treatment program. She 
commented: 
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That would be, kind of like, kind of like what I am doing right now.  Just jump in and see 
how this goes.  I’m apprehensive about it.  Ummmm, I am curious about it so, ummm, it 
would be more of [a] curious[ity to] see how this actually works because it is not 
something that [is] in my experience, in my mindset.  Like I said before, would it be like 
100% ethical, so I would like to see the other side of it and just see, you know, are there a 
lot more?  I don’t know what the statistics are, so it would be interesting to see that, too. 
I asked her to clarify her apprehension, and she answered, “Yeah, I think without experience, 
you really can’t feel 100% comfortable either way.”  Without prompting, she stated how her 
internship had led her to question the effectiveness of abstinence-based treatment:    
Ummm, you know, I always wonder, you know, I’ve only been in internship for a couple 
months, so I mean I do wonder if the complete abstinence, isn’t kind of a little tough for 
some people.  You know, to handle everything else.  Like, you know, changing your 
mindset, changing everything else, changing cognition, changing behavior.  That is kind 
of hard for someone who may have anxiety or, you know.  It’s just a lot to handle.   
By Participant #1’s questioning of the challenges involved in abstinence-based treatment, 
she appeared to increase her curiosity regarding medication assisted treatment, and commented: 
“So I think it would be interesting to see both sides.”  She stated that she would be open to taking 
a job in a medication assisted treatment facility: “I would.” 
I proceeded to ask her how her educational experience may have prepared her for a 
possible job in this area, and she responded:  
Honestly, I think addictions could be a complete degree in itself.  Just, you know, I really 
think it’s so, first of all, it is so, ummm, substance abuse in general is so widespread.  
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Addictions, just, there are too many things that fall under the addictions umbrella, so I 
just, honestly, I think we have really just touched on it in the masters level. I am sure it is 
different in the doctoral level, but in the masters level, I don’t think I have enough, but I 
am also somebody who wants to be 100% confident in things I do.  So, it is not going to 
happen until you get experience.” 
I realized that I had not been specific enough regarding my questioning whether or not her 
educational experience had prepared her for a job in medication assisted treatment, and so I 
asked for clarification.  She stated, “I don’t think I am completely prepared for addictions.  I 
think I am for medically assisted therapy, if that’s what you mean?”  Based on her previous 
statements, I was surprised by her answer, so I asked for additional clarification, to which she 
replied: “Oh no.  I didn’t understand what you were saying to me.”  She stated, “Addictions in 
general.  I am not comfortable with one class and group dealing with addictions group.  You 
know we had so many other things, and talking about ethics is completely different than actually 
talking about, umm, treatment and, you know, setting goals and objectives with a client.  I just, I, 
you know, I definitely think there can be some, umm, additions to that part.”   
In order to clarify further, I asked if she felt prepared to do counseling but not necessarily 
addictions or medication assisted treatment, to which she replied, “Uh huh.”  She explained that 
she felt addictions was “a specialized thing, addictions.   I don’t really think that it is a general 
topical area.” 
She explained that she had not had exposure to clients on medication assisted treatments 
in her fieldwork: “No.  No.”  Without prompting, she proceeded to state, “And that could be 
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something that would enhance the program, you know, between internship one and two. Maybe 
if you are going to do addictions, try both.  Don’t just have an abstinence-based program only.” 
She proceeded to state, “I don’t feel I am completely trained in addictions, to go out and 
get a job in addictions.  Working with someone, you are impacting their life, you know what I 
mean?  I just don’t feel...”  When asked to clarify if she felt her education had prepared her to go 
into addictions, she stated: “No.” 
As I was reviewing the transcript later on, I realized that I could have asked her what may 
have helped prepare her more, but instead I began to finish the interview with the question 
regarding anything else I could have asked her which I had not, but which would help me better 
understand her perception.  She replied, “You know, I think a lot of my attitudes are based in, 
you know, family and the way I was socialized growing up.  So, I mean, a lot of that, ummm, I 
don’t know if you want to add something about family, but that would be completely different 
then.”   
At this point, I encouraged her to say more, in that if she thought these experiences had 
affected her perception of medication assisted treatment, she was welcome to share with me. She 
proceeded to share: 
“Ummm, yeah, just because I have a unique family.  I probably have, I don’t know if I 
have a unique family, I mean, I probably do.  My father is a police officer and he was in 
Narcotics for a long time, so I have that kind of experience, and then I also have a brother 
that was a heroin addict, and you know he passed away recently from complications of 
his addiction, not from overdose but, umm, from his health, and it was more an addiction 
lifestyle.” 
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She acknowledged that, based on her family’s experience, she was able to see both sides: “Oh 
yeah.”  She reflected on how her internship may have affected her perception, “I have seen 
people get so frustrated that they leave a program.  You know, so if they are leaving a program, 
it’s not really helping.  So, maybe they do need that extra.” 
At the conclusion of the interview, I walked the participant to the library lobby and 
thanked her for her participation.  Upon parting, I returned to the library interview room and 
collected my thoughts.  At this time, I took down some field notes reflecting on my experiences.  
I was especially concerned about this interview, as it was the first interview, and I found myself 
very focused on the interview questions.  Despite my initial nerves, I was pleased that I had been 
able to remain engaged and interested throughout the interview.   
The narrative above provides a review of Participant #1’s description of the themes being 
studied.  If information was not relevant to the phenomena, it was excluded from the analysis. 
The following chart provides Participant #1’s supporting statements for phenomena being 
studied. 
Table 2:  
Participant 1’s Supporting Statements 
Analytical Categories 
from Research Questions 
Themes  
 
Supporting Statements 
1.  Attitudes and Beliefs 
Towards Clients 
  
 1. Lack of Commitment  they want their meds but not 
working their program; 
haven’t worked the whole 
recovery program, so to speak 
 
the ones who weren’t, weren’t 
100% into it 
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isn’t completely 100% into 
therapy 
 
not really using the facility the 
right way 
 
use it as a meeting place and, 
you know, kind of doctor 
shopped 
 
are we sharing information? 
 
 
 2. Lack of Motivation are we just going there to get 
by, you know, to the next? 
 
whether they were there 
because of a part court-
mandated type thing 
 
some resistance for somebody 
who isn’t, who doesn’t have 
that, you know, I want to 
completely quit, I just want to 
manage life 
 
 3. Mistrust I think of all the outside stuff. I 
think about the, you know what 
happens in the parking lot. 
Like, are we sharing drugs? 
 
 4. Detachment from Reality being in a fog 
 
 5. Untreated Mental Illness you might be dealing with a lot 
of the anxiety and, you know, 
depression, that kind of 
consumes somebody that [is]be 
a substance abuser 
  
2.  Attitudes and Beliefs 
Affect Perception 
  
 7. “I don’t know” I don’t know, I am not as 
comfortable with the subject 
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I guess it would be kind of the 
opposite of, what, abstinence- 
based program 
 
don’t they just mimic the 
dopamine in the body, in the 
brain?  That is all I really know 
about the actual drug. 
 
I don’t know anything about a 
Suboxone clinic 
 
I wouldn’t feel comfortable 
saying I know that 100% 
 
 8. Mixed Feelings I’m kind of in the middle there. 
I am on the fence, for sure 
   
 
 9. “It is a good thing.” I mean, I know a few people 
that’s its worked wonders for 
 
I mean, I can see the benefits  
 
I think it’s a great, I think it’s a 
good concept 
 
if it is used in the right way, it 
can be highly effective 
 
 10. Harming Someone’s Body the doctor should be 
prescribing things that are 
actually hurting someone’s 
body 
 
any long-term use medication 
affect organs 
 
I worry about anything being 
abused 
 
 11. Uncertainty of Effectiveness you are just learning skills to 
handle the addiction in a 
healthier way 
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kind of managing the addiction 
rather than abstaining from 
use 
 
I don’t know if it ever actually 
treats the addiction part or if it 
kind of prolongs it 
 
whether it is effective? 
 
I just know a lot more where 
they kind of just prolonged the 
addiction 
 
I just don’t know if it has been 
100% effective 
 
I just think we’re maybe a little 
far off being perfect or as 
effective as it can be 
 
I think, you know, it’s just if it 
is used in the right way it can 
be highly effective 
 
I don’t know what the statistics 
[are] 
  
 
 12. Lack of Monitoring One Flew Over the Cuckoo’s Nest 
where they are all like lining 
up at the window for their meds 
 
I just think that comes down to 
regulations. Like, who’s 
regulating the facilities? 
   
 I just think it really does come 
down to who’s really in it for, 
you know, the client and who is 
in it for business 
   
I think he just comes in and out 
and meets with clients once in 
a while 
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3.  Educational 
Experiences 
  
 13. Limited Exposure just of kind of like snippets, not 
like a whole, I wouldn’t say we 
dedicated a whole lot of time, 
umm, to it 
 
I think we have really just 
touched on it in the masters 
level  
 
 
 14. Limited Fieldwork 
Experience 
I actually don’t think I have 
seen any clients that have been 
through an assisted 
   
I’m not quite sure. I’m not 
100% 
 
I am also somebody who wants 
to be 100% confident in things 
I do.  So it is not going to 
happen until you get 
experience 
 
that could be something that 
would enhance the program, 
you know, between internship 
one and two. Maybe if you are 
going to do addictions, try 
both.  Don’t just have an 
abstinence-based program only 
 
 15. Lack of Coursework I think addictions could be a 
complete degree in itself 
 
there are too many things that 
fall under the addictions 
umbrella 
 
I think is a specialized thing, 
addictions   
 
I don’t really think that it is a 
general topical area 
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4.  Other Experiences   
 16. Family and/or Friends in 
Addiction 
anyone I know personally who 
has gone through like AA or 
NA, and that’s, you know, just 
the mindset I have had for 
recovery 
 
 personal experience with 
family members and knowing 
that a lot of, umm, I don’t know 
if the word ‘nefarious’ is the 
correct [term], but, like, the, 
you know, not really using the 
facility the right way 
 
because I know the individual 
and I know what her 
background was.  You know, 
she was [a] recovering addict 
and, umm, and it just kind of 
like soured me on it. Like, you 
know what people are going 
through and you took 
advantage of a pretty 
vulnerable population, and you 
were part of that population, so 
I don’t know how you could do 
that? 
 
 I also have a brother that was 
a heroin addict and, you know, 
he passed away recently from 
complications of his addiction, 
not from overdose but, umm, 
from his health, and it was 
more an addiction lifestyle 
 17. Culture I am 47, so you, I think maybe, 
that plays into it.  Umm, for 
most of my life, that it has been 
‘say no’ [giggling] so ‘just say 
no to drugs’   
 
You know, I think a lot of my 
attitudes are based in, you 
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know, family and the way I 
was socialized growing up 
 18. Others People’s 
Stories/Perceptions 
My father is a police officer 
and he was in Narcotics for a 
long time so I have that kind of 
experience 
  
 
 
 
5.  Perceptions Affect 
Client Care 
  
 19. Increased Curiosity I am curious about it so it 
would be more of [a] 
curios[ity to] see how this 
actually works because it is 
not something that [is] in my 
experience, in my mindset 
 20. No Difference I couldn’t say that I have seen 
the difference 
 
 21. Increased Counselor Anxiety  I worry about anything being 
abused and being part of 
helping someone abuse it, 
that’s where I struggle 
 
6.  Professional Career 
Choices 
  
 23. Not Enough 
Knowledge/Unpreparedness 
I don’t feel I am completely 
trained in addictions, to go 
out and get a job in 
addictions 
 
 25. Fear I think without experience 
you really can’t feel 100% 
comfortable  
 
I’m apprehensive about it  
 
 
Individual interview #2.  This interview was conducted with a 25-year-old male who 
had been enrolled part-time in the Clinical Mental Health Counseling Program for more than 
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three years at the time of the interview.  He was currently enrolled in Internship 2.  He reported 
that, during the course of his education, he had taken one course which included information on 
addictions counseling.  He reported that he had experience working with opioid- addicted 
individuals and had experience working with individuals in medication assisted treatment. 
Participant #2’s interview was conducted in person using the same interview process used 
with Participant #1.  This interview was conducted immediately following the completion of my 
first interview.  The interview lasted approximately 41 minutes, with the entire process including 
the review of consents and procedures taking approximately one hour. 
Participant #2 appeared to be eager to participate in the study.  Prior to the start of the 
interview, he was asking questions about the study and expressing his eagerness to share 
experiences that he had previously had.  As I was preparing to begin the interview, I noticed that 
I was calmer and more confident in my ability to interview than I had been in my first interview.   
I asked Participant #2 to describe what he knew about medication assisted treatment.  He 
started by stating: “I don’t know that much, actually.”  He then stated that what he did know was 
from class and his clients:   
…I mean, we might have gone over it in class, but from what my clients have told me, 
mainly my one client, ummm, and basically that’s, ummm, you know, they have these 
Suboxone and Methadone and other sorts of clinics basically for people who, ummm, 
treat, to titrate – that is the word, right? … Umm, yeah, I knew I was close.  I know the 
word.  Sooo, ummm, they basically, you know, titrate up to a certain amount like they do.  
I think Methadone, it is like 80mg. or whatever, and, uhhh, and then with the expectation 
that it is going to kinda like give you what you need to get through your day, and then 
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you go again.  They have counselors there but then you can also like, and they have 
therapists or workers there that you can talk to about the addiction, but must be because 
of the coding or something, you can still go to a mental health facility and still get 
services there.  I am not really sure how that works.  I think it is a good thing.  But 
anyway, that is as about as much as I know. 
I attempted to clarify that his understanding came from what his clients had told him, and 
he responded: “Ummm huh.”  I asked him what he had learned about it in school, and he said, 
“Not much.”  He explained that: “We didn’t focus on that because there is so much, like, 
abstinence model, you know, and they focus on, you know, and 12 steps, and our teacher wasn’t 
hell bent on it, but was also realistic.”  He explained that: “We talked a little bit, like I said.”  He 
stated that: “The teacher actually brought one of his friends in, clean 6 or 7 years off heroin, and 
uh, yeah, I mean that was, that was educational.”  He proceed to state, “What I learned from that 
was basically [laughing] if you don’t have something really significant, and from my client, if 
you don’t have something significant, uh, to get you away from it, you’re not going to get away 
from it.  Uhhh, so I guess I learned that in school, albeit it not in a PowerPoint situation.” 
I asked him to clarify the term “significant” and he described the circumstances of one of 
his clients: “My other person at the clinic was just like: “[in a funny voice] ‘Yeah, my, uh, 
someone I worked for in the summer realized that heroin addicts, that they work really well and 
this is like, I don’t know, and then she brought me to the clinic, and hey, I’ll try something new.  
I knew, two months later, and there it is.’  You know, ‘try something new,’ that’s not going to 
get you away from your favorite thing in the world.” 
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I attempted to clarify further where he had learned about medication assisted treatment, 
from individuals and, per his words, “not a PowerPoint.”  He stated:  
Yeah, that’s where I learned, really.  I guess what I learned from the PowerPoint 
perspective is, we learned there must have been slides about it, but we just really focused 
on AA, abstinence, non-abstinence models, and how they may be applicable, but you 
know, that’s not gonna [giggling], you know, fit in any jobs that we are likely gonna get, 
so you know we focused on that a lot and I wish I could answer this better, but I 
genuinely don’t remember talking that much about medically assisted heroin. 
While reviewing the transcripts later, I realized I had missed an opportunity to explore 
what he meant by the term “medication assisted heroin.”  In thematic analysis, it is more difficult 
to analyze the language being used; however, it should be noted that this may be related to an 
underlying attitude.   
When asked if basically everything he had been taught was primarily focused on 
abstinence based or AA, NA, he answered, “Yeah.”  For additional clarification, I asked if the 
education had been limited in regards to medication assisted treatment, and he stated, “Yes.” 
I next transitioned into asking him about his thoughts regarding the use of medication 
assisted treatment as a treatment option.  He replied, “I mean, I think it is good and helpful. 
Umm, I wish I didn’t have to say to that, but, umm, some people just don’t have the willpower 
or, let’s be real, sad but true, honest, the reason to kick it, so this is better than being strung out 
and being a complete tool on the economy, family, society, [giggling] umm…”  I sought 
additional clarification in regard to how he viewed the treatment, to which he replied, he saw it 
as a “liability.  Yeah, I see it as positive.  It is simultaneously a crutch, obviously, in its own way, 
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a strain on resources and all that, but I mean if it, we, are looking at the whole picture, the whole 
picture, considering our society and the way they treat substance abuse, and [giggling] how 
cheap heroin is, it is a good alternative.”     
I wanted to clarify his thoughts regarding the term “crutch”, so I asked for additional 
clarification.  He referred back to history, and stated, 
Well, I mean, we’ve all seen the video by now.  I mean, the people came home from 
‘Nam, you know, and they were all, a lot of them were using opium and whatever, and 
then you know, 95% of them had no withdrawal symptoms because they had a good life, 
good family, and all this to return to, so their body didn’t, you know, their body was 
processing all the chemicals probably in a different way from the euphoria of being back 
in the homeland and, you know, not fighting some, like, weird, unnecessary [giggling] 
terrible, legal, whatever, war anymore.  So, ummm, you know, uhh, they didn’t need it. 
They had enough of a reason, they had enough of a desire. They, you know, didn’t have 
any need to go out and find it or stay addicted and go through a terrible withdrawal.  This 
is like, ideally, all these medications for psychotherapy were originally intended to be, 
like, “well, do this and then you are going to see the therapist and we will take you off of 
them,” and all intended to be, and that is how they started, but we know that there are 
some people who need them.  Probably 50% of people I know in psychiatric treatment 
from my internship don’t.  If they really took the reins on their life, they wouldn’t need 
them; 50% definitely need them.  [laughing] So, I am generalizing to that now, but this is 
included I think, you know, I think it is a crutch or, it’s a crutch, it is a stepping stone, it’s 
one or the other. 
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I attempted to ask for additional clarification by asking if he felt that mediation assisted 
treatment in itself is a crutch or that some people use it is a crutch, but that other people may also 
use it as a stepping stone.  He clarified by stating, “Yeah, yeah, it’s hard.  I don’t have a very, I 
have a very a liquid mind.”  He clarified further by stating, “It’s like, I don’t black and white 
things, I don’t do it.”  When asked if he saw if he could “see it both ways,” he stated, “Yeah, 
exactly.” 
I wanted to gain additional information regarding his perception of “medication assisted 
treatment,” so I asked him what came to his mind when he heard this phrase.  He answered, 
“Well, I would get curious, you know.  How long were they addicted?  What kind of family do 
they have?  Ummm, you know, I think medication assisted treatment, oh, what’s their back 
stories?  Is this really applicable? It could be applicable?  It also could not be.  It could be like, 
wow.” 
I attempted to asses where his curiosity came from.  “The curiosity just comes from, I 
think, wonder.  I wonder if, of all the ways to deal with addiction, why this one for this specific 
person?”  I transitioned into asking what his experience had been with clients who use 
medication assisted treatment.  He discussed two clients who he had worked with in his 
internship: 
“Well, like I said, I’ve, before this tape was rolling, I’ve seen, I’ve seen two dope addicts 
– one in recovery who quit cold turkey out of being pregnant and not wanting their child 
not to be messed up, and one who just, who did enter medication assisted and was like 
[giggling], yeah, I’ll just resay it here so you have it on tape, [in a funny voice], ‘yeah, 
you know my old boss brought me to the clinic up on the northside and, um, you know, 
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they made a Facebook post and, you know, like, all these things, and they are really like, 
you know, like, rooting for me and we are going to do this and she is going to open this 
center and she is going to get this funding and she is going to use people like me 
qualitatively to demonstrate that it is effective, and all this stuff and, you know, I was 
like, I’ll try something new.’  And in the back of my mind, I was like [giggling] ‘You are 
30, you have been addicted to heroin for 15 years; it is going to take more than this, it is 
going to take more than, you know, some Methadone and wanting to ‘try something new’ 
to get you away from this stuff.  
Since he was discussing having experience with a client on medication assisted treatment and a 
client not on medication assisted treatment, I wanted to know what his perception was of the 
difference between the two treatments.  In order express this, he seemed to need to clarify what 
medication assisted treatment was: “Methadone or, that is medication assisted, right?  Yeah, that 
is medication assisted.  Sorry, I told you I don’t know much.” 
He proceeded to talk about a client who was pregnant and “quit cold turkey”:  
She tried everything, not only tried, but she didn’t follow everything, and was in active 
addiction and several things, but yeah, she was pregnant, she was having a child, her 
motherly instincts kicked in, and she was just like [in a funny voice:] ‘I’m not gonna 
have, ahhh’ … what do you call a baby who is addicted to heroin?  I was gonna say a 
crack baby, but that is not applicable here, a baby like that, and ‘I’m not gonna have a 
baby that’s born with addictions’ – and she just quit.  And she said she went through the 
sweats and the chills and the this and that for, you know, a whole month, but she stuck it 
out because she knows what happens if you keep using that.     
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In comparison, he described his other client:  
who got involved and was completely enabled by his family.  You know, died multiple 
times, brought back to life 4 or 5 times from what I understand.  Family enabling kept 
him alive through a lot of it, but did all of these things.  I think his favorite, oh, what’s his 
thing?  Is it Xanax and Benzos?  I think it is.  I think it is like, super lethal, but like, super 
awesome; he was like, ‘there’s nothing better, but you are there, but you are super 
relaxed’ – and to be fair, he, that might be what he returned to instead of heroin after he 
left the Methadone.  
He next stated: “We had to close him because he was a liability.”  He clarified that the 
patient was a liability “because he was doing things like ‘ashing’ while laying in his bed” 
but not because he was on Methadone; “On methadone it was fine,” he noted.  
While talking about the client not being a liability while on Methadone, Participant #2 
began talking about his perception of seeing his client on Methadone.  “Yeah, I kept seeing him 
when he was on Methadone.  He was like [in a funny voice:] ‘Uh, I’m good,’ but there is a 
certain lifelessness in these people who, um, you know, who for them, heroin, that is in their 
mind.  I mean you are a zombie.”  Without prompting, he next began talking about another client 
and how the client refused to give money to homeless addicts, and how “They will actually call 
the people out because they know that look because they have had it in their eyes and are like, 
we will never forget you.”  He proceeded to state, “There is a certain lifelessness.”  
When I attempted to clarify what he meant by “lifelessness,” he stated this was related to 
people “who are addictively addicted to heroin,” but then immediately began to refer to his client 
on Methadone and stated: “There wasn’t enough.  He wasn’t lifeless, but where was the desire 
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for something better in life?  It wasn’t, you know, it wasn’t there, wasn’t.”  He stated that, for the 
client, at times, “It was like, ‘oh, I’m gonna be clean.  Oh, good job.  I’m a good boy.’” 
I transitioned into asking him what his perception of individuals who chose medication 
assisted treatment as a treatment option was, and he answered: “I just, I really don’t have a set, 
ahhh, again, it’s hard.”  He proceeded to ask questions that come to his mind when clients enter 
medication assisted treatment: 
“I’m very, like, a human is a human, and, ummm, so I would be more, you know; it’s 
more, what end are they using it towards?  Are they going up on Methadone and then 
going, you know, going to OVR and reconnecting with good people and cutting off 
connections with their old dealers and friends and, umm, you know, are they doing that? 
Or are they just like, going on Methadone, making no other lifestyle changes?  That’s 
basically, yeah, okay, so if you want two concretes, if they are doing Methadone and 
making other lifestyle changes, that’s phenomenal, perfect, they are going to more likely 
in my mind, ummmm, go on [to] succeed, stay clean, and, uhhh, ‘clean’ in quotation 
marks and all that.  If they are just going Methadone to just, this is the difference between 
the stepping stone and the crutch; this is helping me codify in my mind; this is helpful for 
me.  The stepping stone is if they are making other lifestyle changes, if they are just like, 
leaning on the crutch, you know to get around, and not make any other lifestyle changes, 
I’m like, ‘we’ll see how long this lasts.’ 
I wanted to know his attitudes towards Methadone and Suboxone, specifically.  He stated, “I 
honestly don’t know much about them.”  He added that: “There is something that apparently you 
use for a very short term, and a day to a week, some sort of natural thing and, uhhh, you do it for, 
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like, that period of time and you are good.  I forget what it is called.”  He then began to talk 
about the lack of research related to treatment: “Our glorious paid-off scientists in society 
obviously don’t pay attention or, you know, don’t research, blind eye, and unfortunately prey on 
these people to keep these treatments going so, ummm, they are acceptable for now.”  He stated, 
“I think if there are better options out there, that it is horrendous that they’re the only options.”   
After reviewing the transcripts, I realized I could have asked for additional clarification in 
regard to his perception of the effectiveness of treatment.  I recognize that part of the challenge I 
faced was keeping the participant on topic and away from political beliefs, which may have 
made me apprehensive about following up on this particular question. 
I proceeded to ask him about his feelings regarding counseling a client on medication 
assisted treatment, and he answered: “That’s fine.  I wish there was better coordinated.  I wish I 
knew what those counselors were talking about.”  He proceeded to express concern about his 
client: “Like my client, I mean, how are they going to do that?”  He then discussed how he felt 
that “agencies are so, ummm, we’re so in our bubbles and we’re overworked, so we don’t have 
time to step outside of the bubble.” 
I redirected him back to his feelings about counseling his client who was on medication 
assisted treatment, and how he felt about that experience.  He answered:  
I mean, I just, I was, whenever they offered something from the clinic, I was like, ‘Yes, 
thank you for telling me, and I could work this.’ I would let them know, ‘Thank you, 
anything you feel comfortable with, there is no need at all, there is no pressure, but when 
you do, it helps me.  It lets me understand what you are going through out there more,’ 
 78 
and just like, ethically like, as possibly I could, ‘Please feel free to offer me any of this; it 
was helpful when they were sharing.’   
He clarified further, “I’m not going to pressure you.  You can keep, you can very serious 
about confidentiality, you can keep all that there and I’m not going to try to pull a power play on 
you, you know, and do unethical things, but when you do share that, I know what is going on and 
I can help you better.’ That is, basically, I waited for those moments.” 
I wanted to explore his concerns about ethics, and he clarified, “I’m very serious about 
people being able to share certain parts of themselves with certain people, very serious about 
that.  Ummm, and if this person didn’t feel like sharing what went on over there, this person did 
tell me anything, they would tell anyone anything.”  He added, “We have a right to confide in the 
people that we want to confide in and, when you are dealing with a power differential, I try to, 
not in just this case, but many cases as I can, as a counselor in training, I try to really respect 
people, do as little pressuring as necessary and possible, and really let them have control of their 
storyline.” 
I attempted to clarify if he saw medication assisted treatment and mental health treatment 
as two separate treatments, and he responded: “Well, here is the thing: on paper, they are.  Well, 
in someone’s mind, they might be, but life is only one thing.”  He clarified further that: “I have 
to honor that billing, funding, society does it that way and so I did.”  He acknowledged that this 
was his agency’s perspective, but not necessarily his perspective, with the comment, “No, of 
course not.”     
He described a situation in Internship class where his challenges with keeping them separate had 
caused him frustration: 
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I was thinking about how, how some of my classmates [who] are in group supervision are 
like, ‘Yeah, well, I’m in this drug and alcohol facility and my supervisor was there and 
the person was trying to talk about how, like, they use drugs to kind of, and alcohol to 
kind of, like, cover up things from their past with their family, and this and that, [and] the 
supervisor was like ‘we really can’t go there,’ and I was like, ‘we really need to go there.’ 
I was like, I’m just, like, mentally ripping my hair out because I’m just, like, you are 
going to. This managed care is basically to keep some people with yachts, with boats in 
southern states happy, you know, sipping high quality margaritas off the coast of Florida, 
you know.  These managed care people, who really don’t know what is going on, are 
making treatment be restricted to this because, if they go outside of this, they can’t get 
reimbursed for the treatment, and I’m just like, ‘oh my God, you are keeping this person 
a wreck.’ 
I was able to get him to clarify that this separation of care was what he perceived as unethical, to 
“keep them apart, keep them apart as long as you want to, and the client wants to, but it almost 
gets unethical to be like [in a funny voice:] ‘well, we can’t talk about that, we can’t talk about 
your real problems, because you are here for these other problems.”  He proceeded to talk about 
how he felt the need to refocus the addictions treatment back to mental health due to billing and 
how he felt this was ethical, “I had to because that is how billing works.  That is technically 
ethical, considering, because that is what they signed onto for treatment, and if they want to 
bring some of it into it, as long as I can spin it back to mental health, that’s tot’s fine.” 
I wanted to explore his thoughts regarding taking a position on counseling and treating 
clients who use medication assisted treatment.  He stated that “it is community mental health, so 
whoever walks in the door walks in the door.”  He stated that: “My feelings towards it are, here 
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is another person, and I didn’t really think too much about the medication assisted treatment 
besides, I hope I am not contradicting what the other therapist or other facility is saying.” He 
explained that his personal experiences affect his perceptions of individuals.  He stated, “From 
my life being a yogi, you know, a person is a person. We all have, you know, we all have our 
karmas and experiences that bring us to a certain situation, and I am called in to help them with 
their mind at this particular part in their journey.”   
In order to clarify his thoughts regarding working as a counselor, I asked specifically 
about his thoughts on taking a position as a counselor in a medication assisted treatment facility.  
He answered, “I mean, I’d do it because it was a job, and I’d probably get, I’d probably help 
people out, you know.”  He expressed concern about its effectiveness and noted that he might be 
misleading people,  
but at the same time, I would feel kinda like, you know, I had one client who was a 
restaurant manager for a long time and, after a while, they were like, ‘I can’t.’ They were 
good at it, but after this many years of it, they were like ‘I can’t keep telling high school 
kids to get, like, real jazzed up to work minimum wage and, you know, to make mediocre 
food, like, I can’t keep lying like that.’  I think, eventually, I’d be like, I can’t keep 
offering treatment that’s only like 3% effective.  Statistically.  Like, I just, I just can’t. 
He then expanded on his concerns regarding the effectiveness of treatment and how it 
affects his perception, stating, “I feel it is stretching it.  Isn’t that the statistic, that only 3% of 
people who enter rehabilitation programs actually, you know, stay clean, and the average amount 
of times that it takes to enter a treatment program is about 13 for someone to actually stay 
clean?”  I attempted to clarify his concerns about the effectiveness and how it relates to his 
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challenges with keeping treatment separated.  He stated, “I would feel restricted.”  He proceeded 
to express concern about the lack of research related to medication assisted treatment and how he 
focuses on evidence based practices, saying: “I still use evidence based practices for the vast, for 
the most part, but I mean, it’s strictly mental health and it is so broad what you can do that is 
evidenced based, so that’s nice.”  I attempted to clarify his perception of medication assisted 
treatment in regard to being evidenced based, and he responded, “It is evidence based, just, oh 
my gosh, it’s just, it’s, the numbers are just so, just so low, there has to be something wrong.”  
He also talked about experiences in Portugal and how that has affected his perception, noting, “I 
wouldn’t 100% believe in it from the start, but it’s effective for those people who buy into it and 
for those, whom, it is their pattern of desire.” 
Additionally, in response to the information regarding his personal research, I wanted to 
understand how his education might have prepared him for a possible job in medication assisted 
treatment.  He stated, “I have a cursory… ‘cursory’ is not the word, ‘modest’ is not the word… I 
have a functional understanding of how drug and alcohol counseling works.”  He proceeded to 
state that his internship had also helped him: “After about a year working there, I feel I have 
more than a functional understanding, but people learn by experience, so I feel like my education 
did a job, uhhh, functioning, getting me functional.”   
I wanted to clarify whether he felt he was “functional” with addictions in general or 
medication assisted treatment.  He clarified, “With addictions, but with medication assisted 
treatment.  Addictions.  With medication assisted treatment, I’d say my understanding was 
modest.”  He stated that, regarding taking his first job, “Modest works for that, and I would want 
to do more research myself before taking a job.  Even if I got the job, I would still feel, like, 
unethically prepared unless I did legwork on my first day there.” 
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When asked if his education had prepared him, he stated that his education had prepared 
him more for “addictions in general, 100%,” than medication assisted treatment.  He stated that 
he had been given limited preparation for medication assisted treatment, saying, “We went over 
it in a very cursory way.  Maybe it was like one or two days of the fourteen weeks that we were 
in the class, ummm, and it was, you know.  I really don’t remember many specifics, but I do 
remember it being talked about, and so, you know, there was other things to focus on.”  He stated 
that he and his classmates got “the general overview.” 
Without any prompting, he next began to talk about his concerns regarding the CACREP 
requirements and how it would be helpful to learn more about medication assisted treatment 
“because we are in western Pennsylvania, you know, I’d be, I think, you know, if there is still a 
way to meet CACREP requirements if you put a little bit more on that, it would be helpful for 
us.”   
When asked specifically if he thought learning more about medication assisted treatment 
specifically would be helpful, he stated: “I think it would be helpful.  I mean, it is more [that] I 
think it would be fruitful to stay specific to this area because most people don’t leave.”  He 
talked about the easy accessibility of medication assisted treatment:  
Oh my gosh, why not if you are living in western PA., where, you know, Washington 
County is right down the road, you know, why wouldn’t you put a couple extra days into 
medication assisted?  Because, you know, even driving, I drive all over the city for work 
every week; I put, I put, it’s not much, but about 300-400 miles on my car a week all 
over, north, west, south, and the only place I don’t go too often is east.  And, ahh, you 
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know, you see signs everywhere, ‘Methadone phone number,’ ‘Suboxone, this phone 
number,’ and it is just everywhere. 
Participant #2 then discussed his desire to be able to assist people in his personal life with 
addiction and the prevalence of addiction, stating, “Someone I do care for, their brother is 
addicted to heroin, and addiction is everything.  And you know, I’m just like, I wish I could talk 
to the family, but it is not my place – so it’s everywhere.”  He transitioned back to how he 
believed more information about medication assisted treatment could be helpful, adding, “Why 
not, if you are in [a] western PA. counseling program, specialize in that just a little bit more, get 
people a little bit more prepared?  Wouldn’t that be a selling point?” 
I wanted to gain more clarity regarding his fieldwork experience, so I inquired if he had 
any other experience with clients on medication assisted treatment. He answered, “I’m sure there 
have been.”  He discussed the challenges of obtaining that information, saying, “But it is 
community, so people come in and out, and the amount of people who stay for a long period of 
time, umm, is, it is about 50/50.”  
In order to attempt to gain insight into whether his coursework had helped him in his 
fieldwork, I asked him about whether or not his education had helped, and he said, “Yeah, yeah.  
There is a reason this is required coursework beforehand.”  He explained, “I took Addictions 
during my start of Internship 2 and it helps me.”  He expressed that, if he had taken it earlier, it 
may have benefitted him more: “I wish I had taken [it] before, you know, maybe when I was 
Practicum or Internship 1,” and that part of the reason he had not was because “it wasn’t required 
before as a pre-req.” 
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I wanted to understand whether he thought it would be helpful for it to be a pre-req, and 
he answered, “I honestly think it would be because, you know, at the clinic, everyone talks about 
it.  In mental health, I think we all know it, just no one is saying anything yet, but this is the 
direction it is going.”  He explained that he believes this is in part due to: “Drugs are much more 
widespread and, ummm, mental health dual diagnosis is, I mean, where we are going?  I don’t 
think, 50 maybe even 25 years from now, they don’t have to be separated or so far apart.”    He 
explained that not only does he believe it would have helped him in the future, but it would also 
have helped him gain a better understanding in his coursework: “It would have helped me a lot.  
It helped me a lot when I was in that class and I was like, ‘oh, when my person was telling me 
that in Internship 1, that’s what they meant.’” 
When I asked him at the end of the interview if there was anything else he would like to 
share with me, he began talking about CACREP, noting, “I would say the requirements should 
be, like, umm, change them up a little bit.  My gosh, allow for specialization for the area.”  He 
continued to explain that, “I am grateful that CACREP did its job in broadening it and making 
sure all the bases were covered, but you know some of it just, it could have used more 
personalization.”  He discussed how he feels that he: “learned better from my roommate about 
Native Americans because they don’t have the gene to process ethanol, so they get much more 
into the alcohol.”   
At the conclusion of the interview, I walked the participant to the library lobby and 
thanked him for his participation.  Upon parting, I returned to the library interview room and 
collected my thoughts.  I was concerned about this interview, as I felt I had faced challenges 
getting the information I needed, as Participant #2 had tended to go in unexpected directions, and 
I had felt challenged in continually redirecting him to the topic at hand.  I had to remind myself 
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that part of being a researcher is allowing the research participant to take you where they feel the 
story is; it is their story rather than the researcher’s.  At this time, I took field notes on any 
thoughts I had.  I was concerned about the potential results of this interview, as I had not heard 
the participant discuss how his thoughts affected client care or his possible career choices, but he 
had instead focused on the education component.  I had to remind myself not to expect any 
results and that the interviews would be conducted until the themes were saturated.  Additionally, 
one interview would not exclude a research question from being answered. 
 I was also concerned because I found myself focused on the language he had chosen to 
describe the clients.  I felt that I had been able to hear stigmatizing words; however, thematic 
analysis does not allow for interpretation of language.  I was pleased that I had been able to 
remain engaged and interested throughout the interview.  I was able to be mindful of my initial 
internal reactions to the words he had chosen and not allow myself to react to them, thereby 
possibly affecting the results of the interview. 
The narrative above provides a review of Participant #2’s description of the phenomena 
being studied.  If information was not relevant to the phenomena, it was excluded from the 
analysis.  The following chart provides Participant #2’s supporting statements for phenomena 
being studied. 
Table 3:   
Participant 2’s Supporting Statements 
Analytical Categories 
from Research Questions 
Themes Supporting Statements 
1.  Attitudes and Beliefs 
Towards Clients 
  
 1. Lack of Commitment What end are they using it 
towards? 
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If they are just going 
Methadone to just… this is the 
difference between the stepping 
stone and the crutch 
 
leaning on a crutch to get 
around 
 
are they just, like, going on 
Methadone, making no other 
lifestyle changes? 
 
 
 2. Lack of Motivation if you don’t have something 
significant to get you away 
from it, you’re not going to get 
away from it 
 
 where was the desire for 
something better in life? 
 
 
You know, ‘try something new,’ 
that’s not going to get you away 
from your favorite thing in the 
world 
 
some people just don’t have the 
willpower, or let’s be real, sad 
but true, honest, the reason, to 
kick it 
 
 4. Detachment from Reality there is a certain lifelessness in 
these people 
 
I mean, you are a zombie 
  
2.  Attitudes and Beliefs 
Affect Perception 
  
 7. “I don’t know” I don’t know that much actually 
 
I genuinely don’t remember 
talking that much about 
medically assisted heroin 
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Methadone or, that is 
medication assisted, right?  
Yeah, that is medication 
assisted. Sorry, I told you I 
don’t know much 
 
I honestly don’t know much 
about them 
  
 
 8. Mixed Feelings I think, if there are better 
options out there, that it is 
horrendous that they’re the 
only options   
 
 When asked if he saw if he 
could “see it both ways” he 
stated, yeah, exactly 
 
 
 9. “It is a good thing.” I think it is a good thing 
 
I mean I think it is good and 
helpful 
 
I mean, if it we are looking at 
the whole picture, the whole 
picture, considering our society 
and the way they treat 
substance abuse and how 
cheap heroin is, it is a good 
alternative 
 
 11. Uncertainty of 
Effectiveness 
stay clean, and, uhhh, ‘clean’ 
in quotation marks and all that 
 
scientists in society obviously 
don’t pay attention or, you 
know, don’t research, blind 
eye, and unfortunately prey on 
these people to keep these 
treatments going so, ummm, 
they are acceptable for now 
 
I think eventually I’d be, like, I 
can’t keep offering treatment 
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that’s only like 3% effective. 
Statistically.  Like, I just, I just 
can’t 
 
I feel it is stretching it.  Isn’t 
that the statistic, that only 3% 
of people who enter 
rehabilitation programs 
actually, you know, stay clean, 
and the average amount of 
times that it takes to enter a 
treatment program is about 13 
for someone to actually stay 
clean? 
 
It is evidence based, just, oh my 
gosh, it’s just, it’s, the numbers 
are just so, just so low there 
has to be something wrong   
 
 
 
  
3.  Educational 
Experiences 
  
 13.  Limited Exposure I asked him what he learned 
about it in school, and he stated: 
not much 
 
we talked a little bit 
 
I genuinely don’t remember 
talking that much about 
medically assisted heroin 
 
I honestly don’t know much 
about them 
 
With medication assisted 
treatment, I’d say my 
understanding was modest 
   
we went over it in a very 
cursory way 
 
the general overview    
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 14. Limited Fieldwork 
Experience 
I inquired if he had any other 
experience with clients on 
medication assisted treatment, 
and he answered: 
I’m sure there have been   
 
I kept seeing him when he was 
on Methadone 
 15. Lack of Coursework In reference to his Addictions 
course, he stated: I wish I had 
taken [it] before, you know, 
maybe when I was [in] 
Practicum or Internship 1 
 
it wasn’t required before as a 
pre-req 
 
In reference to Addictions as a 
pre-req, he stated: It would have 
helped me a lot 
 
I would say the (CACREP) 
requirements should be like, 
umm, change them up a little 
bit.  My gosh, allow for 
specialization for the area 
 
if you are in a western PA 
counseling program, specialize 
in that just a little bit more 
 
4.  Other Experiences   
 16. Family and/or Friends in 
Addiction 
Someone I do care for, their 
brother is addicted to heroin, 
and addiction is everything.  
And you know, I’m just like, I 
wish I could talk to the family 
 
 
  
5.  Perceptions Affect 
Client Care 
  
 19. Increased Curiosity I would get curious 
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I think medication assisted 
treatment, oh, what’s their back 
stories? 
 
wonder if, of all the ways to 
deal with addiction, why this 
one for this specific person? 
  
 20. No Difference My feeling towards it are, here 
is another person and I didn’t 
really think too much about the 
medication assisted treatment  
 
a human is a human 
 
 
 
6.  Professional Career 
Choices 
  
 23. Not Enough 
Knowledge/Unpreparedness 
Even if I got the job, I would 
still feel like, unethically 
prepared unless I did legwork 
on my first day there 
 
 
 24. Lack of Interest I mean, I’d do it because it was 
a job 
 
 I would feel restricted 
I wouldn’t 100% believe in it 
from the start, but it’s effective 
for those people who buy into 
it and for those, whom, it is 
their pattern of desire  
 
Individual interview #3.  This interview was conducted with a 25-year-old female who 
had been enrolled full-time in the Clinical Mental Health Counseling Program for more than 
three years at the time of the interview.  She was currently enrolled in Internship 2.  She reported 
that, during the course of her education, she had taken one course which included information on 
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addictions counseling.  She reported that she did not have experience working with opioid 
dependent individuals or individuals in medication assisted treatment. 
Participant #3’s interview was conducted in person using the interview process used with 
Participant #1 and Participant #2.  The interview lasted approximately 32 minutes with the entire 
process including the review of consents and procedures taking approximately 45 minutes. 
Participant #3 appeared to be nervous about participating in the study.  As I was 
preparing to begin the interview, I noticed I felt excitement about another interview.  I found 
myself experiencing an intense curiosity about her thoughts.  I was concerned initially because 
she had appeared to give short answers during our first few interactions, and I was concerned 
about my ability to get her to open up and express her thoughts freely.  
I began the interview by asking her what she knew about medication assisted treatment, 
and she answered, “Not much, I guess.  Medication assisted treatment, I am going to assume, is 
what it sounds like and like, you, ummm, get for treatment, for treatment you get medicine.  I 
don’t know.”  I asked her what came to her mind when she heard the term “medication assisted 
treatment,” and she responded: “I think of psychiatrists.  I think, specifically, that is what I think.  
People who are getting, using medicines that help with their, ummmm, I guess, symptoms or 
whatever.” 
I became concerned at this point that my question was not clear, so I attempted to clarify 
what she though in relation to opioid dependent individuals.  She explained that it was a “crazy 
topic” that she had talked about that day in class, and that from her understanding it concerned 
“how you can use different drugs as a medicine instead of, you know, a recreational drug.”  She 
further clarified that, “You want to be careful with what you give them, ummm, especially 
 92 
them.”  Reviewing the transcripts later, I realized I had missed an opportunity to explore her 
concerns further regarding why she had stated you need to be careful.  
Since she was talking about discussing medication assisted treatment in school, I asked 
her for additional information regarding what she had learned.  She answered, “Like, I don’t 
think, I don’t remember it specifically, any one using that term, which is why I am a little bit 
confused.  What, I guess, which is why I am confused by what it means.”  At this point, I 
debated whether or not I should clarify what “medication assisted treatment” meant, but I 
became concerned that I would influence the results of the study, so I decided to give minimal 
prompts and allow the participant to provide insight to her own understanding without influence.   
She proceeded to recall classes where medication assisted treatment may have been 
discussed, saying: “Now I think of it, umm, in all the classes, but you, ummm, when you learn 
about different diagnoses, you learn about medication that they are given, ummm, but then there 
is also the whole, you know, other than [the] pharmacological side point of view, there is a whole 
treatment point of view that is not really depending on drugs.”  She explained that it tended focus 
on abstinence-based treatment: “When I think of maybe, like alcoholism, like the alcoholic, the 
AA, that model.”  She stated that there was also talk of medication assisted treatment, saying, 
“For instance, you know, I don’t know the name of the drug for whatever they use, but like, it 
helps with them staying away from alcohol and be, like, but it helps them get away from [it],” 
but stated, “I can’t remember but it helps them stay away from it.”  In order to make sure that I 
was understanding her correctly, I questioned if she was referring to Vivitrol, and she nodded her 
head “Yes” and chuckled, commenting, “I am really bad with names of drugs.” 
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Since she had introduced the topic of Vivitrol, I determined this was an opportunity to 
redirect her to the concept of medication assisted treatment which I was interested in exploring.  
In order to accomplish this, I asked her if she was aware of other medication assisted treatment 
options such as Methadone, Suboxone, and Vivitrol, and what came to mind when she heard 
those names.  She replied, “Honestly, I think I need to get my phone out and look at them 
because, yeah, I can’t remember.”     
 I attempted to clarify that she had heard of them but was not really familiar with them, to 
which she replied, “Yeah.”  I asked her if she knew what they were used for, and she answered, 
“No, like even my own medications, I wouldn’t know that.  I know the medication.  I know the 
name of it, but the whole scientific name, I would google that.”   
She explained that her interest in this area was limited, commenting, “I lean more 
towards, like, the behavioral aspect anyways.  I never really wanted to get into the whole, ahhhh, 
you know, drugs and psychiatry and all that.  Whatever it is, I’ve always like, I don’t know, if 
I’m just scared of that?  Like, so, yeah, I never really focused much on drugs.” 
Her mention of the behavioral aspect made me curious about what she thought of when 
she thought of the treatment of addictions.  I asked her how she perceived opioid addiction being 
treated.  She requested clarification of the question, so I asked her, when she thought of 
counseling an individual who was using heroin or maybe mis-using opiates, what did she think 
would be a good treatment option?  “I honestly don’t, don’t know because, I don’t, I haven’t 
much experience in that department.  I would have to do a lot more research.”  She referred back 
to her discussion in class that day and her concerns regarding the use of medication assisted 
treatment, saying, “how, like, people who need different kinds of addictions, how is giving them 
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more drugs helping them?”  She expressed indecisiveness in her stance on medication assisted 
treatment, saying, “I’m not sure where I stand on that exactly,” and noted how she can 
acknowledge the concern, commenting, “I guess I see that point of view.” 
I wanted to explore her concerns about the medication helping with treatment, so I 
clarified if she was curious whether it would help or not, and she responded: “They’re already 
mis-using the opiates.”  Without any prompting, she brought up concerns about trust: “How are 
they gonna trust them?  How can you trust them not to mis-use anything else?”  Recognizing that 
trust appeared to be a concern for her, I decided to explore this more deeply, as this was 
becoming a reoccurring theme in my interviews.  
She explained that trust was a factor for her “especially if they are adults.  I mean, now 
you are going to start monitoring them, monitoring them but, then it is like, but you don’t want to 
baby them, but you can’t trust them.”  She explained that this causes confusion for her, in part 
because: “I would need a lot more research, to do a lot more research, and get a lot more 
experience in that department.”  
Since it appeared I was able to get her to associate medication assisted treatment with 
opioid dependence, I attempted to clarify this connection.  When asked if psychiatry comes to 
her mind when she hears that term, she answered, “Yeah,” but I also asked for clarification, to 
make sure she was not referencing Methadone or Suboxone or things like that, and she again 
responded, “Yeah.” 
At this point, I became concerned that her answers were going to be based off of her 
perception of medication assisted treatment being related to psychiatry.  As a result, I attempted 
to redirect her by asking if she had had any experience with clients on medication assisted 
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treatments like Methadone, Suboxone, or Vivitrol.  She answered, “I know some of my clients 
have mentioned it, but it is something they have used in the past.”  She explained that, at her 
internship, “they already, I’m not gonna say they are cured, they are still in recovery, but they 
already, ummm, [have] gone through the whole, they have already gone through the, like, if they 
have substance abuse, they[’ve] already gone through the whole withdrawal.  They have been 
through treatment center.”  She explained that, at her site, “we don’t deal with that part,” and as a 
result, “that is not something, I ever had direct experience, dealing with somebody.”  She stated 
that, while they did talk about their clients’ pasts, she did not have any experience working with 
opioid dependent individuals. 
Due to her lack of experience, I attempted to use a hypothetical situation in order to 
understand her feelings.  I asked her how she would feel if a client told her they were choosing 
medication assisted treatment as an option.  She answered, “I would probably keep a closer eye 
on them.”  She explained that her caseload comes in “3 days a week, and some days we do 
check-ins and see how they are doing.  I would be more focused on that, those individuals rather 
than everyone else.  I would watch those individuals more than the individuals on my caseload.”   
I asked for clarification in regard to what she meant by keeping a closer eye on them, and she 
responded, “See how they are doing, like, behavior-wise sometimes you can tell; sometimes you 
can tell if they are on something or if they are not, but I’d probably.”  She explained that her 
internship “is a really relaxed environment,” but if she had someone on medication assisted 
treatment: “Me, I guess I wouldn’t be as relaxed around that.” 
She explained, “the whole addiction factor” would make it difficult for her to relax and 
lead her to question, “what if they, what if they’re mis-using?”  She explained that she would be 
concerned they would mis-use “the medication assisted” treatment because: “I wouldn’t assume 
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they would have, ahhh, the substance that they are relapsing from.”  She expressed concern that 
they would mis-use the medication assisted treatment because: “a lot of the, my clients, are 
suicidal, and more than once some of them have mentioned using, popping pills as a way out so, 
like, that is – that is what makes me a little tense.” 
I decided to explore her fear that medication assisted treatment would cause more harm.  
She explained that this fear was related to the “whole addictions factor” and her concern that “if 
they are hooked on something once, I mean, yeah, you should have the option to, ummm, get 
better, but that fear is in the back of your mind that something might go wrong.”  She expressed 
further concern, saying, “When any kind of drugs or medications [come in], I think there is a fear 
of overdosing, whether it is knowingly or unknowingly,” and that: “I have fear in the back of my 
head.” 
In order to explore her perception of clients who have chosen this option, I asked about 
how she perceived them.  She responded, “I think I would perceive them to be, ummm, like 
courageous, that they know that can happen, yet they are still doing it.”  Despite seeing them as 
courageous, she expressed concern about their motivation: “I would hope, ummm, because it 
would be that they want to get better and they are sick of the relapse or whatever.”  She 
explained she would “still have that fear,” which I wanted to explore in terms of whether it was 
related to her previous concerns of trust, which she stated was the case, “Yeah.”  She perceived 
these individuals as “taking a big step, a really big risk to trust themselves.”  She explained that, 
“I have seen, like, in my caseload, you know, but it once a small accident, they are prescribed 
pain killers and then they spiral down.  They, like, this person was perfectly fine and doing really 
good in their recovery.”  These experiences “automatically create a fear or doubt” which affects 
her trust.  
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I transitioned into attempting to gain an understanding of her knowledge of Methadone or 
Suboxone, specifically.  She asked: “Are those drugs that make you kind of sick or are they 
different?”  I explained they are used to treat opioid dependence and asked if they sound 
familiar, and she answered, “It does.  It sounds familiar, but I can’t think of what it is.”  I 
attempted to clarify further if she was familiar with them, but she answered, “Nah, I just 
remember reading about it somewhere.” 
I wanted to understand if she had learned about these drugs in her coursework.  She 
stated: “I think.  Ummm, I think in Delmonico for Addictions.  I think I heard him say it once or 
twice.”  I asked for additional clarification, as to whether she had been taught about them 
specifically.  She explained that, “I was out a lot, so I am not even sure,” which could even affect 
whether or not she knows whether they were discussed.  She stated, “I remember reading it in the 
book and I remember him talking about it, but I don’t, I can’t think of what it was on.” 
I transitioned back to discussing her feelings regarding counseling a client who used 
medication assisted treatment.  I wanted to see if I could get additional information regarding her 
thoughts.  She reiterated similar information as before, “I would be a little bit more careful.  
Make sure how they are doing, how they are feeling?  Make sure you know they have supports in 
place and appointments, stuff like that.” 
Due to her ongoing concerns about monitoring, I wanted to see her perceptions regarding 
taking a position as a counselor who treats clients on medication assisted treatment.  She 
answered, “I would have to think, like, I mean if it is a good job, but I think of a job, but it, guess 
it depends on where I am at the moment.  Could I handle that stress, that job?”  I wanted her to 
reflect on what she perceived as stressful about the job.  She perceived this aspect as: “knowing 
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that, ummm, my whole caseload is like that” as stressful.  She expressed concern in saying, “I 
don’t know if, like, especially if at this point, I don’t think I would be able to go home and sleep 
peacefully at night with all of that.”  She stated that, in order to do the job, she felt: “I would 
need a lot of more experience in handling that type of caseload.” 
Other than her fear, I wanted to see if anything about medication assisted treatment 
specifically made her feel hesitant about taking a job, and she responded, “I think it’s the whole, 
I don’t know if it is a misconception of addictions or the whole idea behind it, that there is 
anything that at this point would make me a little hesitant.”  I wanted additional clarification 
regarding the term “misconception,”, and she clarified that she was not sure if “misconception” 
was the right word, but her concern was related to the potential harm of the treatment: “Like, 
someone is addicted to something and now you’re, especially with the whole opiates, like, are 
you taking more medication?  What are you doing?  I think that would be my concern.”  She 
explained that her fear would also cause her a conflict because “it would be really courageous.  I 
think someone would have to be courageous to take that step, especially if they want to get 
better.  So, yeah, it would be really, so, yeah, but my thought at the end, that would be my 
thought process, but then again, I also understand there are only so many options that you have.” 
In order to understand her fear and anxiety, I wanted to see how her education had 
prepared her for a possible job, and she answered: “Not fully.”  I asked her what may have been 
lacking or what may have been needed to make her feel more prepared.  She stated, “I don’t have 
the full understanding.”  In order to feel more prepared, she added “there should have been a 
little bit more, more, I guess, classes, or at least more focus on the drugs part of counseling.”   
She explained, “We got a lot of information about what drugs, about the drugs and the 
behavioral-wise or, like, we got a lot of information on the, they classified what’s what, but I 
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don’t think we actually get a lot of information on how to deal with somebody who is taking a 
specific drug.” 
Due to her perception that her education had been limited, I wanted to understand if she 
saw any difference in the treatment of clients who were and who were not on medication assisted 
treatment.  She explained that treatment would be “not very much different,” but explained that 
she would: “be wary with medical assisted, knowing they have drugs at hand.”  However, she 
expressed concern about commitment, “whereas others who are trying to work on get[ting] 
treatment for their addiction or something, most likely they probably don’t have much, or that is 
something.”  She elaborated upon this view by saying that clients on medication assisted 
treatment “have it at hand,” which would make her “a little bit more waary.”   I referenced back 
to her earlier statements about her being concerned for them and “having difficulty sleeping at 
night,” and if this would affect her with clients who used medication assisted treatment, to which 
she replied, “Yeah.” 
I wanted to confirm whether she had experience with clients on medication assisted 
treatment in her fieldwork, given her reports of increased anxiety.  She stated, “They are not on it 
during it.”  I asked, since she was aware clients were on it, if they ever talked about it, and she 
answered, “Not really.  I mean, they talk about using drugs, but not really the treatment they 
have gone through, ummm, to be clean.” 
The final question of the interview was if there was anything I had not asked that I should 
have asked which would help me understand her beliefs regarding the use of medication assisted 
treatment.  She explained, “I was never really interested in the whole drugs and alcohol concept.”  
She explained that her culture affected this, as “I wasn’t really exposed to much information like, 
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real information, until I went to university, so not even ten years.”  As a result of this limited 
exposure, she explained that she was “still learning about the different drugs and the treatment 
for it.”  She went on to further explain that, “growing up, especially, it was always, why would 
someone even start?  Like, I never really was exposed to all of that, now.”  Due to her limited 
exposure, she added, “it never really interested, in all of that.”  She proceeded to explain that she 
continues to have no interest in the subject, “So even now, like, um, not going to go home and 
start doing research.  It’s not happening.  Like, if I come across an article or a website, I’ll look 
into it, but it is not something I actively pursue.”  She explained that she feels she is in a 
“protective bubble” and that, as she is “coming out of that today, I am learning a lot more and I 
understand that it’s important to be educated about it and to understand,” but “I won’t go home 
and do research, but eventually I will look into it, so we can get exposed to it.”  She 
acknowledged the: “need to be updated.  I need to see what kinds of medications there are, what 
types of programs there are, and what’s in the program.”  She said that, for her, this process is: 
“baby steps, but I’ll get there.”  
At the conclusion of the interview, I walked Participant #3 to the library lobby and 
thanked her for her participation.  Upon parting, I returned to the library interview room and 
collected my thoughts.  I was pleased that some themes appeared to have begun repeating; 
however, this interview also illustrated missing themes.  I became concerned about the risk that 
the data would not become saturated.  At this time, I took field notes on any further thoughts I 
had.   
The narrative above provides a review of Participant #3’s description of the phenomena 
being studied.  If information was not relevant to the phenomena, it was excluded from the 
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analysis.  This chart provides Participant #3’s supporting statements for the phenomena being 
studied. 
Table 4:   
Participant #3’s Supporting Statements 
Analytical Categories 
from Research Questions 
Themes Supporting Statements 
1.  Attitudes and Beliefs 
Towards Clients 
  
 1. Lack of Commitment  whereas others who are trying 
to work on get[ting] treatment 
for their addiction or 
something, most likely, they 
probably don’t have much, or 
that is something 
 2. Lack of Motivation I would hope, ummm, because 
it would be that they want to get 
better and they are sick of the 
relapse or whatever    
 
 
 3. Mistrust How are they gonna trust 
them?  
 
How can you trust them not to 
mis-use anything else?    
 
you can’t trust them 
 
 
 6. “trying to better themselves” I think I would perceive them to 
be, ummm, like, courageous 
 
 they want to get better  
 
taking a big step, a really big 
risk to trust themselves 
 
  
2.  Attitudes and Beliefs 
Affect Perception 
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 7. “I don’t know” Not much, I guess 
 
People who are getting, using 
medicines that help with their, 
ummmm, I guess, symptoms or 
whatever 
 
how you can use different 
drugs as a medicine instead of, 
you know, a recreational drug?   
 
Like, I don’t think, I don’t 
remember it specifically, 
anyone using that term, which 
is why I am a little bit confused.  
What, I guess, which is why I 
am confused by what it means 
   
I can’t remember, but it helps 
them stay away from it 
 
I think I need to get my phone 
out and look at them because, 
yeah, I can’t remember 
 
It sounds familiar, but I can’t 
think of what it is 
 
 8. Mixed Feelings Yeah, but I’m not sure where I 
stand on that exactly 
 
 9. “It is a good thing.” you should have the option to, 
ummm, get better 
 
 10. Harming Someone’s Body they’re already misusing the 
opiates  
  
When asked if psychiatry 
comes to her mind when she 
hears that term, she answered, 
yeah, but not in relation to 
Methadone or Suboxone or 
things like that, again she 
answered: yeah 
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fear is in the back of your mind 
that something might go wrong 
 
I think there is a fear of 
overdosing, whether it is 
knowingly or unknowingly 
 
Like, someone is addicted to 
something and now you’re, 
especially with the whole 
opiates, like, are you taking 
more medication?  What are 
you doing? 
 
 
 11. Uncertainty of Effectiveness How, like, people who need 
different kinds of addictions, 
how is giving them more drugs 
helping them? 
 
  
3.  Educational 
Experiences 
  
 13. Limited Exposure I don’t think we actually get a 
lot of information on how to 
deal with somebody who is 
taking a specific drug 
 
I think I heard him say it once 
or twice 
 
I remember reading it in the 
book and I remember him 
talking about it, but I don’t, I 
can’t think of what it was on. 
I don’t think we actually get a 
lot of information 
 
 14. Limited Fieldwork 
Experience 
 I don’t, I haven’t much 
experience in that department 
[addictions].  I would have to 
do a lot more research 
 
that is not something I ever 
had direct experience dealing 
with [with] somebody 
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I would need a lot of more 
experience in handling that 
type of caseload 
 
 15. Lack of Coursework there should have been  a little 
bit more, more, I guess, 
classes, or at least more focus 
on the drugs part of counseling 
 
 
4.  Other Experiences   
 17. Culture I wasn’t really exposed to 
much information like, real 
information, until I went to 
university, so not even ten 
years 
   
growing up, especially, it was 
always, why would someone 
even start?  Like, I never really 
was exposed to all of that, now 
 
She explained that she feels 
she is in a protective bubble 
  
5.  Perceptions Affect 
Client Care 
  
 19. Increased Curiosity someone is addicted to 
something and now you’re, 
especially with the whole 
opiates, like, are you taking 
more medication?  What are 
you doing? 
 
 
 20. No Difference She explained that treatment 
would be not very much 
different 
 21. Increased Counselor Anxiety  you want to be careful with 
what you give them, ummm, 
especially them 
 
Me, I guess I wouldn’t be as 
relaxed 
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I would be a little bit more 
careful.  Make sure how they 
are doing, how they are 
feeling? 
 
what if they, what if they’re 
mis-using 
 
I have fear in the back of my 
head 
 
automatically create a fear or 
doubt 
 
still have that fear, 
be wary with medical assisted, 
knowing they have drugs at 
hand 
 
 22. Increased Monitoring I would be more focused on 
that, those individuals rather 
than everyone else. I would 
watch those individuals more 
than the individuals on my 
caseload    
 
See how they are doing like 
behavior wise sometimes you 
can tell sometimes you can tell 
if they are on something or if 
they are not but I’d probably 
 
I would be a little bit more 
careful.  Make sure, how they 
are doing, how they are 
feeling? Make sure you know 
they have supports in place 
and appointments, stuff like 
that 
 
She elaborated that clients on 
medication assisted treatment 
have it at hand, which would 
make her a little bit more 
weary 
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I would probably keep a closer 
eye on them 
 
now you are going to start 
monitoring them, monitoring 
them, but then it is like, but 
you don’t want to baby them, 
but you can’t trust them 
 
 
 
6.  Professional Career 
Choices 
  
 23. Not Enough 
Knowledge/Unpreparedness 
I would need a lot of more 
experience in handling that 
type of caseload 
 
I wanted to see how her 
education prepared her for a 
possible job, and she 
answered: Not fully   
 
I don’t have a full 
understanding 
 
 24. Lack of Interest I never really wanted to get 
into the whole, ahhhh, you 
know, drugs and psychiatry 
and all that   
I never really focused much on 
drugs. 
I was never really interested in 
the whole drugs and alcohol 
concept   
it never really interested, in all 
of that 
I mean, if it is a good job, but I 
think of a job 
 
 107 
 25. Fear Could I handle that stress, that 
job? Knowing that, ummm, my 
whole caseload is like that  
I don’t know if, like, especially 
if at this point, I don’t think I 
would be able to go home and 
sleep peacefully at night with 
all of that 
 
 
Individual interview #4.  This interview was conducted with a 25-year-old male who 
had been enrolled full-time in the Masters in School Counseling Program for more than two 
years at the time of the interview.  He was currently enrolled in Internship 2.  He reported that, 
during the course of his education, none of the classes had included information on addictions 
counseling.  He also reported that he did not have experience working with opioid dependent 
individuals or individuals in medication assisted treatment. 
The interview was conducted via telephone.  Due to time constraints, the interview had to 
be rescheduled once.  Prior to the interview, Participant #4 had been emailed the demographic 
questionnaire and consent form for his review.  The consent form and demographic form were 
mailed to him via U.S. Mail in order to obtain original copies since he was unable to email them 
to me.  He sent them back to me via pre-paid postage.   
 I contacted Participant #4 via telephone at our pre-arranged meeting time.  I conducted 
the interview in a private area in my home where the answers would not be heard by others.  
Prior to the start of the interview, I reviewed the consent form and voluntary participation form 
sent via U.S. Mail.  He was advised that his participation was voluntary and that he could end the 
interview at any time.  I reviewed the previously signed consent form, which included 
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information regarding who I am as the researcher, the purpose of the study, study procedures, the 
expected duration of the interview, risks and benefits, compensation, confidentiality, the right to 
withdraw, a summary of results, and voluntary consent.  I asked him if he had any questions 
before we began.  I informed the participant of my intent to audiotape the interview and received 
his consent to do so.  I advised him that I would be transcribing the interview and that, once it 
was transcribed, the tape would be erased.  He stated his agreement.  At this time, he agreed to 
continue his participation in the study.  The interview lasted approximately 31 minutes with the 
entire process, including review of consents and procedures, taking approximately 40 minutes. 
Participant #4 sounded anxious to participate in the study.  As I was preparing to begin 
the interview, I noticed I had anxiety about completing the interview.  I recognized that I was 
concerned because it was the first interview I would be conducting via phone.  I recognized that 
doing the interview via phone might present a challenge for me, as I would be unable to analyze 
body language or facial expressions that could affect my line of questioning or give me 
additional information.  At this point, I made a conscious decision to be more mindful of the 
words or phrases he might use as a way of trying to understand any implied meaning and to 
guide my line of questioning. 
Since this interview was being conducted via telephone, I made the decision to ask the 
participant on tape if I had his permission to audiotape this call, despite his previous consent for 
me to do so, to which he replied, “Yes.”  Once his permission was granted again, I began the 
interview. 
In order to gage his basic knowledge of medication assisted treatment, I asked him what 
he knew about medication assisted treatment.  He responded,  
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What I would know is that, you know, if you have an aliment, you can speak with a 
doctor and a doctor can use their best knowledge of the situation and prescribe you, 
prescribe you medication that can help you with that.  Then use a pharmacy and use 
medication to help you, you know.  You know, whether it be antibiotics or some sort of 
other type of medicine to help you, you know, treat whatever your aliment is.   
I recognized that my question may not have been clear, so I attempted to clarify what he 
knew about medication assisted treatment in regards to opioid dependence.  He stated:  
“I guess I would be a little less knowledgeable about that, but I, what I do know is that, 
ummm, with opioids and medications, they can oftentimes those be linked together and 
correlated.  You know, oftentimes there are people that are, ummmm, addicted to, 
whether it be, umm, heroin or other types of drugs like that, fentanyl.  They can 
oftentimes use drugs like OxyContin, other types of, or Xanax, whatever sort of 
prescription drugs they can get their hands on.  Ummm, oftentimes can be related to one 
another like they have similar chemical build-ups. 
I attempted clarify what he meant by noting “the similar chemicals,” to which he replied, 
“I know that those are very similar.”  Without prompting, he began to discuss his knowledge 
level, “I guess I don’t have too much firsthand knowledge.”  He stated,  
I don’t know many people that abuse, ummm, heroin or hard drugs, but I do know people 
that have had difficulties with, ummm, certain prescription drugs.  I know that both can 
be pretty addicting and they both need to be, ummm, monitored, you know, especially 
prescription drugs that be, being prescribed; that there are certain ways you are supposed 
to take them and, ummm, you have to be very careful and cautious when you use them. 
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In order to try to understand where his understanding of the term “medication assisted 
treatment” came from, I inquired about what he had learned about medication assisted treatment 
in school.  He responded, “Being in counseling, I actually haven’t learned too much.  This is 
from, ummm, school counseling perspective, so I didn’t take Addictions counseling, so I guess I 
wasn’t taught too much, and you are taught in counseling you will run into people with drug 
problems, things like that.”  He explained, “Most of my understanding of drug addiction came 
from kinda more my own readings and more of my own, ummm, personal interests; you know, 
documentaries I have watched, et cetera.”  
At this point in the interview, I became concerned that there was a misunderstanding 
regarding the term medication assisted treatment.  Internally, I debated about whether or not to 
clarify and/or educate Participant #4 regarding the term.  Instead, I attempted to redirect by 
asking if any of his documentaries had mentioned commonly used medications, such as 
Methadone, Suboxone, or Vivitrol.  He answered, “I think I know a little bit about some of those 
like, ahhh...  Is Vivitrol used to help, ummm, curb people’s addictions to drugs?  I think like 
Antabuse is for alcohol and things like that?  Just a few.”  I answered his question with a simple 
“Yeah” with the intent to reassure him that this was what I was referring to.  
Without prompting, he stated: “Most of my knowledge of that did not come from 
graduate school work.  It came from, uhhh, my own, my own research or just like my own, yeah, 
no, just like, you know, reading similar novels regarding counseling books.  Things like that will 
come up, but as far as actual coursework for school counseling, I didn’t come across anything 
like that.”  I asked him specifically if he had been taught about medication assisted treatment in 
terms of Methadone, Suboxone, and Vivitrol in school, and he answered, “No, not really.”  He 
proceeded to explain, “I guess I am not sure if that is like a hindrance on like what I was taught, 
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or not taught in grad school [but…] I think it would have been cool to learn a little bit about 
substances from someone who has firsthand knowledge of how this works.” 
I transitioned the conversation to his thoughts regarding the use of medication assisted 
treatment as a treatment for opioid dependence.  He commented, “I have mixed thoughts.”  He 
explained that he thought “everyone should have, like, the right to choose their treatment.”  He 
stated that “if treatments have, you know, double blind studies and third-party studies and they 
are proven to work, I think it is a wonderful thing and that’s something worth pursuing.”  Despite 
seeing the benefits, however, he questioned the effectiveness: “A few people that are addicted to 
opioids, and you ask them about getting a certain type of, you ask them to take a certain type of 
treatment which may or may not work for them; that might be like asking a drunk person 
whether or not they are good to drive, you know?  Just because they are having difficulties.”  He 
explained that his other concern was “the addictive qualities of a lot of prescription drugs.” 
Without prompting, he next began talking about his personal experience and his 
concerns:   
I just, I mean, I come from a pretty, like, educated background, like most of my friends 
have similar educational backgrounds, whether it be young professionals or people in 
graduate school, things like that.  I know a good amount of people, whether it be from 
high school sports, college, college sports, ummm, different walks of life, but mostly 
similar to mine that have had issues dealing with prescription drug abuse, so I think it’s, I 
think it’s interesting that people want to get off opioid addiction by using prescription 
drugs.  Just because I feel, like, so many people are addicted to prescription drugs 
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themselves, so I think it’s something needs a lot research and needs a lot of, like, being 
monitored heavily.  
I asked him what his additional thoughts were regarding the use of medication assisted 
treatment, and he responded: “I guess I am just not knowledgeable enough on the subject.” 
I attempted to get additional information in regard to his perception, and he began talking 
about how people’s educations or experiences may effect the way they treat clients.  He noted: 
I mean, when people are super-educated on this subject, they might just think drugs are 
bad and, you know, treat every drug the same and... Or, like, people might just use their 
own personal opinions or, like, and their experiences, but that person’s might not be 
everyone’s experience or if, you can’t cite like literature and studies like that, you are 
basically just speaking from your own experience, which may not be a good thing, and it 
may not be beneficial to your client. 
I attempted to understand what thoughts came to his mind when he heard the term 
“medication assisted treatment.”  He responded:   
When I hear medication assisted treatment, what comes to my mind? I think of someone 
that’s obviously addicted to some sort of drug.  And, ummm, I would think mostly in my 
mind, I think mostly addicted to street drugs going to, ummm, a doctor, you know, their 
physician and, you know, talking about how they are addicted.  I am thinking in more of 
a clinical sense, umm, a doctor talking about how they can use medicine to help that and I 
think it is something that a lot of people that may be addicted to, you know, whatever 
drug they’re on…  They may have mixed emotions towards [it] because they, you know, 
is this gonna be something else I am going to become addicted to?   
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He further clarified: “I guess in my limited understanding ,I might think of it as a Band-
Aid.”  He also clarified that his limited knowledge might be affecting his perception, saying, 
“I’m not as knowledgeable on the subject as I would like to be.”  I attempted to explore if he had 
come across any students in his fieldwork who had used medication assisted treatment, and he 
answered, “I haven’t come across any case studies or even in my own limited experience in the 
field; nothing really, ummm, I’ve come across.” 
Due to his limited fieldwork experience, I attempted to understand his perception of 
individuals who may choose this treatment option based off of his own research.  
I guess it is a good thing because they are trying to get help.  I think oftentimes maybe 
they might have looked into, like, the research a little bit, you know, if there is positive 
research out there for medication assisted treatment for, ahhh, you know, whatever their 
ailment is or whatever their addiction is.  Uhhh, I think, I think it’s almost like a futuristic 
type thing, it is… probably hasn’t been around forever.  Like, uhhh, you know, one of 
those ‘talk to your doctor about this’ – it might be like one of those, trying to make 
themselves better. 
I wanted to explore his perception of such patients bettering themselves.  He answered,  
Maybe that they have tried a lot of other things.  Maybe that they have tried a lot of the 
social, umm, you know, maybe they have tried a lot of support groups and got their 
families involved in their lives and things like that; it just hasn’t worked and I guess 
they’re just, more, I wouldn’t say like a last straw, but they really are trying to take care 
of the biological component to their addiction the best they can.   
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I redirected back to his perception of individuals who chose this treatment option.  He answered, 
“I see it as someone being pretty nervous about the whole thing.  They are probably, if they 
chose that option.  They are probably really, ummm… guilt, they feel guilty about, you know, 
their addiction, and they are doing something.”  He stated, “I see them as someone trying to 
better themselves, I guess.” 
I asked him about his perception of Methadone and Suboxone.  He responded, “I guess I 
am not too knowledgeable about everything, uhhh, related to this.”  He explained his concerns 
regarding the possible research: “I mean, if these are drugs that are used, like, if doctors are 
prescribing these drugs, you’d think, you’d think they would do some sort of research to prove 
they work.”  He expressed concern about the negative side effects “with a lot of prescription 
drugs out there, it’s a laundry list of negative side effects but, ummmm, you know, everyone 
reacts to medicine a little bit differently.”  Despite his concerns regarding the side effects, he 
expressed, “I think it could be a good thing for some people and, if it wasn’t a good thing for 
some people, then it probably wouldn’t exist.” 
Participant #4 mentioned the positives of medication assisted treatment.  I attempted to 
see if this translated to his feelings about counseling a client who uses medication assisted 
treatment.  He responded: 
I think it would be interesting to talk about.  I think it would be really interesting to listen 
to their attitudes about it because, as I was just feeling out words to describe, there is 
probably a lot of emotions going on there.  Umm, their experiences with it are probably 
pretty tumultuous, you know.  They are starting a new prescription and, with starting a 
new prescription, you will notice a lot of changes, ummm, in your body and your mind 
 115 
and, ummm….  As I was saying earlier, if you are doing your best to take care of the 
biological aspect of addiction, you can really focus a lot more on the social aspect.  So, I 
think it could be pretty interesting.  Ummmm, I guess I haven’t been super well trained, 
admittedly, in dealing with that population, but at the same time, I think it could be a 
pretty positive experience because it is also showing that clients are at least taking some 
steps towards, you know, work on some of their issues. 
Despite his being in school for counseling, I wanted to understand how his attitudes 
might affect his professional career choices, so I asked him how he would feel about taking a job 
as a counselor, maybe in a school where students chose medication assisted treatment.  He 
commented: 
I think it would be a pretty interesting position and, um, you know, I wouldn’t feel wrong 
about it.  I think with any sort of job, you kinda looking into the company you work for, 
its, ummm, its mission, mission statement, things like that, and you know, as a counselor, 
you are a helper, you want to help people get better, and I think you know if you are 
counseling people with that, like that, as I was saying earlier, it’s people trying to get 
better, then it could be a good population to work with.  Ummm, I think it is important 
that the staff are well trained, you know.  If you hired me and told me tomorrow that I 
would be working with this population, and the only training I had was an HR thing and, 
where, you know, I walked into my cubicle and just gave, ummm, a voided check for my 
deposit and then I had to meet, you know, a dozen new clients the next day, I would be 
kind of worried about taking that job.  Just because I feel like I need, ah, to be 
knowledgeable about, you know, these medication assisted treatments so that I can think, 
just, I think, just keeping everyone knowledgeable about drugs and how they work is 
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pretty much, ummm, key, umm, for keeping a place like that, ummm, functioning highly, 
highly functioning. 
Since he had stated that he would be comfortable taking a job as a counselor working with 
mediation assisted treatment, with proper preparation, I wanted to see how he would feel towards 
individuals and their choice to use medication assisted treatment, or if it would affect the type of 
care he was providing.  He answered: 
I guess I wouldn’t feel any negative attitudes towards them.  You aren’t like my personal 
accounts and my preferences.  I try not to, you know, put too many labels or judge or 
place my own values on people.  I think, like I have been saying the past couple 
questions, if people [are] trying to improve themselves, I think it is good.  At the same 
time, maybe keep them researching and, you know, maybe there is like blogs on the 
internet of, you know, people who are using treatment that monitor them and, you know, 
maybe have a little community there.  I think it is… I think it’s a positive thing.  It is not 
necessarily, I don’t think, anything terribly negative about them.” 
I asked for clarification regarding what he had said about monitoring them.  He explained, “I 
would like to do self-checks, see, how you are feeling?  It is important to be cognizant of how 
you are feeling at the moment and bring patients back down to that sort of here-and-now 
perspective.”  I transitioned back to his thoughts regarding taking a position as a counselor 
treating clients  who use medication assisted treatment.  I wanted to understand how his 
education may have prepared him for taking such a job.  He commented: 
Ummm. Honestly, I was, I liked Duquesne’s program a lot, but at the same time, that’s, 
ahhh, a lot of the addictions related… really didn’t, ummm, addictions related counseling, 
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I felt like was kinda slighted,  you know.  I know a lot of my friends in the cohort were 
required to take addictions counseling, but I as a school counselor wasn’t.  I think I just 
had to take, like, a special education course in its place or something like that.  So, I 
guess I would be qualified technically, like I have a… I’m a National Certified Counselor 
and, um, something that would be my own personal responsibility, you know.   Whether 
that be to take a course or whether it be to do my own research, ummm, you know, study 
up a little bit more on that.  I guess, I would feel a little, ummm, anxious; I would feel a 
little underprepared.  I feel like the Duquesne counseling program could have prepared 
me more for that population because, as a school counselor, I mean, a lot of my friends in 
mental health are like, ‘We can’t be school counselors,’ but school counselors can be any 
type of counselor because they have, allow National Certified Counselors that have a 
school counseling certificate.  And I was thinking about that and I thought it was cool, 
but at the same time, there are a few courses that you guys took that I really wish I took.  
I mean, I got on my CPCE and my NCE, I got really, really high marks and I finished 
them, ummm, super quickly, and I felt really prepared.  And since we are having a 
psychologically undergrad, background in psychology undergrad, I have read like a 
million books by different psychologists and I really feel like I understand a lot of terms 
in psychology and counseling, but at the same time, I feel there are certain things, you 
know… you can read a million books or you can listen to a bunch of podcasts or, um, you 
know, you read Counseling Today magazine, things like that.  But at the same time, you, 
there is still so much you missed by not immersing yourself in things that may not have 
been super interesting to you at first.  I feel like addictions like that might not be my 
favorite, ummm, branch of counseling, but it is something that I think taking a course in 
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would have been really beneficial for me, to kinda learn something new and become a 
better counselor.  
Since he felt his education had not prepared him, I inquired about his experience in his 
fieldwork.  He denied that he had had any exposure to medication assisted treatment in his 
fieldwork, saying: “No, I, ahhh, my fieldwork was at a six-twelve magnet school.” 
    Due to him lacking experience and feeling unprepared, I attempted to ascertain what would 
have made him feel more prepared, and he commented, “I just feel taking, ummm, the addiction 
class would have helped.”  He also stated, “I feel like taking more exams would have been really 
beneficial.”  He proceeded to explain that his lack of exams had not been very beneficial to him, 
saying, “I didn’t really take that many exams in graduate school.”  He explained that he also felt 
it would have been more helpful “to require the students to report on things they might not have 
been as knowledgeable about.”   
     At the end of the interview, I asked him if there was anything that I should have asked him 
that I had not, which would help me better understand his position.  Initially, he stated, “No, not 
in particular.”  Then he went on to further state, “You know, if you don’t know too much, then 
you aren’t going to have too much of an opinion.  I guess I, maybe you know, I connected my 
lack of opinion with my lack of knowledge, so I think that is basically where I stand.” 
     Once the interview was ended, I stopped the tape and thanked Participant #4 for completing 
the interview, and the call was ended.  Once the call ended, I took an opportunity to reflect on the 
call.  I recognized that doing the interview via phone had presented challenges due to my not 
being able to review body language, and this made it more difficult to gage the participant’s 
responses.  I became concerned because he had seemed to be guarded and I had had a difficult 
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time understanding his attitudes and beliefs towards clients.  I was struck by one of his final 
statements regarding his lack of knowledge affecting his lack of opinion.  At this time, I took the 
opportunity to make additional field notes. 
The narrative above provides a review of the participant’s description of the phenomena 
being studied.  If information was not relevant to the phenomena, it was excluded from the 
analysis.  This chart provides Participant #4’s supporting statements for the phenomena being 
studied. 
Table 5:   
Participant 4’s Supporting Statements 
Analytical Categories 
from Research Questions 
Themes Supporting Statements 
1.  Attitudes and Beliefs 
Towards Clients 
  
 1. Lack of Commitment is this gonna be something else 
I am going to become addicted 
to? 
 6. “trying to better themselves” one of those trying to make 
themselves better 
someone trying to better 
themselves 
 
  
2.  Attitudes and Beliefs 
Affect Perception 
  
 7. “I don’t know” I would be a little less 
knowledgeable about that 
I guess I don’t have too much 
first hand knowledge   
I guess I am just not 
knowledgeable enough on the 
subject 
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I’m not as knowledgeable on 
the subject as I would like to 
be 
I guess I am not too 
knowledgeable about 
everything, uhhh, related to 
this 
 
 8. Mixed Feelings I guess I have mixed thoughts 
 9. “It is a good thing.” if treatments have, you know, 
double blind studies and third 
party studies, and they are 
proven to work, I think it is a 
wonderful thing and that’s 
something worth pursuing 
I think it is, I think it’s a 
positive thing   
I guess it is a good thing 
I think it could be a good thing 
for some people 
if people [are] trying to 
improve themselves… I think it 
is good 
 
 10. Harming Someone’s Body He explained that his other 
concern is: the addictive 
qualities of a lot of 
prescription drugs 
  
with a lot of prescription drugs 
out, there is a laundry list of 
negative side effects 
 11. Uncertainty of Effectiveness a few people that are addicted 
to opioids, and you ask them 
about gettinga  certain type of, 
you ask them to take a certain 
type of treatment which may or 
may not work for them, that 
might be like asking a drunk 
person whether or not they are 
good to drive, you know?  Just 
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because they are having 
difficulties. 
 
I think it’s something needs a 
lot research 
 
 I guess in my limited 
understanding I might think of 
it as a Band-Aid 
 12. Lack of Monitoring needs a lot of, like, being 
monitored heavily 
 
 
  
3.  Educational 
Experiences 
  
 13. Limited Exposure Being in counseling, I actually 
haven’t learned too much   
I guess I wasn’t taught too 
much 
most of my knowledge of that 
did not come from graduate 
school work 
as far as actual coursework for 
school counseling, I didn’t 
come across anything like that 
I asked him specifically if he 
had been taught about 
medication assisted treatment 
in terms of Methadone, 
Suboxone, and Vivitrol in 
school, and he responded: No, 
not really 
I haven’t come across any case 
studies 
addictions related counseling, I 
felt like was kinda slighted 
 
 14. Limited Fieldwork 
Experience 
even in my own limited 
experience in the field, nothing 
really, ummm, I’ve come across 
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Denying that he had exposure 
to medication assisted 
treatment in his fieldwork, he 
said, No, I, ahhh, my fieldwork 
was at a six-twelve magnet 
school. 
  
 15. Lack of Coursework I know a lot of my friends in the 
cohort were required to take 
addictions counseling, but I as 
a school counselor wasn’t 
  
I think it would have been cool 
to learn a little bit about 
substances from someone who 
has first hand knowledge of 
how this works 
it is something that I think 
taking a course in would have 
been really beneficial for me, to 
kinda learn something new and 
become a better counselor  
I didn’t take Addictions 
counseling 
I just feel taking, ummm, the 
addiction class would have 
helped 
 
 
 
4.  Other Experiences   
 16. Family and/or Friends in 
Addiction 
I know a good amount of 
people, whether it be from high 
school sports, college, college 
sports, ummm, different walks 
of life, but mostly similar to 
mine, that have had issues 
dealing with prescription drug 
abuse 
 
 18. Others People’s 
Stories/Perceptions 
most of my understanding of 
drug addiction came from 
kinda more my own readings 
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and more of my own, ummm, 
personal interests, you know, 
documentaries  I have 
watched, et cetera. 
 
most of my knowledge of that 
did not come from graduate 
school work.  It came from, 
uhhh, my own, my own 
research 
 
 
  
5.  Perceptions Affect 
Client Care 
  
 19. Increased Curiosity I think it would be interesting 
to talk about.  I think it would 
be really interesting to listen 
to their attitudes about it 
because, as I was just feeling 
out words to describe, there is 
probably a lot of emotions 
going on there 
 
 22. Increased Monitoring I would like to do self-checks, 
see how you are feeling?  It is 
important to be cognizant of 
how you are feeling at the 
moment and bring patients 
back down to that sort of 
here-and-now perspective 
 
 
6.  Professional Career 
Choices 
  
 23. Not Enough 
Knowledge/Unpreparedness 
I guess I haven’t been super 
well trained, admittedly, in 
dealing with that population 
 
Just because I feel like I need 
to be knowledgeable about, 
you know, these medication 
assisted treatments 
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that would be my own 
personal responsibility, you 
know.   Whether that be to 
take a course or whether it be 
to do my own research, 
ummm, you know, study up a 
little bit more on that 
 
I would feel a little 
underprepared 
 I feel like the Duquesne 
counseling program could 
have prepared me more for 
that population 
 24. Lack of Interest I feel like addictions like that 
might not be my favorite, 
ummm, branch of counseling 
 
 
 25.  Fear I would be kind of worried 
about taking that job 
 
I would feel a little, ummm, 
anxious 
 
 
Individual interview #5.  This interview was conducted with a 27-year-old female who 
had been enrolled full-time in the Masters in Marriage, Couple, and Family Counseling Program 
for more than two years at the time of the interview.  She was currently enrolled in Internship 2.  
She reported that, during the course of her education, one class had specifically discussed 
addictions, but “most throw the notion of the possibility of working with an addict.”  She 
reported that she had had experience working with opioid dependent individuals and individuals 
in medication assisted treatment. 
The interview was conducted via telephone.  Prior to the interview, she had been emailed 
the demographic questionnaire and consent form for her review.  The consent form had been 
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received from her during in-person recruiting trip in her internship class.  She was emailed a 
second copy of the demographic form, which she completed and emailed back to me.   
I contacted Participant #5 via telephone at our pre-arranged meeting time.  I conducted 
the interview in a private area in my home where the answers would not be heard by others.  
Prior to the start of the interview, I reviewed the consent form and voluntary participation.  She 
was advised that her participation was voluntary and that she could end the interview at any time.  
I reviewed the previously signed consent form, which included information regarding who I am 
as the researcher, the purpose of the study, study procedures, the expected duration of the 
interview, risks and benefits, compensation, confidentiality, the right to withdraw, a summary of 
results, and voluntary consent.  I asked her if she had any questions before we began.  I informed 
the participant of my intent to audiotape the interview and received her consent to do so.  I 
advised her that I would be transcribing the interview and that, once it was transcribed, the tape 
would be erased.  She stated that she agreed.  At this time, she agreed to continue her 
participation in the study.  The interview lasted approximately 28 minutes with the entire 
process, including review of consents and procedures, taking approximately 35 minutes. 
Participant #5 sounded excited about participating in the study.  As I was preparing to 
begin the interview, I noticed I was more confident about my ability to complete the interview 
via phone, as this was the second phone interview.  Based on my previous experience with a 
phone interview, I made a conscious decision to be more mindful of possible language clues. 
Since this interview was being conducted via telephone, I made the decision to ask 
Participant #5 on tape if I had her permission to audiotape the call, despite her previously having 
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consented to my doing so, to which she replied, “Yeah, that’s fine.”  Once her permission was 
granted again, I began the interview. 
I started the interview by attempting to assess her knowledge of medication assisted 
treatment, and she answered, “I mean, we briefly talked about it in our addictions class.”  She 
began to describe her practicum experience, where “a lot of the women there use, like, 
Methadone kinda as their maintenance drug.”  She also described experience with another client 
outside of her practicum: “I know one of my clients that I was previously working with also used 
it as her maintenance drug.”  For confidentiality concerns, the name of the agencies she 
referenced have been removed.  She explained: “I do know that you can still get a high off of it if 
the dose is too high, or sometimes people will take like, Xanax or something, then will use crack 
or cocaine.  Ummm, so if you do use heroin, it really doesn’t give you that high because it blocks 
that.”  She explained that, in class, they also discussed: “different things, from using, like, LSD 
in a safe environment to treat Posttraumatic Stress Disorder or using, ummmm, certain types of 
drugs to treat different types of disorders versus, like, maintenance kind of drugs in that kind of 
aspect.”   
She explained that most of her knowledge came from her internship experience, “mostly 
from there because the women lived there 24/7.  I was completely in their environment.”   
Without prompting, she described what she witnessed with her clients.  “I mean, seeing them 
when they came back from the clinic, some of them were fine.  Some of them were like asleep, 
some of them, you know, because their doses were too high maybe or they needed changed.”  
She explained that, “I was kinda just thrown in that environment and saw it first hand in that 
aspect versus reading it in a textbook.” 
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I inquired to see what she had learned about medication assisted treatment in school, and she 
responded: 
We briefly, we touched about, in Addictions.  It was more, that class was more geared 
towards, like, if you are working with addicts.  What are different ways you can, like, do 
counseling with them that isn’t just, sit here and talk kinda, of, like multimedia things we 
can bring into the sessions.  Ummm, I guess, like, the medications were kinda, everyone 
had their pros and cons.  Should we allow them to do this?  Should we still have 
Methadone clinics?  Ummmm, there was another one they were talking about.  I can’t 
remember off the top of my head.  Some type of, like, clinic for something, but I can’t 
remember what it was.  It was just, should we keep doing those?  Should we not do 
those?  Whether it is like Suboxone or Narcan, is that okay?  At the time, people who 
overdose are like, ‘Whoa, I can just go and get this Narcan injection or, ummm, the 
inhalant, and I will be fine, so I can just go out and use; doesn’t really matter.’  So, like, it 
kinda, it has pros/cons.  If you are using responsibly, most clients that I have worked with 
have good experiences with it, but then again, some may sell it, some may abuse it.  I 
know some people have to go [to] the clinic to get their doses while other people, once 
they prove that they are responsible enough, they can get, like, take-home prescriptions 
with them.  Ahhh, which I didn’t get that, until a couple weeks ago actually with that.  
So, that’s kind of where we were at in Addictions class, talking about that.  It was more 
of just, like, what were our opinions versus should we keep doing these, should we not, 
and that kinda stuff.” 
Her explanation of her classroom’s discussion and many of the questions they were 
debating prompted me to ask her about her thoughts regarding the use of medication assisted 
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treatment as a treatment option.  She answered, “For me personally, if it’s working for them and 
they are using it responsibly, I don’t see what the issue is with that.”  Despite not seeing the issue 
with it, she talked about her mixed feelings regarding the use: “I’m sure it helps something, but it 
probably damages something else in the long-run and it probably needs to be… more studies 
done with that.”  She discussed a client and noted that she “gets take-home medications like 
Methadone.  She keeps it in, like, a lock box; she keeps the keys on her because there are kids in 
the house.”  She stated that her client “just had a baby last month; CYF was involved in that 
because, obviously, the baby was born with, like, withdrawal.”  She talked about how that was 
“upsetting.”  She also talked to the client about if the “doctors talked about any long-term effects 
that your son might have because of that, and she said no.”  She proceeded to state, “Now, 
whether that is true or not, I don’t know.”  She explained that “things like that can be researched 
more to see, you know, if we are handing out these medications.  Like, what are the 
repercussions with women who are pregnant or women who’ve just given birth and have gone 
through withdrawal, like, what’s that kid’s life outlook going to be for them?  Are there going to 
be struggles?”  
I wanted to clarify that a majority of her concerns were related to the long-term effects, 
and she said, “Yeah.”  She proceeded to state, “I think, like, obviously if they are not abusing it, I 
am fine with that.”  She described her experience at her fieldwork, adding, “You know, there 
were girls getting Benzos and, ummm, other different pills from the Methadone clinic when they 
are going out of the house.”  She stated they were “smuggling them in through various body 
parts” or “put stuff in the kids’ diapers.”  She stated that they “would take other prescription 
medications to get some type of high because it was blocking other certain receptors with the 
Suboxone and, like, Methadone and stuff.” 
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I inquired if this experience caused her trust issues, and she answered,  
Not so much trust issues with me because the girl…. I mean, obviously, I was upset.  
Like, here, really?  There are kids in the house.  They did it really in the hallways where 
everyone walks.  The one girl was pregnant and she was the one bringing them in her 
various body parts, and I’m thinking, like, ‘Come on.’  Ummm, and the standards, and I 
guess my standards are just different.  Ummm, I mean I wasn’t working with those 
clients individually.  I was working with them in groups, and I guess that kind of trust 
was kind of broken.  I mean, I was maybe more annoyed with them, you know, like, we 
are here trying to help you guys.  People in addiction or just people, I don’t know, in 
psychiatric treatment, and they say, ‘oh, you don’t care about me and stuff.’  It’s like, ‘no, 
we do or we wouldn’t be coming back every day.  I mean, and deal with this kind of 
environment.’  So I think that, kinda, I’m coming here and so are these people who are 
paid therapists; we are trying to help you guys out and this is, kinda like, what you do in 
return?  So, it was kinda frustrating. 
At this point, I sensed frustration in her voice, which I asked her to reflect on.  She 
discussed her frustration with them “breaking rules within the faculty.”  She discussed how their 
behavior caused her challenges with their treatment, saying:  
You think you are going through a session, they are making a breakthrough, but at the 
same time, you’ve been in this situation before.  Like, this could be their fifth time they 
were in treatment, so they know how it works and they are kinda just telling you what 
you want to hear and, like, manipulating you to the point that you really have to question 
things in your own mind, which is kind of confusing at times.   
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I asked if she thought they were manipulating her, and she responded, “Yeah.”  After reviewing 
the transcript, I later recognized that I should have asked her to reflect more on her perception of 
manipulation.  
I attempted to assess if she had any knowledge of any other medication assisted 
treatments, asking if she “had any experience working with patients on any other type of 
medication assisted treatment besides Methadone.” She responded, “I think that they use 
Suboxone for certain treatments, but I’m not sure; you can correct me if I’m wrong on that.”  She 
explained, “I’ve really only just dealt with women who were using Methadone as their, like, 
treatment or maintenance drug.”  I attempted to see if she had any other experience with clients 
who use medication assisted treatment, and she answered, “I mean, like, for psychiatric 
disorders, yes, if that’s kind of what you are looking for.” 
Without prompting, she began to discuss connections between mental illness and 
substance abuse, saying:  
In addiction, I mean, I have to guess they go hand in hand.  I mean, the dual diagnosis 
thing, sometimes you need to fix or work on one problem that hopefully can correct the 
other problem in the long run.  Which, sometimes those work hand in hand, but, umm, 
I’ve worked with individuals who were like bi-polar and were on medication for that, but 
at the same time, they are also within the Methadone clinic, so it was kinda like a toss-up 
as to which came first. Which should be looked at more closely, cause I think sometimes 
that can be missed, and when they are just, like, ‘Oh, you are using heroin or you are 
doing this, so we will just put you on this type of maintenance drug,’ when at the same 
time, like, they really just need to work on whatever psychiatric disorder they have, you 
 131 
know, because they don’t know how to cope with something, so that is what they use as 
their method.   
At this point, I recognized that a new idea might be emerging – the connection between 
mental illness and substance abuse.  I inquired about her perception of them and how they are 
interplayed.  She explained that she believed: “Sometimes today, ummm, not all doctors are 
trained.  I mean, they are all trained in the medical model, which is the bio-psycho-social aspect 
and the well-being type model.”  As a result, she felt that some questions were left unanswered, 
such as: “What is the underlying cause versus let’s just give you something that is covering this 
up, but yet we are not really working on what the underlying issue is that could be causing issue 
for you at the moment.” 
I transitioned the interview toward her perception of individuals who choose any of the 
medication assisted treatment options.  She responded, “I mean, if it is working for them and 
they are not abusing it, not selling it, and not taking, you know, like Xanax and then smoking 
crack so they are still getting high from it, then I think that’s fine.  So, if it is working for them 
and they are staying out of trouble and they are clean from the aspect that they are not using 
street drugs, I think that’s fine.”  
I wanted to assess what her thoughts were regarding clients who may not be using it the 
correct way, and to assess if she had different perceptions.  She responded,  
I would maybe question why they are doing that?  Like, why?  What is their underlying 
motive that you know they, maybe they feel if they give it to a friend who is using, then 
they’ll stop or something?  Kinda just trying to figure out, like, what, do you just need 
resources and no one is giving you those resources?  Or trying to, and you need money to 
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pay for a gas bill versus like, going to get on LIHEAP or something, like, trying to figure 
out what the underlying cause is. 
Her thoughts appeared to focus more on curiosity for their motives more than their personal 
behaviors. 
Since her focus appeared to be based on her experience with clients on Methadone, I 
decided to see if I could gain an understanding of her perceptions regarding those treatment 
options as a way to gage her overall attitudes.  She expressed concerns about the side effects of 
the medications, saying,  
I mean, I don’t know much about the other ones and, like, how the side effects affect 
those individuals.  I just know that working with the women who were on Methadone, 
ummm, some of them, I think, are prescribed too much.  But, I mean, the high’s kinda the 
same basically, ummm, between Methadone and heroin.  Like, obviously, because certain 
groups that we ran, when women would come back from the clinic, they would 
completely be asleep or, like, their eyes would be in the back of their head.  Like, you 
could tell they were feeling some type of way because they clearly weren’t paying 
attention because you could tell just by their body language, and most of the time it was 
because, like, their doses were too high.   
She stated that her concerns about the side effects drove her concerns about the lack of 
regulations for the clinics, going on to say: “So, I think that needs to be regulated more now, 
whether or not you know the ones administering it, giving out Methadone.  There is an 
abundance of people there, that they push you through the system and just get you in and out.  I 
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really don’t know how the clinics work, so I don’t know if they need more staff, you know, to 
help regulate that, or what they kinda need to do.” 
I transitioned to her thoughts regarding counseling a client who uses medication assisted 
treatment.  In response, she reflected on her experience with her client who was on Methadone: “ 
I mean, [I] think that, like, the client I was just working with who had a baby, she is completely, 
ummm, like physically present.  She knows who she is.  She is very time oriented, place 
oriented, and obviously we did good work together.”  She further reflected that this client was 
contradictory to some of the other clients who were on Methadone and who she worked with in 
group:  
But some of the other women who were in the residential setting, clearly, when you are 
running groups, I mean, when you are in group, not paying attention and are in and out, 
ummm, but when you are doing an individual session, I don’t think it is any different then 
a client coming in high or drunk.  That’s not ethical; you can’t do, psychologically, like, 
you are not present, so you can’t really do work because they are not going to, maybe 
remember things, maybe not process stuff, especially, like, if you are doing psych kind of 
stuff. 
She proceeded to describe clients who are were misusing methadone as: “Just, like, out of it, not 
really there.” 
I wanted to further assess her thoughts and feelings about working with clients on 
medication assisted treatment.  I asked her to reflect on this.  She expressed that she would feel 
more curiosity.  “I would probably ask them, kinda like, more background information.   How 
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long have they been using it?  What is, kind of, their background history?  Do they even have 
that type of information?”  
I attempted to assess if she saw the treatment of clients on medication assisted treatment 
differently than that for clients who were not, and she answered, “Umm, no.”  She explained, 
“I’m just very non-judgmental.  It’s a safe place; like, I don’t want them to feel I am treating 
them differently whether they are on it or not, or if they bring it up and talk about it.  And I don’t 
really know unless someone pre-warns me or they bring it up and talk about it.”  She again 
referred back to her curiosity and how this would impact her session, saying, “just, normally, I 
just ask, how long have you been using?  That is what, your, like, maintenance?”  She stated that 
she also tended to “empathize with them, that I may not be an addict, but experienced addictions 
within my family, and that it’s not easy with that.  If that’s how you cope, so I am just praising 
them because they don’t always hear that.” 
Even though she had had experience in her internship, I wanted to understand her 
perception about taking a job working as a counselor treating clients using medication assisted 
treatment.  She said, “I haven’t really thought about it.  I mean, I feel like I would probably be a 
little apprehensive at first because I have never been in that type of environment, but I’m sure 
like, once you are there a couple days and you get kinda used to the routine and how things 
work, it would be just like any other agency with clients.” 
I wanted her to reflect on her apprehension about this type of job.  She responded, 
“Sometimes I would catch myself feeling very anxious, sometimes when I was working at the 
RTF center.”  She reflected that she doesn’t “know if it is maybe because their anxiety is real, lot 
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higher” or “talking a lot faster or just moving a lot.”  She expressed concern about “mirroring 
their behaviors and, kind of their, like, anxieties.”    
I asked her to reflect on her perception of their behaviors.  She answered, “I think they 
are just a little bit more on edge.”  She explained this may be in part because “they don’t really 
want to be there; no one really wants to be there.”  She explained: “very few women completed 
the program while I was there.  A lot of the women, ummm, got kicked out because of their 
behaviors or they just left.”  She stated that she believes some of this goes back to their past 
experiences, saying “they have been in and out of, like, jail.”  She reflected that some of this may 
have been affected by other matters: “I mean, it also goes back to, when did they start using?  If 
they began using at that age because that, it kinda like, I noticed that is how they were acting.  If 
they began using when they were twelve or sixteen and they are 30-some, that is kinda how they 
are acting.” 
I asked her if she noticed a difference between the clients who were on Methadone versus 
those who were not on Methadone, and she answered, “Oh yeah.”  I asked her to reflect on the 
difference.  She responded,  
One girl I worked with individually, she, her drug of choice was crack, and she just, so, 
younger than some of the other girls, but she didn’t seem as, like, out of it all the time, 
and you could actually have, like, conversations with her.  And she didn’t seem as on 
edge or in the fight or flight mode versus some of the girls who were on Methadone; they 
kinda just seemed like they were just hyper aware of their, like, surroundings and, like, 
did they need to react to this or how should they react to this?  
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I transitioned the discussion to how education had prepared her for a possible job.  She 
stated: “I mean I, whenever I went into practicum, and I really had to look for stuff.”  She 
expressed limited interest in working in addictions, saying, “I just really don’t want to work in 
[an] addictions kind of environment.”  She explained that the experience: “wasn’t terrible.  I 
could clearly work in this type of environment if I had to because I clearly survived.”  She stated 
that she felt she “could work in an addictions facility.”  She expressed concerns about some of 
the treatment options, saying: 
I know that some of the agencies around her have really, really long group hours which, I 
don’t like that, and kind of, don’t think that’s beneficial to them.  Like, three or three and 
a half hour groups, nobody is really paying attention that long.  And the groups that they 
did in the treatment facility was like an hour and a half hours, which is fine because there 
were sometimes twenty-some women in there, except everyone talked.    
She stated that she “would prefer working, kind of, in an outpatient setting,” and that she only 
“put myself in that situation because I knew some time I was going to run into someone whose 
boyfriend or brother or, you know, someone in their family has struggled with it.” 
I asked her to reflect on her anxiety related to working in addictions at her internship.  
She responded, “I don’t know if I was just stereotyping them; that it would just be a bad 
environment, like, I just didn’t know what to expect.”  I asked her to reflect on her anxiety 
further, and she answered, “What is it, the fear of the unknown that you just really don’t know?” 
I asked her to reflect on whether any of her educational experiences besides her 
internship may have helped her feel more prepared for a possible job, and she responded, “I feel 
like I would be more prepared.”  She stated, “I think putting myself in the RTF setting and then 
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also realizing, in an outpatient setting, like, the majority of the people I worked with, there was 
addiction somewhere – whether it was them.”  I asked her to reflect specifically on her 
coursework, and she said, “I didn’t take an addictions class until after my practicum, so that 
didn’t really help because I didn’t have that class.”  I asked her if she thought the addictions class 
would have helped her if she had taken it before practicum, and she answered, “Probably, yeah.”  
She stated that she also thought, “I think the teachers and professors constantly reminding you, 
like, ‘you may not want to work with this population, but guess what, it is going to come up 
sometime, somewhere, you are going to run into [it], so you probably just be prepared to talk 
about addiction or something.” 
At this point, I asked her if there was anything else that I should have asked her which I 
had not that would better help me understand her attitudes and beliefs.  She stated that there was 
not.  I thanked her for participating and I ended the call.    
The narrative above provides a review of Participant #5’s description of the phenomena 
being studied.  If information was not relevant to the phenomena, it was excluded from the 
analysis.  This chart provides Participant #5’s supporting statements regarding the phenomena 
being studied. 
Table 6:  
Participant 5’s Supporting Statements 
Analytical Categories 
from Research Questions 
 Themes Supporting Statements 
1.  Attitudes and Beliefs 
Towards Clients 
  
 1. Lack of Commitment At the time, people who 
overdose are like ‘whoa, I can 
just go and get this Narcan 
injection or, ummm, the 
inhalant, and I will be fine so I 
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can just go out and use; doesn’t 
really matter 
 
you know there were girls 
getting Benzos and, ummm, 
other different pills from the 
Methadone clinic when they are 
going out of the house 
   
some may sell it, some may 
abuse it 
  
 2. Lack of Motivation they would take other 
prescription medications to get 
some type of high 
 3. Mistrust  She referred to Benzos, stating 
that they were smuggling them 
in through various body parts 
 
that kind of trust was kind of 
broken 
 
telling you what you want to 
hear and, like, manipulating 
you 
 
they put stuff in the kids’ 
diapers  
  
they know how it works 
 
 4. Detachment from Reality Some of them were, like, asleep 
 
their eyes would be in the back 
of their head 
   
when you are in group not 
paying attention and are in and 
out 
 
Just like out of it, not really 
there 
 
 5. Untreated Mental Illness sometimes you need to fix or 
work on one problem that 
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hopefully can correct the other 
problem in the long run. 
 
anxiety is real, lot higher 
 
talking a lot faster or just 
moving a lot 
 
hyper aware 
 
they really just need to work on 
whatever psychiatric disorder 
they have 
  
what is the underlying cause?  
which came first? 
 
 
 
2.  Attitudes and Beliefs 
Affect Perception 
  
 7. “I don’t know” I think that they use Suboxone 
for certain treatments, but I’m 
not sure; you can correct me if 
I’m wrong on that  
 
I don’t know much about the 
other ones 
 
I really don’t know how the 
clinics work 
 8. Mixed Feelings  it has pros/cons 
 
 9. “It is a good thing.” if it [is)] working for them and 
they are using it responsibly, I 
don’t see what the issue is with 
that  
I’m sure it helps something 
If you are using responsibly, 
most clients that I have worked 
with have good experiences 
 
I mean, if it is working for them 
and they are not abusing it, not 
selling it, and not taking, you 
 140 
know, like Xanax and then 
smoking crack so they are still 
getting high from it, then I think 
that’s fine 
 
if it is working for them and 
they are staying out of trouble 
  
clean from the aspect that they 
are not using street drugs, I 
think that’s fine  
 
I think, like, obviously if they 
are not abusing it, I am fine 
with that 
 
 
 10. Harming Someone’s Body what are the repercussions with 
women who are pregnant or 
women who’ve just given birth?  
 
some of them, you know, 
because their doses were too 
high maybe or they needed 
changed 
 
 damages something else in the 
long run 
 
She talked to a client about the 
long-term effects that your son 
might have because of that 
 
I think are prescribed too much   
 
 12. Lack of Monitoring needs to be regulated more 
now, whether or not you know 
the ones administering it, giving 
out Methadone   
 
I don’t know if they need more 
staff, you know, to help regulate 
that, or what they kinda need to 
do 
 
 141 
abundance of people there that 
they push you through the 
system and just get you in and 
out 
 
 
  
3.  Educational 
Experiences 
  
 13. Limited Exposure  I mean, we briefly talked about 
it in our addictions class 
It was more of just, like, what 
were our opinions versus 
should we keep doing these, 
should we not, and that kinda 
stuff 
 14. Limited Fieldwork 
Experience 
I’ve really only just dealt with 
women who were using 
Methadone as their, like, 
treatment or maintenance drug 
 
 15. Lack of Coursework I didn’t take an addictions 
class until after my practicum, 
so that didn’t really help 
because I didn’t have that class 
 
  
4.  Other Experiences   
 16. Family and/or Friends in 
Addiction 
I may not be an addict, but 
experienced addictions within 
my family 
 
 
5.  Perceptions Affect 
Client Care 
   
 19. Increased Curiosity I would probably ask them 
kinda, like, more background 
information.  How long have 
they been using it? What is, 
kind of, their background 
history?  Do they even have 
that type of information? 
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When talking to patients on 
Methadone, she said: normally 
I just ask, how long have you 
been using?  That is, what, 
your, like, maintenance? 
 
 20. No Difference I don’t want them to feel I am 
treating them differently 
whether they are on it or not 
 
 
 21. Increased Counselor 
Anxiety  
What is it the fear of the 
unknown, that you just really 
don’t know? 
 
I would catch myself feeling 
very anxious 
 
 22. Increased Monitoring we did do searches of them 
 
 
6.  Professional Career 
Choices 
  
 23. Not Enough 
Knowledge/Unpreparedness 
 I feel like I could be more 
prepared 
 
 24. Lack of Interest I just really don’t want to work 
in addictions 
would prefer working, kind of, 
in an outpatient setting 
When referring to her 
fieldwork experience, she said 
it: wasn’t terrible.  I could 
clearly work in this type of 
environment if I had to 
because I clearly survived   
 
I could work in an addictions 
facility 
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 25. Fear  I mean, I feel like I would 
probably be a little 
apprehensive at first because I 
have never been in that type of 
environment 
 
What is it the fear of the 
unknown, that you just really 
don’t know? 
 
 
Individual interview #6.  This interview was conducted with a 24-year-old male who 
had been enrolled full-time in the Clinical Mental Health Counseling Program for less than two 
years at the time of the interview.  He was currently enrolled in Internship 2.  He reported that, 
during the course of his education, he had taken courses which included information on 
addictions counseling.  He reported that he had had no experience working with opioid 
dependent individuals. 
Participant #6’s interview was conducted in person using the same procedure as was used 
for Participants 1-3.  The interview lasted approximately 29 minutes with the entire process, 
including review of consents and procedures, taking approximately 40 minutes. 
Participant #6 appeared to be eager to participate in the study.  As I was preparing to 
begin the interview, I noticed I was calmer than I had been prior to my previous interviews.  I 
found that I was more confident in my ability to interview and to get the questions answered. 
I began the interview by asking Participant #6 what he knew about medication assisted 
treatment.  He stated that he did: “have adjacent experience working with some addictions, but 
my work was all integrated dual diagnosis work, so we didn’t use it.”  He stated that “it is 
 144 
popular among some of the treatment centers we have in this area.”  He began to discuss his 
thoughts regarding it, saying: 
There’s still a really big debate about if you should give someone with an addiction any 
additional medication.  How much does it work?  But, like, especially, like, Vivitrol has 
become extremely popular because there are advisements on buses now.  Ummm, so I 
think what I know is it can be helpful for some people, but I know it is such a 
controversial topic that I feel like people are afraid to talk about it, so…  
I asked him for particulars regarding what he knew about the medication.  He stated:  
I know there’s, ummm, medications that can, like, if you are, if you have an addiction to 
alcoholic substances, that any time you drink that they make you violently ill, or there is, 
ummm, I don’t remember which one it is, but there is a substance that kinda gives you, 
ummm, feeling of that high if you are addicted to… is it opioids?  I think, and it gives 
you the feeling of the high without having to, and I think they’re supposed to wean you 
off of it.  And to me, even saying that sounds kinda strange.  Ummm, then that one of the 
dangers with that thing is that, ummmm, I think that is a different one; there is one that, 
ummm, it blocks your, ah, dopamine receptors and that, the big danger with it is that you 
can shoot up and it doesn’t matter how much you shoot up;, you are not going to feel it 
but it can still kill you.   
He explained that his “roommate did his internship working in addictions, and so he would 
always constantly talk [to] people who were prescribed that one; I don’t remember which one it 
is.”  He further explained, “I know he would talk a lot about that one because he, we, have 
people who would OD, but they didn’t really know they were.” 
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Besides his roommate having provided him information, I attempted to understand what 
he had learned about medication assisted treatment in school.  He responded: 
“So, we talked about it in Addictions class and we touched on it in community-based 
interventions.  We also touched, ummm, on cause; the professor had experience with 
integrated dual diagnosis work, so she touched on it there.  Ummm, and kind of didn’t 
explain a whole lot because that just didn’t, wasn’t her area, but we talked about it a good 
bit.  Ummm, in Addictions class, ummm, just kind of weighing the pros/cons, there was a 
lot, a lot of group discussion about it, just….  Just what we thought and the consensus 
was people were, like [in a funny voice] ‘we don’t know,’ so yeah.  Ummmm, I don’t 
[know] if that answers your question. 
I asked him if he remembered anything specifically.  He responded, “I remember, like, 
specifically learning about Vivitrol and I remember learning about Suboxone; ummmm, and I 
think they briefly talked about Antabuse.”   He explained that he also:  
had to know what, like, what you had, what certain courses of action you were supposed 
to take, like versus pills versus tabs and, like, is it paired with therapy?  Is it paired with 
groups?  Is it paired with individual?  Aand then try to match to what kind of program the 
client might have been in, whether it be partial, in-patient, stuff like that, so we touched 
on all of that.  God, please don’t ask me for specifics. 
I clarified that he did not remember the specifics and, without prompting, he stated: “I 
remember that because I, because I have no desire to work in addictions.  Yeah, so I know that 
no matter where you work, it’s probably going to touch you, somehow, but, ummm, I’ve never 
really been in the thick of it, so I just remember the gist.”  When I asked him to clarify that it did 
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not interest him, he stated, “I don’t like the way it sounds; I feel like a bad therapist.  Ummmm, 
you know it wasn’t like, I was not, yeah, not… my jury is still out on how I really think about it, 
so I don’t know.” 
After he stated that “My jury is still out on how I really think about it,” I asked him to 
reflect on his thoughts regarding the use of medication assisted treatment as a treatment option.  
He answered: 
I definitely think it should be available because, if there is someone that it works for 
them, I would absolutely advocate for that.  Ahhh, to me, it is just, it’s scary to expose 
someone who is already in active addiction to another substance that can be, ummm, so 
addictive, as much good as it might do.  So, I, I don’t know how you would design a 
system that, like, is able to say, like, ‘it would be good for this person but not this 
person.’  Ummmm, I, but I just believe that there are people who, ummmm, either for 
their own preferences would prefer to be on some kind of medication because that feels 
like treatment to them, ummm, and maybe those people need to have some individual 
work done, to do some re-programming.  But that, if that’s important to them and that’s 
what works for them, then I think it should be an available option, but I just don’t think it 
is for everybody and I don’t think it is something that should be done in, like, mass 
groups of people. 
I asked him to reflect on the term “re-programming” and if this related to clients on medicated 
assisted treatment, and he answered:  
No, that would be like, I’ve had clients – you know, not in addictions work – who are 
very perseverant on being on their medications.  They feel their medications are really 
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what helps them, [so] it’s important to them and, if that’s what works for you, that is 
good.  But if that’s, can also be an addictive substance, you know, I feel like there might 
be some education given there.  And, yeah, if the person wants to do it, you know they 
are going to do it and, if it’s the best option for them, it makes the most sense.  But, 
ummm, that’s what I mean by re-programming; education is probably a better word. 
I asked him to reflect on his fear related to the use of medication assisted treatment, and 
he answered: “It’s just the pure thought of, and especially if someone is far along in recovery 
and, you know, not that relapse is out of the question, but just kind of mirror the exposure effect.  
Here is a substance that can be really addictive, but as much as it is going to help you.”  He 
explained that his fear leads to mixed feelings regarding the use of the medication, saying: “I 
think you can do a lot of harm in that sense, but it can also be good, but it is very much a double-
edged sword.”  He further explained, “If that’s what works for the person, then it does more good 
than it does harm, then why not?” 
I asked him what comes to his mind when he hears the term “medication assisted 
treatment,” and he answered: 
I always have vivid imagines of, like, Vivitrol even has commercials now.  Like 
[giggling], ummm, so that’s always the big one that comes to mind.  And I just have this, 
ummm, because I have never been in, like, an addictions treatment center, I have this 
vision of, I think, and – I think this is even perpetuated by some of the questions on the 
NCE, because they ask, you know, would you do the tabs versus the pills or this versus 
that, paired with this, would a doctor have to do this themselves, and so it almost, I have 
this image of,, like a dispensary with, ummmm, like, you just go in, you get it, you go to 
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your groups and you leave.  So, if it sounds kind of silly when you say it, but immediate 
thought, yeah. 
Based on this description, I asked him how he envisioned the people who chose that treatment 
option.  He responded, “If that’s what works for them, then that’s great.”  When I asked him if he 
visualized them going in and getting their pill, he said, “Yeah.”  I questioned how he perceived 
their interaction with therapy, and he answered:   
If they are open to therapy, so that vision of them isn’t about the person, I think it is more 
about the system.  So, like, that vision for me is like, if that is the way it is set up, then 
what the hell are we doing as clinicians to just kind of like cycle people through?  So, 
ummm, but that’s what it sounds like, and maybe I don’t know enough cause, like I said, 
I have never been in a treatment center, but that’s maybe worst case scenario but, ummm, 
yeah. 
I asked him to reflect on his image of a dispensary, and he answered: 
I don’t know, probably sheer lack of, like, experience.  ‘Cause like, I said I have never 
been in an addiction treatment center and what it looks like is framed by my experience 
in class and what my roommate tells me, what his is like.  And, ummmm, he’s there and 
some of the folks he had depending on what track in the program they were in were on.  
Ummmm, at least Suboxone, I know that, ummm, and he didn’t make it sound like that, 
but that’s just kind of the image I have in my head.  And to me that’s not like, ‘Oh, the 
person is here to get their pill.’  It is a system, a system failure if that is really how it is 
and we would just like shove medication on people and hope it works, and then be, like, 
‘Oh, yeah, you should go to group, too.’    
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Reflecting on this comment, I asked if he thought counseling was an afterthought, and he 
answered, “If medication assisted treatment was, like, the way to go, and they were like, ‘you 
should probably go to therapy, too, but make sure you take your pills’.” 
I transitioned the discussion to his experiences with clients who used medication assisted 
treatment.  He stated, “I have not had any who were on, ummm, any at least of any medication 
that I knew was for substance abuse.”  He explained that, at his internship: “I worked for two 
psychiatrists who were very anti-medication assisted treatment for addiction.”    He further 
explained that the “IDD treatment was very much about motivational interviewing and stages for 
change and really just focusing on that.  And, ummmm, and kind of figuring out which was the 
bigger issue at the time, the person’s addiction or the person’s mental health?”    
I asked him if his attendings’ beliefs affected him at all, and he said:  
No, because I think I am still open to it.  Ummm, and I don’t want to make a solid 
opinion about it if I don’t know enough about it, so, and I don’t feel I know enough about 
it.  Ummmm, just because I don’t have any work experience in the area.  You know, it is 
one thing to sit in class and, like I said, I told you how much I remember but, to actually, 
to actually go and do it if we had more in Vivo, I don’t know, maybe I would be able to 
make a more concrete opinion. 
I asked him what his perception was of individuals who chose medication assisted 
treatment as a treatment option. He responded:  
You know, I think that’s, ahhh, I think that is a difficult call to make because, even in 
even in our education for addictions, it is made very clear that addicts lie.  They do 
whatever they can, ummm, and I believe that on a case by case basis.  Yeah, umm, 
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because I, and that is very much shaped by my experience that, ummmm, I work with a 
lot of people who are still very much in the old mindset of mental health.  That, like, all 
our patients are trying to manipulate us, and they just want their meds and they want to be 
left alone and, kind of.  And so here I am, the new young therapist who is like, ‘no, no.’  
Like, so I, you know, if they are doing it for the right reasons, then that’s what I think.  If 
the person just wants to be addicted to Vivitrol or Suboxone, but then I’m like, I don’t 
know.  Do they go into [it] being, like, ‘I want another addiction?’  Kind of, ummmm, so 
if it’s being used for the right reasons, then that’s what my perception of the person is. 
I asked him to reflect back on his comment that “addicts lie” and whether he believes that 
to be truer with clients who use medication assisted treatment.  He answered: 
I would say it is about the same because I am kind of torn.  Like, that, if the person elects 
to go on treatment like I said, unless they are actively looking for another substance, 
that’s still a step in the right direction; it’s some kind of treatment.  It is something they 
are trying and maybe they don’t know if [it] will work for them or it’s kinda like that last 
resort.  They’ve tried other things, umm, and you know, maybe they know themselves 
and this is what works or maybe it is one those people that’s taking a medication… is 
very important to them, and how they perceive their health and getting better, so I would 
say it is about the same.  Ummm, just because I don’t, I don’t believe that all addicts lie, 
so, but that’s what everyone tells you, so I don’t know. 
He further stated that his experiences had been shaped by what others had told him, saying, “I’ve 
heard very few good, good recovery stories about [it] from people who have worked in 
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addictions.  So, it’s not to say that, you know, those people are only focusing on the bad ones, 
but I want to hear more; I want to hear more good about people, so yeah.” 
I asked him what he knew about Methadone and Suboxone, specifically.  He answered, 
“Well, a methadone clinic that, that I am not a 100%.  I would not be able to describe to someone 
how a Methadone clinic works.  I know that… I know that it is a positive thing, but I couldn’t 
tell you I know what they do; I’d be afraid, I’d be afraid of misconstruing in it, ummm.”  
I asked him to reflect on why he perceived it as a positive, “Because I think it’s, it’s that  
the whole purpose of methadone clinics is harm reduction.”  He stated that  “people are going to 
make their own choices, but if I can get them to be safer about it, that’s great.  I think that is 
great.”  He expressed frustration with himself regarding his lack of knowledge regarding a 
Suboxone clinic, saying, “I wish I could tell you I remember what Suboxone does.”   
I asked him to reflect back on his perception of medication assisted treatment as a 
dispensary and how it may relate to his perception of a Methadone or Suboxone clinic.  He 
responded: 
No, it’s just I think that’s, like, a worst case, a worst case scenario.  Ummmm, and like I 
said, that’s a, you know, system failure on our part if that’s the way it is.  Ummmm, and 
you know, I think a methadone clinic does kind of sound like that, but if you are doing it 
for the right reasons, I don’t really believe I can, you know, that it can be truly harmful.  
Like I said, it kind of operated from some kind of harm reduction perspective, so even if 
it’s just a dispensary, maybe it is what those people need and that is all they want, too.  
So, a dispensary could be good or bad if we’re doing it and not advocating for the other 
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piece of it, then I think that is what the failure is.  Then that’s all the person wants; there 
is not really much we can do. 
I asked him about his feelings about counseling a client who uses medication assisted treatment. 
He stated, “I’d see it as a wonderful addition to, ummm, any type of treatment.”  He 
acknowledged that he is “with a lot of people, clinicians, who are like, ‘those are the people who 
are not capable of therapy,’ and I feel like these folks get [that] to that.”  He proceeded to state 
that:  
They just want to come in, get their medication, and they lie and they will do anything to 
get the next fix.  And I’m sure that’s true on the individual level sometimes, but I, I 
cannot believe that there are not, that there are not people who therapy would not benefit 
in addition to medication assisted treatment because if, maybe, you know, similar to anti-
psychotics.  If medication assisted treatment is what gets you, to you, where you can be 
capable of therapeutic work, then that is wonderful, that is great.  Ummmm, if the client 
doesn’t want to be there, that is another story.  That’s another story if, ummm, you know, 
if they don’t want to be in therapy, that doesn’t mean I am not going to do my job, but 
you have to want it, so… 
Based on his feelings about counseling a client who uses medication assisted treatment, I 
asked him what his thoughts would be in regards to taking a position as a counselor treating 
clients who use medication assisted treatment as an option for opioid dependence.  He answered: 
I would do it if I knew more about it because I, ummm, like I said, I’m considering a job 
as a dual diagnosis therapist.  So, I’m, like I said, most of my experience is with, like, 
serious mental illness, ummm, but it’s, umm, yeah, I would do it, no problem.  I wouldn’t 
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want to go in blind and I would feel like I’d have to be very open about that, like, ‘This is 
my first job in addictions, so help me out.’  But yeah, I would do it.   
I reflected back on his previous statement about having no desire to work in addictions, and he 
said: “I don’t have desire to work in addictions, but I would do it.”  He explained further, “It’s 
one of those things that, as you go through your Masters program, they ask, ‘What do you not 
want to do?’  And I’m like, ‘addictions,’ but I am capable of change.  You know, I can’t ask my 
clients to be if I’m not, so…”  I asked him what would make him open to it, and he said, “I am 
open to it.  It’s just not, like, it just not my first choice.”  He explained further, “I would never 
want to put myself in a position where I totally rule something out.  And, but, yeah, not my first 
choice, has never been.”   
I wanted him to reflect on why it is not his first choice in order to see if his perception 
had effected his career choices.  He responded:  
I think, just because I am just more passionate about, ummmm, about working with other 
groups of people.  But, like I said, my main focus and what I’ve wanted to do forever is 
to work with LGBT youth and families.  Ummm, and you know, kinda dabble in some 
older adults who are within the community, too, just because of the health care 
disparities.  Ummm, but I know addictions touches all those communities, too.  And 
actually, umm, I was reading something the other day that, especially among gay men my 
age, that alcoholism is becoming almost as big of a problem as HIV is right now.  And so 
I think, when I get down to it, it’s that straight addictions counseling does not appeal to 
me, but I am absolutely open to working with...  I don’t think I will find myself in a 
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treatment center, but in a role, you know, working with people in active addiction, 
absolutely. 
At this point, I wanted to see if his educational experiences may have prepared him for a 
possible job in an addictions center, and he said, “Education, yes; experience, no.”  I asked him 
to elaborate on what may have helped him, and he answered: “I mean, like I said, we, you touch 
on, you touch on addictions in some courses and then, to have the addictions course, it is a great 
course.  It gives you a great overview.  Like I said, it’s not my focus, so I would need a little 
refresher, but as you know, as an entry level person looking for greater experience, if I had no 
other options, I would take it.”  
Since his answers appeared to be slightly contradictory, I asked him, if he were offered a 
job in medication assisted treatment, did he feel that his education would have prepared him to 
know enough about it to be able to do the job, and he answered, “No.”  I asked him to elaborate 
on what may have helped.  He replied: 
Ummmm, you know, it’s almost one of those… it’s an entire treatment modality.  So, I 
think that we just needed to spend more time on it.  Ummm, because like I said, I have 
basic knowledge of it from class, but you know, ummmm, but I feel like I should 
remember more and I don’t, like, but I’m like, I don’t know if we got too deep.  We 
talked a lot about what our feelings were around it, and that is important, but as far as, 
like, who offers it, how you go about getting it…  Ummm, like I said, don’t even 
remember, like, what you actually do at a Methadone clinic.  So, it’s almost as if it could 
be its own course.  Umm, yeah, or even if what, during summer, yeah, but that 
specifically, no.” 
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I asked him if he had had any experience in his fieldwork with clients being on 
medication assisted treatment, and he answered: “No, I had a lot of patients ask for anti-anxiety 
meds, but no, no, no Vivitrol, Suboxone, Methadone; no, I’d be like, ‘Talk to the doctor.’” 
I asked him if there was anything I could have asked him that I had not which would 
better help me understand his attitudes and beliefs.  He stated that there was not.  At this point, 
the interview was ended.  
The narrative above provides a review of Participant #6’s description of the phenomena 
being studied.  If information was not relevant to the phenomena, it was excluded from the 
analysis. This chart provides Participant #6’s supporting statements for phenomena being 
studied. 
Table 7:   
Participant #6’s Supporting Statements 
Analytical Categories 
from Research Questions 
 Themes Supporting Statements 
1.  Attitudes and Beliefs 
Towards Clients 
  
 1. Lack of Commitment If they are open to therapy 
 
just want their meds 
 
want to be left alone, 
want to come in, get their 
medication 
 
just wants to be addicted 
 
even if it just a dispensary, 
maybe it is what those people 
need and that is all they want 
 
 2. Lack of Motivation if they are doing it for the right 
reasons 
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 3. Mistrust all our patients are trying to 
manipulate us 
 
they lie 
 
they will do anything to get the 
next fix 
 
addicts lie  
 
They do whatever they can 
 
 5. Untreated Mental Illness kind of figuring out which was 
the bigger issue at the time, the 
person’s addiction or the 
person’s mental health?  
 
 6. “trying to better themselves” It is something they are trying 
 
 
  
2.  Attitudes and Beliefs 
Affect Perception 
  
 7. “I don’t know” I don’t feel I know enough 
about it   
 
I would not be able to describe 
to someone how a Methadone 
clinic works 
 
I wish I could tell you I 
remember what Suboxone does 
 
 8. Mixed Feelings my jury is still out on how I 
really think about it 
 
if that’s important to them and 
that’s what works for them, 
then I think it should be an 
available option, but I just 
don’t think it is for everybody 
and I don’t think it is 
something that should be done 
in, like, mass groups of people 
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It can also be good, but it is 
very much a double-edged 
sword  
 
I am kind of torn 
 9. “It is a good thing.” I definitely think it should be 
available because, if there is 
someone that it works for them 
If that’s what works for them 
then that’s great 
 
if the person elects to go on 
treatment, like I said, unless 
they are actively looking for 
another substance, that’s still a 
step in the right direction; it’s 
some kind of treatment 
 
I know is, it can be helpful for 
some people 
 
I know that it is a positive 
thing, but I couldn’t tell you I 
know what they do 
 
if that’s what works for the 
person, then it does more good 
then it does harm, then why 
not? 
 
the whole purpose of 
Methadone clinics is harm 
reduction 
 
people are going to make their 
own choices, but if I can get 
them to be safer about it, that’s 
great. I think that is great 
   
If medication assisted 
treatment is what gets you to, 
you where you can be capable 
of therapeutic work, then that 
is wonderful 
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I’d see it as a wonderful 
addition to any type of 
treatment 
 
 
 10. Harming Someone’s Body to expose someone who is 
already in active addiction to 
another substance that can be 
so addictive, as much good as 
it might do 
 
a substance that can be really 
addictive, as much as it is 
going to help you, ummm, I 
think you can do a lot of harm 
in that sense 
 
 11. Uncertainty of 
Effectiveness 
there’s still a really big debate 
about if you should give 
someone with an addiction any 
additional medication 
 
How much does it work? 
 
 
 12. Lack of Monitoring I have this image of, like a 
dispensary with like, you just go 
in, you get it, you go to your 
groups, and you leave 
 
I think it is more about the 
system.  So, like that vision for me 
is like, if that is the way it is set 
up, then what the hell are we 
doing as clinicians, to just kind of, 
like, cycle people through? 
 
When referring to a system 
failure, he said: I think a 
Methadone clinic does kind of 
sound like that 
 
just a dispensary 
 
So a dispensary could be good 
or bad if we’re doing it and not 
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advocating for the other piece 
of it, then I think that is what 
the failure is   
 
I said that’s a, you know, 
system failure on our part if 
that’s the way it is 
 
It is a system, a system failure 
if that is really how it is and we 
would just, like, shove 
medication on people and hope 
it works, and then be like, ‘Oh 
yeah, you should go to group, 
too’ 
 
they were like, ‘You should 
probably go to therapy, too, but 
make sure you take your pills’ 
 
 
 
3.  Educational 
Experiences 
  
 13. Limited Exposure we talked about it in Addictions 
class and we touched on it in 
community-based interventions 
 
We also touched on cause; the 
professor had experience with 
integrated dual diagnosis work, 
so she touched on it there and 
kind of didn’t explain a whole 
lot because that just didn’t, 
wasn’t her area, but we talked 
about it a good bit   
In Addictions class, just kind of 
weighing the pros/cons, there 
was a lot, a lot of group 
discussion about it, just…  Just 
what we thought, and the 
consensus was, people were 
like, [in afunny voice:] ‘We 
don’t know’ 
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I remember, like, specifically 
learning about Vivitrol and I 
remember learning about 
Suboxone, ummmm, and I think 
they briefly talked about 
Antabuse 
I mean, like I said, we, you 
touch on, you touch on 
addictions in some courses 
 
It gives you a great overview 
 
 14. Limited Fieldwork 
Experience 
 I had a lot of patients ask for 
anti-anxiety meds, but no, no, 
no Vivitrol, Suboxone, 
Methadone 
 
 15. Lack of Coursework  you know, it’s almost one of 
those; it’s an entire treatment 
modality 
So it’s almost as if it could be 
its own course 
  
4.  Other Experiences   
 18. Others People’s 
Stories/Perceptions 
I worked for two psychiatrists 
who were very anti-medication 
assisted treatment for addiction 
 
I’ve heard very few good, good 
recovery stories about, from 
people who have worked in 
addictions 
my roommate did his internship 
working in addictions, and so 
he would always constantly talk 
[about] people who were 
prescribed that one; I don’t 
remember which one it is 
 
  
5.  Perceptions Affect 
Client Care 
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 19. Increased Curiosity Do they go into [it] being, like 
‘I want another addiction?’ 
 
 21. Increased Counselor Anxiety  it’s scary to expose someone 
who is already in active 
addiction to another substance 
 
 
 
6.  Professional Career 
Choices 
  
 23. Not Enough 
Knowledge/Unpreparedness 
I’d would do it if I knew more 
about it 
 I wouldn’t want to go in blind 
and I would feel like I’d have to 
be very open about that, like, 
‘This is my first job in 
addictions, so help me out’   
 
 
 24. Lack of Interest I have no desire to work in 
addictions  
I think, when I get down [to] it, 
is that straight addictions 
counseling does not appeal to 
me 
It’s just not, like, it’s just not my 
first choice 
 I don’t have desire to work in 
addictions, but I would do it  
if I had no other options, I 
would take it 
 
Cross-Case Analysis 
The six participants in the individual interviews frequently shared similar statements or 
sentiments as they described their perceptions of medication assisted treatment.  Despite the 
commonalities, not all of the analytical categories were represented in each individual interview.  
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Table 8 provides a cross-case analysis of each analytical category, theme, and the supporting 
statements across all of the individual interviews.  These themes are discussed in more detail in 
Chapter 5.  
Table 8 
Cross-Case Analysis 
Analytical Categories Int. 1 Int. 2 Int. 3 Int. 4 Int. 5 Int. 6 
1.  Attitudes and Beliefs Towards Clients       
Theme 1: Lack of Commitment    x x x x x x 
Theme 2: Lack of Motivation x x x  x x 
Theme 3: Mistrust x  x  x x 
Theme 4: Detachment from Reality x x   x  
Theme 5: Untreated Mental Illness x    x x 
Theme 6: “trying to better themselves”   x x  x 
2.  Attitudes and Beliefs Affect Perception       
Theme 7: “I don’t know” x x x x x x 
Theme 8: Mixed Feelings  x x x x x x 
Theme 9: “It is a good thing.” x x x X x x 
Theme 10: Harming Someone’s Body x  x x x x 
Theme 11: Uncertainty of Effectiveness x x x x  x 
Theme 12: Lack of Monitoring x   x x x 
3.  Educational Experiences       
Theme 13: Limited Exposure x x x x x x 
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Theme 14: Limited Fieldwork Experience x x x x x x 
Theme 15: Lack of Coursework x x x x x x 
4.  Other Experiences       
Theme 16: Family and/or Friends in 
Addiction 
x x  x x  
Theme 17: Culture x  x x   
Theme 18: Others People’s 
Stories/Perceptions 
x  x   x 
5.  Perceptions Affect Client Care       
Theme 19: Increased Curiosity x x x x x x 
Theme 20: No Difference x x x x x  
Theme 21: Increased Counselor Anxiety x  x  x x 
Theme 22: Increased Monitoring   x x x  
6.  Professional Career Choices       
Theme 23:  
Not Enough Knowledge/Unpreparedness 
x x x x x x 
Theme 24: Lack of Interest  x x x x x 
Theme 25: Fear x  x x x  
 
Summary 
This chapter provided an overview of the data explicated from the six key informant 
interviews.  The narratives of each interview provide supporting statements from the participants 
and illustrate how these statements are related to this study’s theoretical framework and the 
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identified themes.  In addition to analyzing the themes within their supporting statements, my 
field notes and observations were included in the narratives.  The data was organized into tables 
to demonstrate the supporting statements in relation to the themes, where applicable.  At the 
conclusion of the chapter, a cross-sectional analysis of the themes and supporting statements was 
developed to demonstrate the commonalities among the participants’ statements.  The data that 
was obtained from the narrative descriptions of the key informant interviews was used in the 
development of the themes.  These themes and their implications for the research questions are 
explored in more detail in Chapter 5. 
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CHAPTER V: DISCUSSION 
Introduction 
The previous chapters provided an inquiry into counseling students’ attitudes toward the 
use of medication assisted treatments for opioid dependent clients.  A review of the problem, 
background, and rationale was provided in earlier chapters in order to help develop an 
understanding of how these attitudes might be fostered during the professional education of 
counseling students.  The review of the literature, the research questions, and the methodology of 
the study were described.  The data was collected and analyzed using thematic analysis, and this 
resulted in the identification of twenty-five themes related to the research questions posed in this 
study.  This chapter will examine these findings and develop insight into how the attitudes that 
counseling students hold toward the use of medication assisted treatment of opioid addictions is 
related to their educational experiences and the effects these attitudes may have on the 
professional counselors’ attitudes toward clients and their career-related decisions. 
Discussion of the Findings 
The theoretical orientation that was used to inform the analysis of the data produced in 
this study was ognitive Behavioral Theory (CBT).  In CBT, the stimulus influences the 
development of thoughts, feelings, and associated attitudes, which then affect behaviors 
(National Alliance on Mental Illness, 2014).  In this study, this theory suggested that the 
stimulus, a client addicted to opioids who includes the use of medication assisted treatments as 
part of a treatment protocol, stimulates thoughts and feelings in the counselor who, based on 
these thoughts and feelings, will form attitudes and beliefs that will in turn influence their 
behavior toward the client and in their career decision-making process.    
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The themes in this study were developed through an analysis of the attitudes and beliefs 
reported in response to the associated stimuli.  This study found that counseling students’ 
educational experiences and personal experiences contained stimuli that contributed to the 
development of counseling students’ attitudes and beliefs surrounding the use of medication 
assisted treatment for opioid dependent individuals.  Additionally, this study found that these 
experiences also affected their attitudes and beliefs toward clients selecting to participate in 
MAT, as well as having an impact on their career choices.  
Themes 
The twenty-five themes that emerged from the thematic analysis of the narratives 
produced by the participant interviews were reorganized and categorized to address the research 
questions proposed for this study.  
Research Question #1 “What are the attitudes and beliefs of counseling students towards clients 
who use medication assisted treatments for the treatment of opioid dependence?” 
  Theme #1 lack of commitment.  The theme that the clients who use medication assisted 
treatment lack commitment to recovery was common among the participants.  They used phrases 
such as “[they] want their meds,” “just come in and get their medication,” “just going on 
Methadone,” and “that is all they want” to indicate their perceptions regarding the clients only 
wanting to obtain their medication.  Participants also indicated that, in addition to only wanting 
their medications, clients had a lack of commitment to the overall program and recovery.  This 
was implied by the use of phrases such as: “not working their program,” “not really using the 
facility the right way,” “haven’t worked the whole recovery program,” “isn’t completely 100% 
into therapy,” “if they want therapy,” and “want to be left alone.”  Comparisons were made to 
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abstinence-based treatment, “whereas others… are trying to work on, get treatment for their 
addiction.”  The use of Narcan was also discussed as a rationale for clients’ lack of commitment 
to treatment, suggesting “people who overdose are, like, ‘Whoa, I can just go and get this Narcan 
injection or, ummm, the inhalant and I will be fine, so I can just go out and use; doesn’t really 
matter.”  The participants appeared to lack awareness that Narcan is often distributed in 
medication assisted treatment programs as part of their programs in order to help decrease the 
number of deaths from overdoses.      
  Lack of ommitment to treatment was referenced by participants citing the behaviors that 
clients engage in while at a treatment center.  Participants referred to these behaviors in stating 
that they believe they occur in medication assisted treatment by using phrases like: “use it as a 
meeting place,” “doctor shopped,” “getting Benzos and other different pills from the Methadone 
clinic,” and “some may sell it, some may abuse it.”  The long-term commitment to treatment and 
recovery was noted by one participant, who questioned, “what end are they using it towards?” 
and “are they just going on Methadone, making no other lifestyle changes?”    These statements 
were similar to those presented in a study by Gordon, et al. (2011) which found that staff’s 
perceptions that clients would be drug seeking and using the clinic as a meeting place presented a 
barrier to the implementation of Buprenorphine in the Veterans Health Administration.   
The participants perceived the clients as using medication assisted treatment as a 
“crutch,” and “leaning on a crutch to get around” while another described an individual who did 
not succeed in MAT because they “weren’t 100% into it.”  This data indicates that the key 
informants believed that clients who choose to participate in medication assisted treatment do so 
with minimal commitment to the treatment process and recovery.  This finding is consistent with 
a study by Kayman, Goldstein, Deren, and Rosenblum (2006), where the counselors in the study 
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perceived their clients as ambivalent and not really interested in ending their substance abuse.  
The belief that medication assisted treatment is a crutch has been perpetuated by both counselors 
and clients.  Studies have shown that clients in MAT also feel that medication assisted treatment 
is a crutch, which further perpetuates this stigma (Brown, Benn, & Jansen, 1975; Conner & 
Rosen, 2008)   
Theme #2  lack of motivation.  Participants perceived that clients who use medication 
assisted treatment lack motivation for recovery.  Participants questioned the clients’ motivation 
for seeking medication assisted treatment, suggesting that they are motivated to participate in 
MAT just to acquire drugs.  As a way to question clients’ motivation for getting treatment, they 
used phrases such as: “are we just going there to get by, you know, to the next?” and “would take 
other prescription medications to get some type of high.” Participants questioned if clients were 
motivated by external factors, “whether they are there because of part of a court-mandated type 
thing,” “if they are doing it for the right reasons,” or to “try something new.”  Others noted a 
perceived lack of internal motivation: “where was the desire for something better in life?,” “I just 
want to manage life,” and “some people just don’t have the willpower.”   
The participants’ statements indicate that they questioned the internal and external 
motivation of the clients for both treatment and recovery.  This belief has also been demonstrated 
in previous studies where the participants – both counselors and staff – have indicated that many 
individuals see Methadone as a drug substitute and a crutch that does not motivate individuals or 
allow them to fully recover from their addiction (Brown, Benn, & Jansen, 1975; Conner & 
Rosen, 2008).   
Theme #3  mistrust.  Mistrust of the patients was a theme identified by the participants.  
In order to describe their mistrust, they questioned the MAT clients’ commitment to recovery: 
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“how are they gonna trust them?, “how can you trust them not to misuse anything else?,” and 
“you can’t trust them.”  Another participant discussed how, after they initially gave trust to the 
patient, eventually, that “trust was kind of broken.” 
Participants also used phrases such as “addicts lie,” “they do whatever they can,” “they know 
how it works,” “telling you what you want to hear,” and “manipulating” in order to describe their 
mistrust of patients.  Others expressed concerns about the clients’ behavior and how the mistrust 
is connected in part to concerns about their motivation and commitment, stating, for instance, “I 
think of all the outside stuff.  I think about the, you know what happens in the parking lot. Like, 
are we sharing drugs?  Are we sharing information?”  Another participant talked about other 
behaviors they have seen in clients, such as “smuggling them in through various body parts” and 
“put stuff in the kids’ diapers.”    
The acknowledgement of counselor mistrust is important, as it has long been established 
in the counseling community that counselor trust is a necessary component to the therapeutic 
relationship (Leach, 2005).  Earnshaw, Smith, and Copenhaver (2013) reported that clients in 
Methadone treatment reported being sterotyped as “untrustworthy” by others, while a study by 
Ahern, Stuber, and Galea (2007) found that 85% of clients surveyed reported feeling devalued or 
being seen as unreliable by people because of their drug use history.   
Theme #4 detachment from reality.  Just like any medication, there are side effects of 
the medications used in medication assisted treatment.  Participants in this study described the 
clients on medication assisted treatment as being detached from reality.  Participants used 
phrases such as “being in a fog,” “just like, out of it, not really there,” “lifelessness,” and 
“zombie” to describe clients on medication assisted treatment.  The sedative effects of 
Methadone were described as “asleep” and “eyes in the back of their head.”  Participants did not 
 170 
appear to understand the sedative effects that Methadone can have on some individuals, as they 
identified them as being “in and out” during group therapy.   
 The words used by the participants to describe their perceptions of clients who use 
medication assisted treatment, in particular Methadone, are reflective of Methadone side effects 
which include fatigue, unusual tiredness, and confusion (Mayo Clinic, 2018).  The participants’ 
lack of education and understanding regarding medication assisted treatment most likely 
contributed to their misunderstanding of the side effects of the medication and affected their 
perceptions of the clients. 
Theme #5  untreated mental illness.  It has been documented that there is a strong 
connection between mental illness and substance abuse (Grant, Goldstein, & Saha, 2015; 
Nesvåg, et al., 2015).  Approximately 7.9 million individuals in the United States had a 
substance abuse disorder and another mental health issue in 2014 (Substance Abuse and Mental 
Health Services Administration, 2015).  Despite the number of individuals who could qualify as 
having a dual diagnosis, participants discussed their perceptions that clients on medication 
assisted treatment might have untreated mental illness.  The participants perceived the clients as 
having symptoms of both mental illness and substance abuse, noting that the mental illness often 
goes untreated.  Participants used phrases to express perceptions such as that the clients have “a 
lot of anxiety” or “anxiety is real lot higher” with one further describing the clients as “talking a 
lot faster or just moving a lot” and being “hyper aware.”  The participants questioned the 
connection between untreated mental illness and medication assisted treatment with phrases such 
as “which came first?” “underlying cause,” “which was the bigger issue at the time, the person’s 
addiction or the person’s mental health?,” and “they really just need to work on whatever 
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psychiatric disorder they have.”  It was stated that “sometimes you need to fix or work on one 
problem that hopefully can correct the other problem in the long run.” 
  These statements indicate that the participants were aware of the symptoms of mental 
health issues; however, they initially attributed them to the use of medication assisted treatment.  
The participants questioned the clients’ mental health concerns and their connection to their 
addiction.  They indicated that they believed the clients’ mental health concerns were going 
untreated in order to focus on the treatment of their addiction.    
Theme #6  “trying to better themselves”. The five preceding themes indicate a negative 
perception of clients on medication assisted treatment.  While participants did indicate negative 
perceptions and attitudes towards clients on medication assisted treatment, some of the 
participants had positive perceptions of clients who chose medication assisted treatment.  Phrases 
indicating this perception included: “courageous,” “they want to get better,” “trying to better 
themselves,” “trying to make themselves better,” “taking a big step,” and “something they are 
trying,” demonstrating positive perceptions of the clients.  Despite having a negative perception 
of clients on medication assisted treatment, participants identified a positive attribute.  It is 
possible that their professional counseling education and experiences, even with their limited 
understanding of medication assisted treatment, promoted the development of this more 
favorable view of  clients who chose to use medication assisted treatment.  Despite an extensive 
literature review, there appears to be a lack of literature related to this theme.  This theme may be 
an area of possible further research.  
Implications of research question 1.  The potential for stigma was the basis of the first 
research question.  The implications of the first research question are that counseling students 
might have a predetermined view of clients who use medication assisted treatment.  These 
 172 
perceptions of clients who choose this treatment appear to be influenced by participants’ 
perceptions of medication assisted treatment, which emerged as a result of their counselor 
education experiences and their work and other personal and professional experiences.  Stigma 
has been found to have a significant impact on the treatment and recovery efforts of individuals 
dealing with addictions (Earnshaw, Smith, & Copenhaver, 2013; Conner & Rosen, 2008; 
Matusow, et al., 2013; Hunt, Lipton, Goldsmith, Strug, & Spunt, 1985-86).  Conner and Rosen 
(2008), and Hunt, Lipton, Goldsmith, Strug, and Spunt (1985-86), have found that the 
development of negative professional attitudes towards medication assisted treatment may affect 
a client’s willingness to enter treatment and negatively affect the development of the therapeutic 
relationship, also influencing the therapists’ perception of the client.   
Despite the participants in this study identifying negative attitudes towards the clients 
who use medication assisted treatment, there was also recognition of some positive attributes 
associated with clients choosing to use MAT as part of their treatment.  This is notable because, 
if knowledge and understanding of the treatment modality increases, there is potential and an 
increased likelihood that more positive attitudes towards these clients will be developed by 
counselors in training and, subsequently, in novice professional counselors.  Additional evidence 
to support this conclusion is considered under the analysis of subsequent themes. 
Research Question #2  How do the attitudes and beliefs of counseling students regarding the 
use of medication assisted treatments for the treatment of opioid dependence affect their 
perceptions of individuals using these treatment options?  
Theme #7  “I don’t know”.  Participants indicated that they had limited knowledge of 
medication assisted treatment.  They used phrases such as “don’t know,” “not much,” “not 
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comfortable with the subject,” “I don’t know much about them,” “little less knowledgeable,” and 
“I don’t know much” when asked to discuss mediation assisted treatment.  In order to try to 
explain their limited knowledge, participants reflected on their limited education on the subject, 
using phrases such as “snippets,” “touched on it,” and “briefly talked about it,” to describe their 
exposure to the subject.     
Participants’ lack of understanding was further demonstrated when they attempted to 
describe it with phrases such as “kind of the opposite of what an abstinence based program [is],” 
“using medicines to help with their, I guess, symptoms or whatever,”  and  “how you can use 
different drugs as a medicine instead [of], you know, a recreational drug.”  One participant 
referred to medication assisted treatment as “medically assisted heroin.”   
When participants were asked about two of the more common medication assisted 
treatments for opioid dependence – Methadone and Suboxone, they continued to demonstrate a 
lack of knowledge.  They used phrases such as “I don’t know anything about a Suboxone,” 
“don’t know,” “not too knowledgeable about everything related to this,” “I don’t know how the 
clinics work,” and “I wouldn’t be able to describe to someone how a Methadone clinic works.”  
The participants referred to their lack of education as a component of their lack of 
knowledge regarding medication assisted treatment.  Madison, Bethea, Daniel, and Necaise 
(2008) found that, in the offered substance abuse courses,  24% of students were taught about 
Methadone and 5% were educated about Suboxone in their counseling program.  This is 
consistent with findings that suggest that counselors from abstinence-based backgrounds who 
report having no education regarding the use of these medications also report having limited 
understanding of how medication assisted treatment programs work (Caplehorn, Hartel, & Irwig, 
1997).  The findings of this study and the relevant literature appears to indicate that a lack of 
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education affected the participants’ understanding and acceptance of medication assisted 
treatments as a treatment option.  
Theme #8  mixed feelings.   The participants expressed mixed feelings about the use of 
medication assisted treatment as a treatment option.  They used phrases such as “I am on the 
fence,” “in the middle,” “not sure where I stand,” “mixed thoughts,” “it has pros/cons,” and “my 
jury is still out on how I really think about it” to express their mixed feelings.  The participants’ 
mixed feelings appeared to be related to their lack of knowledge regarding medication assisted 
treatment and their uncertainty of its effectiveness.  The participants used phrases such as 
“double-edged sword” and “if there are better options out there, that it is horrendous that they’re 
the only options” to indicate their mixed feelings and how they are related to concerns about 
treatment effectiveness.  Despite an extensive review of the literature, there appears to be a lack 
of literature regarding counselors’ mixed feelings regarding the use of medication assisted 
treatment in relation to the effectiveness of this treatment option.  
Theme #9  “it is a good thing”.  The participants expressed beliefs that, despite any 
concerns they have about medication assisted treatment, it could be a positive factor in the fight 
against the opioid epidemic.  Participants demonstrated their belief  in the value of medication 
assisted treatment by using phrases such as “good thing,” “benefits of it,” “great concept,” “it 
helps something,” and “helpful for some people.”  Participants referred back to their concerns 
about trusting patients by stating that it is positive “if it is used in the right way” and mentioning 
the importance of “using it responsibly.”   
Participants discussed that having the option to use  medication assisted treatment is a 
positive alternative for treating opioid addiction.  They referred to it as “a good alternative” and 
noted that clients should “have the option to get better” while another participant noted, “I think 
 175 
it should be available because, if there is someone that it works for,” and suggested that 
medication assisted treatment was a “wonderful addition to any type of treatment.”   
Theme #10 harming someone’s body.  Methadone and other harm reduction 
medications have been established as safe medications for the treatment of opioid dependence 
(Schwartz, et al., 2008; Aletraris, Edmond, Paino, Fields, & Roman, 2016).  Despite this 
research, participants expressed concern about medication assisted treatment having the potential 
to be harmful.  Participants expressed fear of a risk that clients will be prescribed another 
medication that has the potential to be “addictive” or “abused.”  Participants expressed concerns 
that the prescribed medication had potentially harmful side effects.  Phrases such as “any long-
term use medication effects organs” and “laundry list of side effects” were used to support this 
theme.  Concerns were expressed about the efficacy of using Methadone on pregnant women 
with the comments: “repercussions with women who are pregnant or women who’ve just given 
birth” and “things like that can be researched more.”  Participants’ experiences working with 
clients in Methadone clinics effected their perceptions about harm and were reflected in 
statements such as “their doses were too high” and “[they] are prescribed too much.”    
Theme #11  uncertainty of effectiveness.  The question of effectiveness of medication 
assisted treatment has been demonstrated to be a concern coming from counselors.  Methadone 
has been shown to be perceived as the least effective MAT while Suboxone and Naltrexone were 
shown to be perceived as more effective by counselors  (Bride, Abraham, Kintzle, & Roman, 
2013). When surveyed, it was determined that two-thirds of counselors surveyed “don’t know” 
how to respond when asked to rate their perceptions in regard to Suboxone’s effectiveness 
(Knudsen, Ducharme, Roman, & Link, 2005).    
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The question of medication assisted treatment’s effectiveness was discussed by the 
participants in this study, as well.  Participants questioned “how much does it work?” and 
“whether it is effective?”  Phrases such as “Band-Aid” and “prolonged the addiction” were used 
to question the effectiveness of this treatment approach.    
Despite Methadone having a significant history of recognition as an effective treatment 
for opioid dependence (Schwartz, et al., 2008; Aletraris, Edmond, Paino, Fields, & Roman, 
2016), participants continued to question its effectiveness.  It was stated that “it is evidence 
based [but] its numbers are just so low there has to be something wrong,” and “[it] needs a lot 
more research.”  Concern regarding its effectiveness was also related to giving additional 
medication to someone with an addition.  One participant questioned if there is “a really big 
debate if you should give someone with an addiction any additional medication?” while another 
questioned, “how is giving them more drugs helping them?”  The participants’ concerns were 
similar to those demonstrated in a study by Aletraris, Edmond, Paino, Fields, & Roman (2016), 
where approximatley 20% of the participants questioned the effectiveness of Methadone and 
Suboxone.  
Theme #12 lack of monitoring.  Concerns regarding a lack of monitoring were 
demonstrated in two ways by the participants, regarding both a lack of monitoring of clients and 
a lack of monitoring of facilities.  Participants described their belief that medication assisted 
treatment facilities do not monitor the clients receiving treatment, in particular in Methadone and 
Suboxone facilities.  The title One Flew Over the Cuckoo’s Nest was used to describe treatment, 
and referenced clients as “lining up at the window for their meds.”  The counselors perceived the 
agencies as having limited monitoring of their clients through a lack of counselor engagement.  
Participants used phrases such as “like a dispensary with, like, you go in, you get it, you go to 
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your groups, and you leave;” “you through the system and get you in and out;” and the doctor 
“just comes in and out, and meets with the clients once in a while;” and “they were like ‘you 
should probably go to therapy, too, but make sure you take your pills.’”  This lack of monitoring 
was described as a “system failure on our part if that’s the way it is.” 
While some of the participants expressed concern about a lack of monitoring of clients, 
others expressed concern over the lack of monitoring of the facilities themselves.  Participants 
demonstrated their concerns about the lack of regulation of the facilities by stating that 
medication assisted treatment “needs a lot of, like, being monitored heavily” and “they need 
more staff, you know, to help regulate,” and through the question, “who’s regulating the 
facilities?”  These thoughts demonstrate the lack of knowledge that the participants have 
regarding the strict oversight of medication assisted treatment providers by several governing 
bodies.  Medication assisted treatment is regulated by the Federal Drug Enforcement Agency 
(DEA), individual state drug and alcohol departments, individual counties, and insurance 
providers through both announced and unannounced site visits and audits. 
Implications of research question 2.  The participants’ perceptions of clients who use 
medication assisted treatment appear to affect their perception of the clients who choose this 
treatment option.  The predominant themes among the participants indicate their limited 
understanding and knowledge of medication assisted treatment.  The perception of Methadone 
has received attention in the literature and there is support for the belief that many individuals 
seek Methadone as a drug substitute and a crutch that does not permit individuals to fully recover 
from their addiction (Brown, Benn, & Jansen, 1975; Kayman, Goldstein, Deren, & Rosenblum, 
2006).  Many facets of society, including addiction counselors and clients, do not perceive 
medication assisted treatment as a legitimate treatment option for opioid dependence. As a result 
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of the negative perceptions surrounding medication assisted treatment, many clients feel 
ostracized by their families, friends, peers, and treatment providers, and this creates a barrier to 
effective treatment (Matusow, et al., 2013; Humphreys, Noke, & Moos, 1996; Conner & Rosen, 
2008; Kayman, Goldstein, Deren, & Rosenblum, 2006; Hunt, Lipton, Goldsmith, Strug, & 
Spunt, 1985-86).    
It is important to understand counseling students’ perceptions of medication assisted 
treatment in order to understand their potential thoughts, feelings, and responses towards the 
clients who use this treatment modality.  A study by Smye, Browne, Varcoe, and Josewski 
(2011) noted that the negative attitudes of providers towards the use of medications to treat 
opioid dependence have been identified as a potential barrier for treatment professionals.  From 
the perspective of cognitive behavioral theory, this study suggests that counselors’ perceptions of 
medication assisted treatment is stimulated by the quality and quantity of their experiences with 
MAT, and this  affects their perceptions of clients who use this treatment option.  This finding is 
consistent with the conclusions reached by Smye, et. al.  
Research Question #3 How do pre-professional counselor education experiences affect the 
attitudes and beliefs of counselors regarding the use of medication assisted treatments as a 
treatment option? 
Theme #13 limited exposure.   The participants in this study indicated that exposure to 
medication assisted treatment was limited.  Participants used phrases such as “snippets,” 
“touched on it,” and “briefly talked about it” to describe their exposure to medication assisted 
treatment in coursework.  Addictions class was identified as a course in which medication 
assisted treatment was “talked about.”  Their limited educational exposure to medication assisted 
treatment was demonstrated by phrases such as “briefly talked about it,” the professor would 
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“say it once or twice,” “went over it in a very cursory way,” and “I don’t think we get a lot of 
information.”  Participants discussed what was covered during such conversations with phrases 
including “opinions,” “pros/cons,” and “went over it in a very cursory way,” as well as saying,“I 
don’t think we get a lot of information” to describe their limited exposure.   
When asked if they thought it would be helpful to have exposure to medication assisted 
treatment in school, they stated it would.  The participants used phrases such as “I think it would 
be helpful,” “if there is still a way to meet CACREP requirements and put a little bit more on 
that, it would be helpful,” and suggested “classes or at least more focus on the drugs part of 
counseling” to indicate that they believed they would benefit from more exposure to medication 
assisted treatment in coursework.  
Theme #14  limited fieldwork experience.  In CACREP accredited counseling 
programs, fieldwork is a required component of formal education (Council for Accrediation of 
Counseling and Related Educational Programs, 2015).  Even if some students were not exposed 
to medication assisted treatment in classrooms, there was the potential for them to be exposed to 
it in their fieldwork experiences.  A study by Salyers, Ritchie, Cochrane, and Roseman (2006) 
found that 71% of respondents stated that between 11-50% of clients seen by their practicum 
students presented with substance abuse issues while 18% responded that half of the clients seen 
presented with substance abuse issues, and 64% reported that between 11-50% of their internship 
students worked in substance abuse facilities.    
Despite these statistics, most participants in this study denied having had exposure to 
clients on medication assisted treatment.  Participants stated, “I actually don’t think I have seen 
any clients that have been through an assisted,” “that is not something I ever had direct 
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experience, dealing with somebody,” and “[it’s] nothing I’ve come across” to demonstrate their 
lack of exposure to clients on medication assisted treatment.  A few participants stated they had 
had exposure to clients on “Methadone” but denied having had exposure to clients on other types 
of medication assisted treatment.  This lack of exposure to patients in their fieldwork is 
surprising considering that approximately 21 to 25% of all substance abuse users were involved 
in Methadone treatment, and an additional 32,000 individuals received Suboxone treatment for 
opioid dependence (Substance Abuse and Mental Health Services Administration, Center for 
Behavioral Health Statistics and Quality, 2013).   
Theme #15 lack of coursework.  Addictions is a very widespread and comprehensive 
topic, and all of the participants discussed a lack of coursework.  Participants discussed the pre-
requisites as a problem by stating: “I wish I had taken, you know [addictions], when I was in 
Practicum or Internship 1,” “I didn’t take addictions until after my practicum, so that didn’t 
really help because I didn’t have that class,” and “it wasn’t required before as a pre-req.”  One 
participant stated that taking Addictions before his fieldwork “would have helped me a lot.”   
Participants discussed their perceptions that addictions or medication assisted treatment 
could be specialized.  They used phrases such as: “it’s almost one of those, it’s an entire 
treatment modality;” “it’s almost as if it could have been its own course;” “I would say that 
[CACREP] requirements should be like, ummm, change them up a little bit. My gosh, allow for 
specialization for the area;” and “addictions could be a complete degree in itself.”    
A study by Lambie and Davis (2007) noted that most professional school counselors do 
not have the training and supervision to provide substance abuse counseling.  As a result, it is 
important that they increase their personal awareness and knowledge base regarding substance 
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abuse.  This was confirmed by one participant who stated that, as a school counseling student, “I 
wasn’t taught too much” and that “I didn’t take Addictions counseling.”  One participant stated 
that he felt “the addictions class would have helped.” 
CACREP requirements do not specifically require medication assisted treatment 
education as part of required coursework (Council for Accrediation of Counseling and Related 
Educational Programs, 2015).  Despite it not being required, it has been determined that either 
formal training related to medication assisted treatment or employment in a program where 
medication assisted treatment was used were the strongest predictors of knowledge of medication 
assisted therapy (Bride, Abraham, Kintzle, & Roman, 2013).    
Implications of research question 3. Several studies have correlated counselors’ levels 
of formal education to the acceptance of medication assisted treatment (Forman, Bovasso, & 
Woody, 2001; Rieckmann, Kovas, McFarland, & Abraham, 2011; Fitzgerald & McCarty, 2009; 
Humphreys, Noke, & Moos, 1996; Aletraris, Edmond, Paino, Fields, & Roman, 2016).  
According to a study by Bride, Abraham, Kintzle, and Roman (2013), the content of a 
counseling student’s education is an important factor in their formation of attitudes and beliefs.  
If a counselor is exposed to and encouraged to adopt evidence-based practices for the treatment 
of opioid addiction during training, it may increase their acceptance of harm reduction practices.  
A strong predictor of a counselor-in-training’s acurate knowledge of and attitudes toward 
medication assisted therapy is formal training specifically related to medication assisted 
treatment or employment in a program where medication assisted treatment is used (Forman, 
Bovasso, & Woody, 2001; Rieckmann, Kovas, McFarland, & Abraham, 2011; Fitzgerald & 
McCarty, 2009; Humphreys, Noke, & Moos, 1996).  
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The themes associated with this research question that were identified in this study 
appear to support the conclusion that limited knowledge and experience with medication assisted 
treatment limits the counselors’ understanding of its viability and effectiveness as a treatment 
option for opioid dependent clients.  
Since the participants reported having had limited exposure to medication asisted 
treatment during their formal education and training, it seems reasonable to conclude that there is 
a relationship between this lack of exposure and their demonstration of some misperceptions and 
distortions of this approach to treatment.  This  evidence suggests that the participants’  minimal 
exposure to and knowledge of medication assisted treatment contributes to their questioning of 
its effectivness and their having mixed feelings about its use as an effective  treatment modality 
for opioid addiction. 
Research Question #4 What other experiences influence the counselor-in-training’s 
development of attitudes and beliefs towards clients who use medication assisted treatments as a 
treatment option? 
Theme #16 family and/or friends in addiction.  Participants discussed personal 
experiences they had had in their lives regarding addictions.  Participants related their experience 
with addictions based on family and friends’ experiences, using phrases such as: “anyone I know 
personally has gone through AA or NA,”  “a brother that was a heroin addict,” “I know a good 
amount of people… that have had issues dealing with prescription drug abuse,” “experienced 
addictions in my family,” and “someone I care for, their brother is addicted to heroin.”  One 
participant stated that their experience had affected their perception of treatment because “that’s, 
you know, just the mindset I have had for recovery.”   
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The participants had previously expressed negative sentiments regarding clients who use 
medication assisted treatment and only one participant who had experience with family and/or 
friends in addiction perceived them as “trying to better themselves” by using medication assisted 
treatment.  This indicates that personal experience does not have an impact on their perceptions 
of medication assisted treatment, as they are more aware of the problems that the individuals 
experienced more so than the treatment modalities available.  
Theme #17 other people’s stories/perceptions. Some of the participants indicated that 
other people’s stories and perceptions had an effect on their perceptions of addictions and 
medication assisted treatment.  Participants described: “my father is a police officer and he was 
in Narcotics,” “most of my understanding of drug addiction came from kinda more my own 
readings,” “documentaries,” “own research,” and one noted a roommate who  “would always 
constantly talk about people who were prescribed that one.”      
Another participant “worked for two psychiatrists who were very anti-medication assisted 
treatment” and said that “I have heard very few good, good recovery stories about [it], from 
people who have worked in addictions.”  Despite the participant denying that these elements 
influenced their perceptions, this participant expressed negative themes about the use of 
medication assisted treatment as a treatment option.    
The statements of these participants indicate that, despite believing they are not affected 
by the perceptions of others, it appears that the perceptions of others do have a relationship to 
their negative perceptions about medication assisted treatment and the clients who use it.  
Additionally, if a counselor has not received formal education to suggest the contrary opinion 
about medication assisted treatment, they are likely to continue to be influenced by outside 
factors.  
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Theme #18 culture.  The effect of culture was discussed by some of the participants as 
something that affected their perceptions of medication assisted treatment as a treatment option.  
Participants stated: “I think a lot of my attitudes were based in, you know, family and the way I 
was socialized growing up;” “for most of my life, that, it has been ‘say no’ so ‘just say no to 
drugs’;’” and “[I] wasn’t really exposed to much information until I went to university.”  The 
culture in which these participants grew up appeared to have helped shape their perceptions of 
addictions and medication assisted treatment, as it reinforced abstinence-based treatment as the 
primary modality for treatment. 
Implications for research question 4.  This study explored how other experiences, 
outside of a counselor’s pre-professional experiences, affected a counseling student’s perception 
of medication assisted treatment.  These other experiences in a counseling student’s life appeared 
to affect their perception of medication assisted treatment as a treatment modality and their 
perception of the clients involved.  There appears to be a lack of literature concerning how pre-
professional or other personal experiences affect counseling students’ perceptions of medication 
assisted treatment.  This lack of literature in this area suggests a need for further study and 
exploration. 
All of the participants who identified the theme family and/or friends in addiction 
expressed negative sentiments regarding clients, and they acknowledged more understanding of 
the problem as it related to addiction than the treatment modalities available to treat opioid 
addictions. This indicates that personal experience does not have an impact on their perceptions 
of medication assisted treatment, as they are more aware of the problems that the individuals 
dealing with addiction experience, but less accurately informed about the treatment modalities 
available.   
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 Another theme identified was other people’s stories/perceptions.  Some of the 
participants discussed experiences with other’s perceptions or stories via either internship 
experience, documentaries, or family members’ jobs.  Each of these participants expressed 
several negative sentiments related to medication assisted treatment as a treatment modality.  
This indicates that, consciously or subconsciously, the participants may have been influenced by 
other people’s shared experiences and perceptions. 
Culture was another theme identified by participants as affecting their perceptions of 
medication assisted treatment.  Participants stated that they either had limited exposure to 
addictions and medication assisted treatment or were of the mindset that abstinence was the 
preferred approach to recovery, and noted that this belief was influenced by experiences with 
their family culture.  The participants’ personal experiences do not have an impact on their 
perception of medication assisted treatment, as they are more aware of the problems that the 
individuals experienced more so than the treatment modalities available.   
Research Question #5  “How do the attitudes and perceptions affect client care?”  
Theme #19 increased curiosity. Increased curiosity was a theme noted by the 
participants.  The participants stated that, when caring for clients, they would have increased 
curiosity regarding the use of the medication assisted treatment and in regard to the clients 
themselves.  Participants used phrases such as “curious how this actually works,” “get curious,”  
and “I do wonder if complete abstinence isn’t kind of a little tough for some people.”  Some 
participants expressed curiosity regarding the backgrounds of clients.  Participants questioned, 
“what’s their back stories?,” “wonder if, of all the ways to deal with addiction, why this one for 
this specific person?,” “are you taking more medication? What are you doing?,”  and that they 
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might “ask them [for]… more background information” and question “what is their background 
history?”   
In addition to curiosity regarding a client’s backstory, curiosity was also related to their 
motives for treatment: “do they go into being, like, ‘I want another addictions?’”  and said that 
“it would really be interesting to listen to their attitudes about it.”  
The participants’ curiosity appeared to be connected to their lack of knowledge regarding 
the subject.  The participants appeared to be seeking out the clients’ perceptions of medication 
assisted treatment in order gain additional information to form their own opinions and 
hypotheses regarding treatment.  
Theme #20 no difference.  Participants stated that they did not see a difference between 
clients who use mediation assisted treatment versus people with another type of addiction or with 
no addiction.  As a result, they did not feel their treatment would be any different.  Participants 
used phrases such as “I couldn’t say that I have seen the difference,” “not very much different,” 
“a human is a human,” and “here is another person and I don’t really think too much about the 
medication assisted treatment” when asked if they perceived a difference between clients who 
chose either modality.  One participant expressed concern that she did not want to be perceived 
as treating clients on medication assisted treatment differently: “I don’t want them to feel I am 
treating them differently whether they are on it or not.” 
Theme #21 increased counselor anxiety.  When caring for clients who use medication 
assisted treatment, participants noted increased anxiety when considering the potential for caring 
for clients who use medication assisted treatment.  Participants mainly expressed concern about 
helping a client continue to abuse medications, which was noted by phrases such as: “helping 
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someone abuse it,” “what if they’re mis-using it?,” “it’s scary to expose someone who is already 
in active addiction to another substance,” and “fear of the unknown.”  
One participant drew on her previous experience working with clients who use 
medication assisted treatment, noting that, “I would catch myself feeling very anxious” when 
providing care, while another stated that they “wouldn’t be relaxed” when providing care. 
Increased counselor anxiety demonstrated itself through fear and the unknown.  They 
expressed concerns about mis-use and being part of helping clients mis-use it either directly or 
indirectly. 
Theme #22 increased monitoring.  Participants suggested that they would undertake 
increased monitoring of clients who use medication assisted treatment.  Participants commented 
that they “did do searches” at their internship, focus on how the client was “feeling,” and “do 
self-checks,” as well as that they would “be more focused on that, those individuals rather than 
everyone else” and “keep a closer eye on them.”  
The increased monitoring appears to be related to the participants’ previous statements 
regarding mistrust of the clients and an increased anxiety related to counseling a client on 
medication assisted treatment.   
Implications for research question 5. Several studies have reported that the therapeutic 
relationship is a significant factor that has the potential to influence the efficacy of a treatment 
(Conner & Rosen, 2008; Hunt, Lipton, Goldsmith, Strug, & Spunt, 1985-86).  A common theme 
among the participants was “I don’t know” in regard to knowledge and experiences with 
medication assisted treatment, which appears to be connected to the theme of increased 
curiosity.  The participants identified the fact that they have limited knowledge of medication 
assisted treatment and “don’t know” enough about it.  The results of this study appear to indicate 
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that they had limited exposure, limited fieldwork experience, and a lack of coursework related to 
this approach, but remain curious about its effectiveness in treating opioid addiction.  As result, 
they might be inclined to be more curious about the clients they are treating and attempt to gain 
more insight into their histories and backgrounds as a way of learning about the clients and the 
potential effectiveness of MAT as part of their treatment modality.  The American Counseling 
Association Code of Ethics states that counselors only practice within their boundaries of 
competence as based on their education and training.  It is expected that, while working to learn 
skills in a new specialty area, counselors would seek education, training, and supervised 
experience in this area.  Thus, they may be inclined to be more careful about the treatment they 
provide (American Counseling Association, 2014). 
Another common theme for counselors-in-training was that they believed their 
perceptions of clients, and the care and treatment they would provide, would be no different for 
clients who chose to select MAT and for those who did not.  These participants believed 
medication assisted treatment is a “good thing.”  By believing that medication assisted treatment 
is positive and feeling they would not treat the clients any differently, the efficacy of treatment 
for clients who choose MAT is likely to be at least on par with the treatment efficacy seen with 
their clients who are not engaged in MAT.  
Increased counselor anxiety was another common theme.  This appeared to be significant 
and related to their attitudes of “I don’t know” regarding medication assisted treatment.  When a 
counselor has limited experience and knowledge of a subject, it is reasonable to assume that their 
anxiety will increase.  As a result, this anxiety might be the impetus for the counselor 
conforming to professional ethical guidelines, taking increased precautions to ensure that the 
care they provide their clients in MAT is consistent with the care they provide other clients.   
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As a result of their increased anxiety, some of the participants stated they would 
undertake increased monitoring of the clients as part of their care, which may suggest their 
increased professional care; however, it may also be related to their lack of trust in clients.  If a 
counselor mistrusts their client, they may be inclined to increase their monitoring.  According to 
Leach (2005), trust is an imporant component of the rapport between client and counselor.  If the 
rapport and thereuapitic relationship is harmed due to a lack of trust, it will ultimately affect 
client care.  
Research Question #6  How do the attitudes and perceptions affect professional career choices?   
Theme #23 not enough knowledge/unpreparedness. When asked about whether their 
education had prepared them to take a job as a counselor working in medication assisted 
treatment, the participants stated that they did not feel prepared.  The participants used phrases 
such as “I don’t feel I am completely trained,” “unethically prepared,” “not fully,” 
“underprepared,” “I could be more prepared,” and “I wouldn’t want to go in blind” when asked 
about their preparation for taking a related job.  According to Cellucci and Vik (2001), when 
indiviudals feel  unprepared to treat clients for substance use disorders, they hesitate to address 
the co-morbidity of mental health and substance abuse or they may avoid working with 
substance-abuse clients all together.   
Theme #24 lack of interest.  When asked about taking a job as a counselor working in 
medication assisted treatment, participants cited lack of interest as a reason for not taking such a 
job.  Participants commented: “I never really wanted to get into the whole, ahhhh, you know, 
drugs and psychiatry and all that;” “addictions like that might not be my favorite, umm, branch 
of counseling;” “I just really don’t want to work in addictions;” “no desire to work in 
addictions;” and “[it] does not appeal to me.” 
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When asked about taking a job as a counselor working in medication assisted treatment, 
some of the participants stated they would because of the employment options.  They used 
comments such as “I mean, I’d do it because it was a job;” “if I had no other options, I would 
take it;” and “if it is a good job” to indicate that they would take such a position not due to 
interest, but due to employment options.  
 Theme #25 fear.  Fear was expressed by some of the participants in regards to taking a 
position in medication assisted treatment.  Some of the participants indicated that this fear was 
related to their lack of exposure to medication assisted treatment in regard to fieldwork.  
Participants expressed their fear through phrases to suggest they would be “apprehensive about 
it,” “little apprehensive at first because I have never been in that type of environment,” and 
“would be kind of worried about taking that job.”  Participants related their fear back to their 
lack of experience by explaining that: “without experience you really can’t feel 100% 
comfortable.”  One participant also explained that he “would be kind of worried about taking that 
job” in part because he felt he had limited knowledge and felt unprepared by his educational 
experience.  
Implications of question 6.  This question was intended to explore how attitudes and 
perceptions toward MAT affect professional career choices.  When the data related to this 
question was analyzed, it was discovered that the participants’ lack of education, experience, and 
exposure to medicaiton assisted treatment affected their potential career choices.    
The predominant theme among the participants was that they felt they do not have 
enough knowledge and felt unprepared for a career in medication assisted treatment.  This is 
significant, as the participants also stated that their educational experience lacked coursework, 
lacked fieldwork, and provided limited exposure to medication assisted treatment.  According to 
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Cellucci and Vik (2001), when indiviudals feel  unprepared to treat clients for substance use 
disorders, they hesitant to address the co-morbidity of mental health and substance abuse or they 
may avoid working with substance-abuse clients all together.   
Lack of interest in addictions and/or medication assisted treatment was a common theme 
among the participants.  Participants stated that they had no interest in working with addictions.  
It is possible that their limited exposure to medication assisted treatment and addictions in 
general contributed to this lack of interest, as several of the participants indicted fear as a 
concern.  The participants appeared to be fearful of assisting in furthering their clients’ addiction 
and not having the knowledge or experience to appropriately treat clients in medication assisted 
treatment.  The theme of fear was another  potential reason they would be hesistant to consider a 
career working with clients in medication assisted treatment.  By failing to provide counselors, 
and especially counselors in training, with the knowledge of and experiences with clients in 
medication assisted treatment, we decrease the likelihood that students will choose addictions as 
a specialty or work with clients in medication assisted treatment as a long-term career choice.  
Implications for the Field 
This qualitative study provides an important contribution to the field.  As the opioid 
epidemic in the United States continues to increase and the use of medication assisted treatments 
is being included in more treatment protocols for the treatment of opioid dependence, it is 
important to understand how the next generation of counseling students perceive the use of 
medication assisted treatment.  It is important to understand how their professional education and 
experience affect their perceptions of clients and this modality, influence their career choices, 
and ultimately influence the care they provide to clients seeking treatment for their opioid 
addictions.     
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As several studies have indicated (Forman, Bovasso, & Woody, 2001; Rieckmann, 
Kovas, McFarland, & Abraham, 2011; Fitzgerald & McCarty, 2009; Humphreys, Noke, & 
Moos, 1996), the quality of experiences with MAT in a counselor’s formal education is related to 
their positive attitudes toward the use and acceptance of it as an efficacious treatment for opioid 
dependence.  The findings of this study, which are consistent with this literature, indicate that a 
counseling student’s lack of formal education in addictions, harm reduction, and specifically 
medicated assisted treatments, can distort and negatively affect their perception of this treatment 
modality.  While it may be premature to make significant changes in the curriculum and 
fieldwork requirements in counselor education programs, if future research supports this 
emerging opinion, then changes in training standards and practices will be warranted.  Counselor 
educators might begin this process by incorporating more systematic evaluations and analyses of 
the perceptions that current students in training have toward MAT and the clients who select it as 
part of their treatment protocol.  These results might provide a foundation for adjusting the pre-
professional training currently being provided.  
Counselor educators might also want to consider adding additional courses to their 
program to cover addictions-related material more specifically and more extensively.  Programs 
may also want to consider making an addictions course a pre-requisite to fieldwork experiences 
for counseling students.  These additional courses, or modules in existing courses, could provide 
opportunities for counselor educators to address medication assisted treatment modalities 
specifically in courses or in supervision.  By spending additional time on these harm reduction 
topics, counseling students would be better prepared to enter the field and might be more open to 
working with clients in medication assisted treatment as a career choice. 
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In addition, counselor educators and professional counselors should be encouraged to 
conduct research to expand our knowledge and understanding of medication assisted treatments. 
The results of this research could be useful in documenting how to modify training experiences 
related to the efficacy of MAT.  Furthermore, the results of this research agenda might produce 
results to influence the training standards the counselor education programs must meet if they are 
to be accredited by Council for Accreditation of Counseling and Related Educational Programs 
(CACREP).  Finally, as the evidence linking effective care to the quality of treatment provided 
and the expanding demand for appropriately trained counselors grows along with the opioid 
epidemic, counselor educators can use the data generated by studies of this kind to encourage 
universities to make resources available to encourage this increased training focus on medication 
assisted treatment.   
Supervisors who work in programs where medication assisted treatment is a potential and 
viable option for the treatment of addictions may also need to consider being mindful of their 
new counselors’ educational backgrounds.  By understanding the specific educational 
experiences that novice counselors bring into the workplace, they may be better able to offer 
continuing professional education and training to help their employees develop a more accurate 
understanding of this approach to treatment.  Additionally, they may want to consider being 
more observant of their supervisees’ attitudes and beliefs towards this treatment modality as one 
way of monitoring any potential inappropriate or negative behaviors in the treatment process or 
in their relationship with clients in treatment.  By proactively exploring a counselor’s knowledge 
and experience with MAT, the supervisor may be more likely to identify potentially inaccurate 
perceptions which might support negative attitudes and beliefs which, in turn, may produce 
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behaviors that threaten the quality of care provided for a client as well as the counselor’s job 
satisfaction. 
Finally, professional counselors must assume their professional and ethical responsibility 
to seek the professional development they need to maintain their effectiveness.  According to the 
American Counseling Association Code of Ethics, counselors should only practice within their 
boundaries of competence, which are based on their education and training (American 
Counseling Association, 2014).  These ethical standards require that, when a counselor begins 
work in a new area, they are expected to learn skills in that new specialty area by seeking 
education, training, and supervised experience in the area (American Counseling Association, 
2014).  This might be especially significant for novice counselors.    
Implications for Future Research 
The data collected from this qualitative research study indicate the potential need for 
research in several related areas.  Many of the partipant statements support themes related to a 
lack of knowledge for and experiences with medication assisted treatment.  It would be 
beneificial to determine if this result is similar across all CACREP accredited schools, and how 
this compares to non-CACREP accredited schools.  A possible research question would be,  “Are 
there differences in addictions education between CACREP-accredited schools vs. non-CACREP 
accredited schools?”  A related question would be, “Are there differences in the perceptions of 
clients who use medication assisted treatment concering students in CACREP-accredited schools 
vs. non-CACREP accredited schools?”  Since this study was limited to one CACREP university 
during a particular time period, another possible area of study would be to replicate the study at 
other CACREP universities in different  geographic regions to see if similar results would be 
obtained.  
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It would also be beneficial to replicate this study with participants from programs that 
have an addictions specific track or major.  A possible research question to explore is, “Are  
there differences in the students’ perceptions of medication assisted treatment between 
counseling programs that offer an addictions major and those programs that do not offer an 
addictions major?” 
A  predominant experience reported in this study was a lack of exposure to medication 
assisted treatment in coursework and fieldwork experiences.  Future investigations are needed to 
describe the outcomes of increased exposure to medication assisted treatment through 
coursework and field experiences.  Investigations into the relationship between course coverage 
of medication assistant treatments and the students’ perceptions, beliefs, and attitudes toward 
MAT and clients who choose this treatment need to be reported.  Similar studies of field 
placement exposure to MAT and the resulting outcomes are also needed.  These studies  would 
add to our understanding of how these variables contribute to the development of the counselor-
in-training.  Specifically, these studies would help us understand if and how these curriculum 
requirements could change the attitudes and beliefs of counseling students towards the use of 
medication assisted treatment as a treatment for opioid addictions.   
Another theme that arose in this study was how a counselor-in-training’s personal 
experience with addictions affects their perception of addictions treatment in general.  There 
appears to be a lack of research regarding how family or friends’ in recovery or other personal 
experiences affect their perceptions.  This leads to two possible questions that could guide future 
research: “How does experiece with family and/or friends in addiction affect perception of 
medication treatment?” and “How do the cultural experiences and awareness of the counselor in 
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training affect their perception of addictions treatment, MAT, and the clients who choose harm 
reduction approaches such as MAT?”  
While several negative themes and perceptions emerged  during this study, only one 
resulting theme was positive, this being “trying to better themselves”.  One potential area of 
further research would be to address the question, “Does exposure to medication assisted 
treatment and harm reducation practices during formal counselor education training lead to more 
positive perceptions of  MAT and the clients who use this modality?”  Another possible research 
question would be, “Does placement in a harm reduction treatment facility during fieldwork lead 
to more positive perceptions of the treatment modality and the clients?” 
Several of the themes constructed in this study presented with similarities.  This, along 
with the unique perspective on the data provided by the researcher, could indicate the possibility 
that future replication of this research might yield broader or larger themes that encompass the 
data used to form multiple themes in this study.  Replication of this study would provide the 
opportunity to compare the current construction of themes and determine if similar themes would 
be produced, as well as determine any convergence of the data into the same, fewer, or more 
themes.  For example, a future researcher may choose to combine the data that supported the 
development of the themes Limited Expsosure, Limited Fieldwork Experience, and Lack of 
Coursework into a mega-theme that explains how these data are related to another mega-theme 
that combines data used to support the themes of  I don’t know and Not enough 
knowledge/unpreparedness, This research could describe relationships between these themes and 
variables like the university curriculum, field experiences, and personal experiences related to 
addictions, and specifically harm reduction approaches to treatment, such as MAT.  
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Finally, in doing this study, I became aware that the 2014 American Counseling 
Association’s Code of Ethics requiring counselors to work within their scope of training and  
outlining the professional responsibility to seek professional development to ensure that 
counselors are able to work effectively with their clients might provide a reason for novice 
counselors who lack training and experience in working with harm reduction strategies to avoid 
working with clients in MAT.  Even more fundamental to our understanding of how novice 
counselors’ may feel about working with clients in MAT is the finding that suggests that they 
consider MAT to be an unethical approach to the treatment of addictions because it violates our 
professional values of nonmalfesence and benificence.  The ACA Code of Ethics states that 
counselors “act to avoid harming their clients” and, if a counselor perceives medication assisted 
treatment as harmful, they may avoid it because they believe they are violating their professional 
code of ethics (American Counseling Association, 2014).  In this study, these concerns were 
revealed in comments related to novice counselors making career decisions and not being 
attracted to positions working with clients in medication assisted treatment.  Future research is 
needed to examine the relationship between their ethical concerns regarding the use of 
medication assisted treatment with opioid dependent individuals and their career decision-
making process.  Potential research questions might include “What ethical concerns do you have 
regarding the use of medication assisted treatment?” and “How do these ethical concerns 
influence your career decision-making?”  
Limitations 
 As with any study, this study has several limitations.  This research was exploratory, and 
it provided descriptions of the counseling students’ attitudes, beliefs, and perceptions of 
medication assisted treatment.  When considering the findings of this study, one limitation that 
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needs to be considered is purposive sampling, and especially the decision to select all of the 
participants from the same counseling program.  The data reflects the perspectives of this 
purposive sample of individuals who volunteered and agreed to share their experiences.  One 
cannot assume that their perspectives and experiences are representative of all counseling 
students in their program, nor those who may be currently studying in other counseling 
programs. 
 Purposeful sampling is not intended to support broad generalizations, but instead to 
provide information-rich cases related to the phenomenon of interest (Palinkas, et al., 2015).  In 
this study, I attempted to provide vivid descriptions of the particular details of the key 
informants’ characteristics and circumstances in order to encourage analysis of these conditions 
and findings that would allow considerations of transferability (Yin, 2016).  Both are valued 
puposes of qualitative research, but are recognizably different than the stasticially and 
probability-based generalization common in quantitative research.  Readers of this study will 
need to judge for themselves the appropriateness of applying the findings to another sample 
profile, setting, or case. 
 While I attempted to bracket my perspective on this phenomenon and keep it separate 
from the data provided by the informants through the use of journaling and field notes, 
phenomenological descriptions are always limited by a researcher’s orientation, interest, 
questions, and circumstances.  It is possible that, despite my best attempts at bracketing the data, 
some of my personal beliefs could have potentially affected the data, leading to another potential 
limitation of the study.  
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Conclusion 
The purpose of this qualitative study was to examine, describe, and understand how the 
attitudes and beliefs of counseling students regarding the use of medication assisted treatments 
develop, and how these attitudes and beliefs may affect client care and professional career 
choices.  This study examined how their professional counselor education experiences played a 
role in the formation/development of these attitudes and beliefs. 
The data from six key informants was collected through individual, semi-structured 
interviews.  Based on the analysis of their attitudes, beliefs, and experiences, a total of twenty-
five themes emerged in relation to the six research questions posed in this study.  These themes 
revealed that counseling students may have negative attitudes and beliefs towards clients who 
use medication assisted treatment options.  While these negative attitudes were present, some of 
the informants provided data to suggest that they were able to identify positive aspects and the 
utility of this approach to opioid addictions treatment.  Specifically, there was some recognition 
that clients were able to use medication assisted treatment to support their recovery.  The 
participants’ perceptions of clients who choose medication assisted treatment was developed 
during their professional counselor education experience and their personal experiences.   
One factor that appears to be related to the development of attitudes toward medication 
assisted treatment is the limited exposure to this treatment modality provided during the 
participants’ formal counselor education and training.  This lack of knowledge and experience 
resulted in the participants having a limited understanding of the modality, and ultimately the 
clients who use it.  In this study, this situation demonstrated  the potential to cause 
misinfomration and misperceptions to develop.  This finding is consistent with prior research 
suggesting that the acceptance of medication assisted treatment has been correlated to a 
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counselor’s level of formal education (Forman, Bovasso, & Woody, 2001; Rieckmann, Kovas, 
McFarland, & Abraham, 2011; Fitzgerald & McCarty, 2009; Humphreys, Noke, & Moos, 1996).  
Additionally, it has been found that counselors who are exposed to and encouraged to adopt 
evidence based practices during their academic training are at an increased likelihood of 
accepting harm reduction practices (Bride, Abraham, Kintzle, & Roman, 2013).   
 Other experiences in a counseling student’s life appear to affect their perceptions of 
medication assisted treatment as an effective and legitimate treatment modality, as well as their 
negative perceptions of the associated clients.  The participants’ appeared to acknowledge that 
ineffective client care was related in part to their attitudes and beliefs about MAT.  The concerns 
of counselors-in-training regarding their ability to provide quality care appeared to be related to 
the participants’ concerns over their lack of knowledge and their limited educational experiences 
with medication assisted treatment.  As a result, participants seemed to identify that it is this lack 
of knowledge and experience that also has an influence on their career choices.  
This study provided a unique analysis of how counseling students’ pre-professional 
education and other personal experiences affect their perceptions of medication assisted 
treatment and clients who chose medication assisted treatment to support their recovery.  In this 
research, I examined the professional counselor educational experience and how students’ lack 
of knowledge may be a significant or important factor in their development of perceptions and 
attitudes toward the practice of MAT.  The intent of this study was to provide counselor 
educators with a richer and thicker description of this phenomenon of how the education they 
provide may shape the attitudes and beliefs of  their students in relationship to MAT and clients 
who elect to utilize this treatment approach.  The hope of this researcher is that the results of this 
study will stimulate additional research in this area and encourage counselor educators and the 
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professional associations responsible for defining training standards, including The Council for 
Accreditation of Counseling & Related Educational Programs (CACREP), to reflect on how the 
educational content and associated field experiences provided to counseling students can be 
evaluataed and adjusted to better prepare students to address clients with opioid dependence.  
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Appendix  A   
Email invitation  
  
Dear Counseling Student,  
 
My name is Bethany Ackerman and I am Doctoral Candidate in Duquesne University’s 
Counselor Education and Supervision Program.  I am conducting my dissertation research on 
counseling students’ attitudes and beliefs towards the use of the medication assisted therapy for 
the treatment of opioid dependence.  I am looking for students who are willing to participate in 
an initial 30-60 minute individual interview.  The total time commitment should not exceed 1 
hours.  You will be compensated with a $10 Starbucks gift card for the interview.  
 
In order to be eligible to participate, you must be currently enrolled in a CACREP accredited 
counseling program at the Master’s level.  Also, you must have completed at least one semester 
of your fieldwork.  
 
If you have any questions or are interested in participating please contact me at 
ackermanb@duq.edu or xxx-xxx-xxxx.   If you are interested in participating, please include 
your name, email address, and telephone number so that I may contact you.  
 
This study has been approved by Duquesne University Institutional Review Board. 
 
Thank you in advance.  
 
Sincerely,  
Bethany L. Ackerman, MS, LPC, NCC  
Doctoral Candidate   
Duquesne University School of Education 
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DUQUESNE UNIVERSITY 
600 FORBES AVENUE      PITTSBURGH, PA 15282 
 
 
 
CONSENT TO PARTICIPATE IN A RESEARCH STUDY 
 
 
TITLE:  A Qualitative Study of Counseling Students’ Attitudes 
Toward the Use of Medicated Assisted Treatments in the 
Treatment of Opioid Dependent Clients 
 
INVESTIGATOR:   Bethany L. Ackerman, MS, LPC, NCC   
      Doctoral Candidate 
Duquesne University School of Education   
Pittsburgh, PA 15282 
Phone:  xxx-xxx-xxxx 
Email:  ackermanb@duq.edu 
  
ADVISOR: (if applicable)  William Casile, Ph.D. 
     Duquesne University School of Education 
     Pittsburgh, PA 15282 
     Phone:  412-396-6112 
     Email: casile@duq.edu 
      
 
SOURCE OF SUPPORT: This study is being performed as partial fulfillment of the 
requirements for the doctoral degree in 
Counselor Education and Supervision at Duquesne 
University. 
 
PURPOSE: You are being asked to participate in a research project 
investigating the attitudes and beliefs towards the use of 
medication assisted treatment in the treatment of Opioid 
Dependent clients.  
 
 In order to qualify for participation, you must be enrolled in 
a CACREP accredited counseling education program and 
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also have completed at least one semester of your fieldwork 
experience.  
 
PARTICIPANT 
PROCEDURES:  To participate in this study, you will be asked to 
complete a short demographic questionnaire and  
participate in a individual interview about your thoughts, 
feelings, and beliefs about the use of medication assisted 
treatment as a treatment for opioid dependent clients.  The 
interview will ask about your knowledge of medication 
assisted treatment, your educational history in regards to 
medication assisted treatment, your experience with using 
medication assisted treatment as a treatment option, and 
your perceptions of individuals who use medication 
assisted treatment as a treatment option. These interviews 
will be audio recorded, but any information that identifies 
you will be removed when the recordings are transcribed.  
It is estimated the total time of involvement for the 
individual interview will be 30-60 minutes.  The total 
involvement time of this study should not exceed 1 hours. 
  
  These are the only requests that will be made of you. 
 
RISKS AND BENEFITS: Information gathered through this research project will add 
to our understanding of how education and experiences 
may affect a counseling student’s attitudes and beliefs 
towards the use of medication assisted treatments as a 
treatment option for opioid dependent individuals.  In an 
interview setting, it is impossible to predict all the topics 
may arise during the course of the individual interview.  
Topics discussed will include, but are not limited to, your 
knowledge of medication assisted treatment, your 
educational history in regards to harm reduction practices, 
in particular medication assisted treatment, your 
experiences with medication assisted treatment as a 
treatment option, and your perceptions of individuals who 
use medication assisted treatment as a treatment options.  It 
is likely that these topics are discussed within the 
counseling profession and within the education community, 
so we do not expect any risk from such conversations.  A 
trained counselor will be conducting the individual 
interview and will lead the discussion to minimize risks to 
participants.   
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COMPENSATION: At the end of the individual interview each participant will 
be given a $10 Starbucks gift card for their participation in 
each interview.  Total compensation will not exceed $10 
for participation in this study.     
 
Participation in the project will require no monetary cost to 
you.   
 
CONFIDENTIALITY: Your participation in this study and any personal information 
that you provide will be kept confidential at all times and to 
every extent possible.  
 
Your name will never appear on any survey or research 
instruments.  All written and electronic forms and study 
materials will be kept secure. Your response(s) will only 
appear in statistical or narrative data summaries.  Any study 
materials with personal identifying information will be 
maintained for three years after the completion of the 
research and then destroyed. 
 
The audiotapes, field notes, transcripts, participant codes, and 
all data backup files will be kept in a secure safe.  Once the 
audiotapes are transcribed, they will be deleted.    The 
researcher will keep the field notes and transcripts for no less 
than 3 years from the completion of the study.    
.  
 
RIGHT TO WITHDRAW: You are under no obligation to participate in this study.  
You are free to withdraw your consent to participate at any 
time by notifying the researcher in writing of your desire to 
withdrawal consent to participate.  Any data obtained up to 
that point will not be used. 
 
SUMMARY OF RESULTS: A summary of the results of this research will be supplied 
to you, at no cost, upon request. 
 
VOLUNTARY CONSENT: I have read the above statements and understand what is 
being requested of me. I also understand that my 
participation is voluntary and that I am free to withdraw my 
consent at any time, for any reason. On these terms, I 
certify that I am willing to participate in this research 
project. 
 
 I understand that should I have any further questions about 
my participation in this study, I may call Bethany 
Ackerman, MS, LPC, NCC at xxx-xxx-xxxx or Dr. 
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William Casile at 412-396-6112.  Should I have questions 
regarding protection of human subject issues, I may call Dr. 
David L. Delmonico, Chair of the Duquesne University 
Institutional Review Board, at 412.396.1886.   
 
 
 
 
_________________________________________    __________________  
Participant's Signature      Date 
 
 
_________________________________________    __________________ 
Researcher's Signature      Date 
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Appendix C         Identification Code: _____________ 
Questionnaire 
Please complete the following information and bring to the individual interview. 
1.  Age:  ___________ 
2. Telephone Number: _______________________  
a. Can a message be left at this number?  Yes or No 
3. Program (Please circle): 
a. Masters in Clinical Mental Health Counseling 
b. Masters in School Counseling 
c. Masters in Marriage, Couple, and Family Counseling 
d. Other (Please Specify): _____________________________________ 
4. Are you Part-time or Full- time? ________________ 
5. How far along are you in your counseling education program? 
a. ≤ 1 year 
b. ≤ 2 years 
c. ≤ 3 years 
d. Other (Please Specify):___________________ 
6. Did you transfer from another program?  Yes or NO 
a. If yes, was that school CACREP accredited?   Yes or No 
7. Do you have any work experience in an agency or program where clients receive 
addictions treatment?   Yes or No 
a. If yes, what is the name of the program? _____________________________ 
8. How many addiction counseling classes have you completed? ______________ 
9. What were the names of these courses?  _______________________________________ 
             _______________________________________________________________________ 
10. Did the courses discuss medication assisted treatment?  Yes or No 
11.   Have you completed your: 
a. Practicum?      Yes or No 
b. Internship I?    Yes or No 
c. Internship II ?  Yes or No 
d. Do you have any professional counseling experience?  Yes or No 
12. Have you worked with opioid dependent individuals in practicum, internship, or 
professional experience?   Yes or No 
a. If yes, how much experience do you have?    
________ number of clients seen         _________ months of treatment 
 
13.  Have you worked with individuals in medication assisted treatment in practicum, 
internship, or in any other professional experience?   Yes or No 
a. If yes, how much experience do you have?   
________ number of clients seen         _________ months of treatment 
 
Thank you for taking the time to complete this questionnaire. 
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Appendix D 
Semi-structured interview questions 
 
The following questions will be used to structure each individual interview: 
1. What do you know about medication assisted treatment?  
2. What did you learn about medication assisted treatment in school? 
3. What are your thoughts regarding the use of medicated assisted treatment as a 
treatment option? 
4. What comes to mind when you hear medicated assisted treatment? 
5. What has your experience been with patients who use medication assisted treatment?  
6. How do you perceive individuals who chose this treatment option? 
7. Two of the more common medicated assisted treatment options are methadone and 
Suboxone, what are your attitudes towards these the use of these medicated assisted 
treatment options? 
8. What are your feelings about counseling a patient who uses medication assisted 
treatment? 
9. What would your thoughts be in regards to taking a position as a counselor treating 
patients who use medicated assisted as a treatment option for opioid dependence? 
10. How do you feel your educational experience has prepared you for a possible job as a 
counselor working with patients who use medicated assisted treatment?   
11. Were you exposed to patients on medicated assisted treatment in your fieldwork? 
12. If you felt that it hasn’t prepared you, what do you believe may have helped prepare 
you? 
13. What should I have asked you that I didn’t that would help me better understand your 
beliefs and attitudes regarding the use of medicated assisted treatment as a treatment 
option? 
 
